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Abstract 
Evidence based medicine (EBM) is defined as the use of best available evidence for 
decision making, and it has been the predominant paradigm in clinical decision 
making for the last 20 years. EBM requires evidence from multiple sources to be 
combined, as published results may not be directly applicable to individual patients. 
For example, randomised controlled trials (RCT) often exclude patients with 
comorbidities, so a clinician has to combine the results of the RCT with evidence 
about comorbidities using his clinical knowledge of how disease, treatment and 
comorbidities interact with each other. Bayesian networks (BN) are well suited for 
assisting clinicians making evidence-based decisions as they can combine 
knowledge, data and other sources of evidence. The graphical structure of BN is 
suitable for representing knowledge about the mechanisms linking diseases, 
treatments and comorbidities and the strength of relations in this structure can be 
learned from data and published results. However, there is still a lack of techniques 
that systematically use knowledge, data and published results together to build BNs. 
This thesis advances techniques for using knowledge, data and published results to 
develop and refine BNs for assisting clinical decision-making. In particular, the 
thesis presents four novel contributions. First, it proposes a method of combining 
knowledge and data to build BNs that reason in a way that is consistent with 
knowledge and data by allowing the BN model to include variables that cannot be 
measured directly. Second, it proposes techniques to build BNs that provide decision 
support by combining the evidence from meta-analysis of published studies with 
clinical knowledge and data. Third, it presents an evidence framework that 
supplements clinical BNs by representing the description and source of medical 
evidence supporting each element of a BN. Fourth, it proposes a knowledge 
engineering method for abstracting a BN structure by showing how each abstraction 
operation changes knowledge encoded in the structure. These novel techniques are 
illustrated by a clinical case-study in trauma-care. The aim of the case-study is to 
provide decision support in treatment of mangled extremities by using clinical 
expertise, data and published evidence about the subject. The case study is done in 
collaboration with the trauma unit of the Royal London Hospital.  
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Introduction 
Evidence based medicine (EBM) has been the predominant paradigm in medical 
decision making for the last 20 years (Evidence-Based Medicine Working Group, 
1992; Sackett et al., 1996; Straus et al., 2005). The underlying idea of EBM is to 
search and employ the best available evidence to make clinical decisions. Several 
ranking systems have been proposed to weigh the evidence when multiple sources of 
evidence is available (Guyatt et al., 2008; Hadorn et al., 1996; Harbour and Miller, 
2001). These systems rank the evidence according to the way it is collected: the 
evidence from randomised controlled trials (RCT) has higher ranks than the evidence 
from datasets, and the evidence from expert opinion have the lowest ranks. However, 
a study with lower rank must never be ignored unless a higher rank study targets 
exactly the same population with exactly the same inclusion criteria (Marshall, 2006; 
Rawlins, 2008). RCTs provide the highest ranked evidence as they are powerful 
tools for understanding treatment effects by eliminating confounding and biases. The 
absence of RCTs, however, is not the same as the absence of evidence (Sackett et al., 
1996; Smith and Pell, 2003). Evidence from clinical expertise and datasets should be 
used even when RCTs are available since: 
1. It is not possible to conduct RCTs for many clinical problems because of 
ethical or practical difficulties (Horton, 2000; Rawlins, 2008; Sackett et al., 
1996). For example, although a prosthesis following a limb amputation can 
be beneficial for patients with painful or non-functioning limbs, it is ethically 
impossible to conduct an RCT for studying the benefits and disadvantages of 
this intervention. Horton (2000) describes the time and cost challenges of 
trialing the clinical use of coronary stents, with the results that several types 
of these stents are commonly used without any RCTs supporting their use. 
18 
 
Clinicians evaluated the benefits and risks of the coronary stents based on 
their expertise and the information from medical datasets.  
2. The results from RCTs often cannot be generalised to the individual patients 
treated by clinicians (Marshall, 2006). Bradford Hill, the architect of RCTs, 
notes the issues about generalisability: “it is wise to limit the questions 
strictly to a few and to be absolutely precise upon those few. The loss in so 
doing lies, of course, in the fact that the answers are limited to very specific 
questions and clearly cannot be generalised upon outside their fields.” (Hill, 
1951). RCT studies are designed with strict inclusion criteria to observe the 
effects in less time, and to decrease the already high costs (Rawlins, 2008). 
For example, as comorbidities can interact with treatment effects, patients 
with comorbidities are often excluded from RCTs to observe the effects in 
less time and with fewer patients. Individual patients, however, can have 
comorbidities and thus the result of such RCTs may not be valid for them. 
Moreover, RCTs about the same subject can have conflicting results because 
of the differences in their inclusion criteria (Marshall, 2006; Rawlins, 2008).  
In order to make evidence-based decisions for individual patients, all of the relevant 
evidence about the disease, treatment options, and background factors of the patient 
must be taken into account, and combined, whether they are RCT or not. Clinicians 
are an essential part of this: the evidence can be combined for individual patients 
only by using 1) the clinical opinion about the similarities and differences between 
an individual patient and the available evidence, 2) the clinical expertise about the 
disease mechanisms of how different evidence relates to each other (Guyatt et al., 
2004; Haynes et al., 2002; Marshall, 2006; Sackett et al., 1996). 
There are, however, significant challenges for clinicians to apply EBM in daily 
practice. The time that clinicians can spare for reviewing evidence keeps getting 
smaller as their workload continues to increase (Royal College of Nursing, 2012; 
Smith, 2013). Even though technologies, such as PubMed and MeSH, has made it 
easier to access publication, identifying the relevant evidence is often time 
consuming. The ever increasing number of medical journals and publications makes 
this even more challenging (Alper et al., 2004; Haynes, 1993). Moreover, combining 
19 
 
the results of the related studies can be both mathematically challenging and time 
consuming.  
Evidence can potentially be encoded in quantitative models, which can then make 
mathematically correct predictions for individual patients. For example, a model that 
combines the separate pieces of evidence regarding treatment and comorbidity 
outcomes can make predictions for the individual patients who have both of these 
factors. In order to combine such evidence, a quantitative model must be capable of 
modelling the clinical knowledge about the mechanisms between the treatment, 
comorbidity and outcome. Most traditional modelling approaches, however, cannot 
represent the clinical knowledge about disease mechanisms especially when the 
mechanisms are complicated containing multiple and interrelated pathways (Buchan 
et al., 2009). For example, statistical tools, such as meta-analysis, can effectively 
combine the evidence about simple relations but they are not well suited for 
integrating knowledge about the complicated mechanistic relations from clinicians.   
A Bayesian network (BN) is a probabilistic graphical model that is composed of a 
graphical structure that represents the relations between the variables, and a set of 
parameters that defines the strength of these relations. A BN can be used to make 
probabilistic inferences given the information observed. BNs offer a convenient and 
powerful approach for providing decision support based on knowledge and data. The 
graphical structure of the BN is well suited for representing knowledge about the 
disease mechanisms and clinical pathways. Evidence, from RCTs, data and clinical 
opinion, can be combined to learn the strength of relations in this structure. As a 
result of these unique features, BNs offer a powerful way of providing evidence-
based decision support for individual patients. Moreover, the reasoning mechanism 
and predictions of BNs can be presented to clinicians as they have a graphical 
structure suited for representing knowledge.  
BNs for EBM, however, cannot be built automatically from data. Clinicians must be 
closely involved in various stages of the modelling to identify the related evidence 
and to provide clinical knowledge about the mechanistic relations. Although several 
knowledge engineering methodologies exists (Cano et al., 2011; Flores et al., 2011; 
Helsper and van Der Gaag, 2007; Laskey and Mahoney, 2000; Neil et al., 2000), 
20 
 
there are still many issues in BN development that need to be addressed with 
methods that systematically combine knowledge and evidence.  
Another challenge in applying BNs for EBM is to present the evidence behind the 
BNs. Many publications do not give a thorough description of the BN structure even 
when the BN is based on extensive clinical knowledge (for examples of inadequately 
described knowledge-based BNs see Ahmed et al., 2009; Burnside et al., 2006; 
Onisko et al., 1998; Wasyluk et al., 2001). This makes it difficult, if not impossible, 
to understand the evidence supporting the BN and its derivation steps.  
1.1 Research Objectives 
The primary objective of this thesis is to provide practical tools that combine 
evidence to provide decision support for EBM. The secondary research objectives 
that contribute to the primary objective are: 
1. To show that it is possible to build decision support models that are 
consistent with the best available evidence by combining clinical knowledge 
with data. The observed data is more useful when it is analysed consistent 
with clinical knowledge.  
2. To show that it is possible to provide clinical decision support by combining 
the evidence from systematic reviews that is pooled by meta-analysis with 
clinical knowledge and data about the domain.  
3. To show how a practical decision support model can be derived through a 
series of simplifications without losing the link between the simplified 
model and underlying domain knowledge. 
4. To represent both supporting and conflicting clinical evidence about the 
important clinical factors and relations involved in decision making whether 
or not they are included in the decision support model. 
The novel contributions are illustrated by a case study about the treatment of 
mangled extremities. In an attempt to provide decision support for this treatment, we 
propose two BNs that are developed by combining clinical knowledge, previous 
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research and data about the domain. We examine systematic ways of using different 
sources of evidence in BN development, and presenting the evidence to the user. 
The case-study was done in collaboration with the trauma sciences unit of the Royal 
London Hospital (RLH). The RLH provided the clinical expertise and patient 
datasets that are used throughout the thesis. The AgenaRisk software was used for 
building and calculating the BNs models presented in this thesis (Agena Ltd, 2013). 
1.2 Structure of the Thesis 
Chapter 2 presents an introduction to BNs and their conditional independence (CI) 
properties. The introduction is followed by a review of the existing methods for 
building BNs from knowledge and data. The BN properties presented in this chapter 
are necessary to follow the methodologies presented in Chapters 5 – 8. 
Chapter 3 examines the potential benefits of quantitative models in medical and 
surgical decision making. It reviews the existing approaches for developing medical 
decision support models, and investigates why some models are not being adopted 
by clinicians.  
Chapter 4 introduces the trauma case study and reviews the previous models that 
have been developed for this domain. This chapter examines the decision making in 
mangled extremity treatment, and discusses the challenges of building useful 
decision support models for the domain. Finally, this chapter gives an overview of 
Chapters 5 – 8, with a brief discussion of how these chapters address the challenges. 
Chapter 5 proposes a methodology of combining knowledge and data to build BNs 
that reason in a way that is consistent with knowledge and data by allowing the BN 
model to include variables that cannot be measured directly. The methodology is 
illustrated by a BN that is used to provide decision in mangled extremity treatment 
by predicting a potentially fatal physiological disorder in early stages of the 
treatment. Several variables in this BN, including the variable indicating the state of 
the physiological disorder, cannot be directly measured and thus they are not present 
in the dataset. 
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Chapter 6 proposes a methodology of building decision support BNs by combining 
the results of systematic reviews and meta-analyses with knowledge and data. The 
methodology is illustrated by a BN that predicts the short-term – viability – 
outcomes of the treatment of mangled extremities. A systematic review and meta-
analysis have been conducted to collect information about the factors affecting this 
treatment.  
Chapter 7 proposes a knowledge engineering methodology to derive a BN structure 
through a series of simplifications. The proposed methodology shows how each 
simplification step affects the knowledge encoded in the BN.   
Chapter 8 proposes a framework to represent clinical evidence behind BNs. The 
evidence framework is able to organise and present both conflicting and supporting 
evidence related to fragments, variables and relations in a BN. 
Chapter 9 summarises the novel contributions of the thesis, and discusses the future 
directions of research. 
1.3 Publications and Awards 
This section shows a list of the publications, conference presentations and awards 
that are based on this thesis. 
Publications 
1. Yet B, Marsh DWR (2014) “Compatible and Incompatible Abstractions in 
Bayesian Networks” Knowledge-Based Systems. DOI: 10.1016/j.knosys. 
2014.02.020 
2. Yet B, Perkins ZB, Fenton NE, Tai N, Marsh DWR (2013) “Not Just Data: A 
Method for Improving Prediction with Knowledge” Journal of Biomedical 
Informatics. DOI: 10.1016/j.jbi.2013.10.012 
3. Yet B, Marsh DWR, Perkins ZB, Tai N, Fenton NE (2013) “Predicting 
Latent Variables with Knowledge and Data: A Case Study in Trauma Care” 
29th Conference on Uncertainty in Artificial Intelligence (UAI-13) 
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Applications Workshop: Part-1 Big Data Meets Complex Models, Bellevue 
Washington, USA, 11-15 July, p.49 
4. Perkins ZB, Yet B, Glasgow S, Brohi K, Marsh DWR, Tai N (2013) “Early 
Prediction of Acute Traumatic Coagulopathy Using Admission Clinical 
Variables”, In Proceedings of the 15th Congress of the European Shock 
Society, September 12-14 Vienna, Shock, 40 (Supp-1) ,  p. 25, DOI: 10.1097/ 
SHK.0b013e3182a590b8 
5. Yet B, Perkins ZB, Marsh DWR, Fenton NE (2011) “Towards a Method of 
Building Causal Bayesian Networks for Prognostic Decision Support” 
ProBioMed-11 - Probabilistic Problem Solving in BioMedicine 2011, Bled, 
Slovenia , 2-6 July, pp. 107-120 
6. Yet B, Perkins ZB, Rasmussen TE, Tai N, Marsh DWR “Combining Data 
and Meta-analysis to Develop Bayesian networks for Clinical Decision 
Support” submitted to Medical Decision Making. 
7. Yet B, Perkins ZB, Tai N, Marsh DWR “Explicit Evidence for Clinical 
Bayesian Networks” submitted to Artificial Intelligence in Medicine. 
Conference Presentations (Abstract Submission) 
Yet B, Perkins ZB, Kokuer M, Tai N, Marsh DWR (2012) “Decision Support for 
Trauma Surgery: Causal Modelling Using Bayesian Networks” World Trauma 
Congress 2012, Rio de Janeiro, Brazil, 2012 22-25 August. 
Awards 
Our work “Early Prediction of Acute Traumatic Coagulopathy”, presented by Mr 
Zane Perkins, received the Young Investigator Award at the 15th Congress of the 
European Shock Society. The presentation that received the award was focused on 
the description and results of the Acute Traumatic Coagulopathy (ATC) BN. The 
details of the development methodology and validation of the ATC BN are presented 
in Chapter 5.  
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Bayesian Networks 
This chapter provides an introduction to Bayes’ theorem and BNs. We illustrate the 
reasoning mechanism and flow of evidence in BNs by a simple example. Next, we 
describe the mathematical properties of probability distributions and conditional 
independence in BNs. These properties are necessary to follow the novel 
methodologies described in Chapters 5 – 8. Finally, we summarise the steps of 
building BNs and review the existing methods for building BNs from knowledge and 
data. 
2.1 Bayes’ Theorem 
Bayes’ theorem is a simple equation that shows how a conditional probability 
depends on its inverse conditional probability. According to Bayes’ theorem, the 
probability of an event 𝐴 conditioned on an event 𝐵 can be calculated as: 
𝑃(𝐴|𝐵) =
𝑃(𝐵|𝐴)𝑃(𝐴)
𝑃(𝐵)
 
Bayes’ theorem expresses how a prior belief about a probability should change in the 
light of new evidence. For example, it can be used to update the probability of a 
diagnosis hypothesis given the observation of a symptom. Suppose that the 
prevalence of tuberculosis in a particular community is 1%, and 44% of the people in 
the same community suffers from shortness of breath. By considering the historical 
patient records, we know that 79% of the patients who had been diagnosed with 
tuberculosis also suffered from shortness of breath. Although this information tells 
nothing about the probability of having tuberculosis given that one suffers from 
shortness of breath, this probability can be calculated using Bayes’ theorem.  
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Let 𝑇 represent the event ‘the patient has tuberculosis’ and 𝑆 represent the event ‘the 
patient has shortness of breath’. The probability of having tuberculosis given that the 
patient has shortness of breath can be calculated as: 
𝑃(𝑇|𝑆) =
𝑃(𝑆|𝑇)𝑃(𝑇)
𝑃(𝑆)
=
0.79 ∗ 0.01
0.44
=̃ 0.02 
The probability of tuberculosis increased from 1% to 2% when we observe that the 
patient suffers from shortness of breath.  
When we need to apply Bayes’ theorem to complex problems with many variables, 
we can use graphical models called BNs to represent the problem and update the 
probabilities. The following section introduces the basics of BNs.   
2.2 Introduction to Bayesian Networks 
BNs are graphical probabilistic models that are composed of a graphical structure 
and a set of parameters. The graphical structure of a BN contains nodes representing 
variables and directed edges representing relations between those variables. If a 
directed edge connects variables 𝐴 and 𝐵 as in 𝐴 → 𝐵, 𝐴 is called a parent variable 
and 𝐵 is called a child variable. Figure 2.1 shows a BN model, known as the Asia 
BN, which has 8 nodes and 8 edges.  
 
Figure 2.1 Asia BN 
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Variables in a BN can either be discrete or continuous. Discrete variables are defined 
by mutually exclusive and collectively exhaustive set of states. All of the variables in 
Asia BN are discrete variables that have 2 states.  
Each variable in a BN has a set of parameters that defines its probabilistic relation 
with its parents, or its prior distribution if the variable does not have any parents. The 
parameters of discrete nodes are encoded by node probability tables (NPT). A NPT 
contains probability values for each state of the variable given every combination of 
the states of its parent variables. Table 2.1 shows the NPT of the ‘Has tuberculosis’ 
variable in the Asia BN. The NPT has 4 probability values since the variable has 1 
parent, and both the variable and its parent have 2 states each.  
Table 2.1 NPT of the ‘Has tuberculosis’ variable 
  Visit to Asia? 
  Yes No 
Has tuberculosis 
Yes 0.05 0.01 
No 0.95 0.99 
The probability distributions of continuous variables can be defined by using 
statistical distributions or functions of their parent variables (see Fenton and Neil 
(2012a; 2012b) for a thorough introduction to modelling with discrete and 
continuous variables in BNs). In the following chapter, we illustrate how BNs reason 
by an example about the Asia BN. 
2.3 Reasoning with Bayesian Networks  
Mr John Doe has been suffering from an unusual shortness of breath lately. He 
cannot stop worrying about the possibility of having cancer even though he tries to 
reassure himself by thinking of more common causes of this condition such as 
bronchitis. Eventually, he decides to visit a clinician to get a diagnosis. The clinician 
uses the Asia BN (see Figure 2.1) as a decision support tool to diagnose Mr Doe’s 
condition. The clinician initially considers 3 disease hypotheses: cancer, tuberculosis 
and bronchitis. The BN model has a variable representing each of these hypotheses 
(‘Has tuberculosis’, ‘Has lung cancer’, ‘Has bronchitis’), and it can make 
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probabilistic calculations about the hypotheses based on information entered to the 
model.  
First, the clinician asks about Mr Doe’s symptoms, and recalculates the probabilities 
as he enters the symptom about shortness of breath. Bronchitis is the most probable 
hypothesis at this stage (see Figure 2.2a). The clinician demands a chest x-ray as he 
does not want to misdiagnose a life-threatening disease such as tuberculosis or 
cancer. The result of the x-ray turns out to be positive which makes the clinician 
more worried about the cancer hypothesis (see Figure 2.2b). 
 
Figure 2.2 Probabilities updated after observing a) symptoms and b) X-ray 
In order to collect more information, the clinician asks questions about the cancer 
cases in Mr Doe’s family and his smoking habit. Mr Doe says that he does not 
smoke regularly but he smoked a few cigarettes at his recent holiday in Cambodia. 
The trip to Cambodia may be an important piece of information for the tuberculosis 
hypotheses at this stage of treatment as tuberculosis is more prevalent in this country 
(World Health Organization, 2012). The probability of cancer is much lower after 
the information about smoking and visit to Asia is entered, and tuberculosis, which 
initially had a low prior probability, is now a more convincing diagnosis (see Figure 
2.3a and Figure 2.3b). 
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Figure 2.3 Probabilities updated after observing a) smoking history and b) visit to Asia 
This simple example illustrates the 3 ways that BNs propagate information to update 
probabilities:  
1. Causal reasoning: Entering an observation to a ‘cause’ node will update the 
probabilities in its ‘effect’ nodes. In Asia BN, knowing the patient’s visit to 
Asia increased the probability of tuberculosis 
2. Diagnostic reasoning: Entering an observation to an ‘effect’ node will update 
the probabilities in its ‘cause’ nodes. For example, observing the patient’s 
shortness of breath increased the probability of bronchitis 
3. Explaining away: If any of the ‘effect’ nodes or their descendants is 
observed, entering an observation to a ‘cause’ node will update the 
probabilities of the other ‘cause’ nodes. For example, after knowing the 
results of the x-ray and the presence of shortness of breath, knowing the visit 
to Asia increases the probability of tuberculosis and decreases the probability 
of cancer, which is the other cause of a positive X-ray and shortness of 
breath. In other words, a higher probability of tuberculosis, resulting from the 
trip to Asia, explained away the other causes of the positive X-ray and 
shortness of breath. Such flow of information would not happen if the state of 
the X-ray result and shortness of breath were not known.  
The following section presents a formal definition of BNs and their conditional 
independence (CI) properties. 
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2.4 Condition Independence and Bayesian Networks 
A BN can represent a joint probability distribution compactly in a factorised way. 
The graphical structure of a BN is a directed acyclic graph that encodes a set of CI 
assertions about its variables. Every node in a BN is independent of its non-
descendants given that the state of its parents is known. Therefore, each node has a 
conditional probability distribution (CPD) that defines its probabilistic relation with 
its parents. A probability distribution 𝑃𝑋 factorises over a BN structure 𝐺𝑋 if 𝑃𝑋 can 
be decomposed into the product of factors 𝑃𝑋 = 𝑃(𝑋1, … , 𝑋𝑛) = ∏ 𝑃(𝑋𝑖|𝑃𝐴𝑋𝑖
𝐺𝑋)𝑛𝑖=1  
where 𝑋1, … , 𝑋𝑛 are a set of variables, 𝑃𝐴𝑋𝑖
𝐺𝑋  is the set of parents of 𝑋𝑖 in 𝐺𝑋. 
The CIs that can be encoded in a BN can be shown by the relation between three 
variables. 
1. If two variables, 𝐴 and 𝐵, are directly connected by an edge, as shown in 
Figure 2.4a, a BN does not assert any CI conditions between these variables. 
2. If there is a serial relation between three variables 𝐴, 𝑉 and 𝐵, as shown in 
Figure 2.4b, then 𝐴 and 𝐵 becomes independent given that the state of 𝑉 is 
known. 
3. If there is a diverging relation between 𝐴, 𝑉 and 𝐵, as shown in Figure 2.4c, 𝐴 
and 𝐵 becomes independent given that the state of 𝑉 is known. 
4. If there is a converging relation between 𝐴, 𝑉 and 𝐵, as shown in Figure 2.4d, 
𝐴 and 𝐵 are independent. However, this independence disappears if the state 
of 𝑉 or one of its descendants is known. 
 
Figure 2.4 (a) Direct Connection (b) Serial Relation (c) Diverging Relation (d) Converging 
Relation 
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In general, CI assertions of a BN can be determined by d-separation (Pearl, 1988): 
d-separation: A trail 𝑋1 ⇋ ⋯ ⇋ 𝑋𝑛 is a consecutive sequence of edges that can be 
in any direction. Let 𝐺 be a BN structure, 𝐴, 𝐵 and 𝑉 be a three disjoint sets of 
nodes in 𝐺. 𝐴 and 𝐵 are d-separated by 𝑉, 𝑑𝑠𝑒𝑝𝐺(𝐴; 𝐵|𝑉), if and only if there is no 
active trail between 𝐴 and 𝐵 given that 𝑉 is observed. An active trail requires the 
following conditions: 
1. For every converging relation 𝑋𝑖−1 → 𝑋𝑖 ← 𝑋𝑖+1 in the trail, the node 𝑋𝑖 or 
one of its descendants is a member of 𝑉. 
2. The other nodes in the trail are not members of 𝑉. 
If 𝐴 and 𝐵 are d-separated given 𝑉 in the BN structure 𝐺, then 𝐴 and 𝐵 are 
conditionally independent given 𝑉 in any probability distribution that factorises over 
the BN. 𝐴 and 𝐵 are called d-connected if they are not d-separated. It follows from 
the definition of d-separation that adding an edge to a BN increases the number of 
trails and therefore does not increase the number of CI conditions.  
A BN structure 𝐺 asserts a set of conditional independencies 𝐼(𝐺). 𝑃 can factorise on 
𝐺 if 𝐼(𝐺) is a subset of 𝐼(𝑃), i.e. the set of conditional independencies in 𝑃. Such 𝐺 
is called an I-map of 𝑃. 
𝐺 is an I-map of 𝑃 if and only if 𝐼(𝐺) ⊆ 𝐼(𝑃) 
Any CI that holds on the BN structure 𝐺 must also hold on the probability 
distribution 𝑃, if 𝑃 factorises over 𝐺. On the other hand, 𝑃 can have additional CI 
conditions that are not reflected in 𝐺. Therefore, a probability distribution can 
factorise over various BN structures. 
An example of this situation can be seen by the two BNs in Figure 2.5. Some 
probability distributions can factorise on both of these BNs even though their 
graphical structure is different. In the BN in Figure 2.5a, as well as in the probability 
distribution 𝑃 that factorises over this BN, 𝐴 and 𝐵 are conditionally independent 
given that the state of 𝐶 is not known. This CI is not represented in the graphical 
structure of the BN in Figure 2.5b. However, the CI condition can still be present in 
the probability distribution that factorises over this BN structure. In other words, the 
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CI between 𝐴 and 𝐵 can be encoded in the parameters of this BN rather than its 
structure. The BN on the left is preferable since an edge between 𝐴 and 𝐵 is 
unnecessary for this probability distribution, and additional edges increase the 
computational burden of a BN. The obvious conclusion is to choose a BN structure 
that encodes all of the independencies of the probability distribution in its graphical 
structure. Unfortunately, this is not possible in general. Symmetric variable-level CIs 
or some regularities in the parameters do not have a BN structure that represents all 
of the CIs (Pearl, 1988). 
 
Figure 2.5 Same Probability Distribution Factorised over Two Different BN Structures 
2.5 Features of Bayesian Networks 
Algorithmic breakthroughs in the 1980s (Lauritzen and Spiegelhalter, 1988), and 
more recent advances for using continuous variables (Neil et al., 2007), have made it 
possible to calculate inferences on a large number of continuous and discrete 
variables in BNs. The strengths of BNs in knowledge representation and 
probabilistic reasoning made them an attractive tool for providing decision support 
in a wide variety of domains including medicine (Lucas et al., 2004), finance (Neil et 
al., 2009), law (Fenton, 2011; Fenton et al., 2013), sports (Constantinou et al., 2013, 
2012),  reliability (Marquez et al., 2010) and safety (Bearfield and Marsh, 2005; 
Marsh and Bearfield, 2004). The benefits that BNs offer include: 
 Knowledge Representation: BNs have a graphical structure that is well-
suited for representing causal relations. This makes it possible to encode 
domain knowledge about the causal and associational relations in the BN 
structure. Unlike the statistical – black box – approaches, the reasoning and 
predictions of a BN can be explained as its graphical structure can be built in 
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a way that make sense to domain experts. 
 Causal Structure: The structure of knowledge based BNs are often built 
based on causal relations since 1) this is a natural way of expressing 
knowledge by domain experts (Fenton and Neil, 2012c; Lucas, 1995) 2) 
probability distributions can be represented more sparsely this way (Koller 
and Friedman, 2009a). Moreover, variables that are important in a domain 
but not available in data can be modelled using causal relations elicited from 
domain experts. Causal BNs also makes it possible to distinguish between 
observations and interventions allowing analysis of interventions and 
counterfactuals (Pearl, 2000). 
 Missing Observations: Statistical models, such as regression models, 
require values for all of the independent variables in the model to calculate 
the value of the dependent variable. The predictions cannot be generated 
when some of the values are missing. BNs, on the other hand, have no 
specific set of variables that must necessarily be observed. A BN can 
calculate the posterior probability distribution of its unknown variables 
whenever an observation is entered to any of its variables. When additional 
observations are entered, the BN updates the probability distribution based on 
the new information. 
 Flow of Information: When a variable is observed in a BN, it can update the 
probability distribution of its both ‘cause’ and ‘effect’ variables. Information 
can flow both forwards and backwards in BNs allowing both causal and 
diagnostic reasoning as shown in the Asia BN example (see Section 2.1). 
Moreover, when the state of an ‘effect’ variable is known, observing the state 
of its causes can be used to update the probability of the other – unobserved – 
causes. This type of reasoning is crucial for making what-if analysis and 
cannot be done by statistical models such as multivariate regression. 
 Probability Distribution: BN can represent probability distributions 
compactly in a factorised way as every variable is conditioned on its parents 
(see Section 2.4). In other words, probability distributions can be defined 
more sparsely in BNs therefore requiring less data and expert resources for 
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their parameters. 
2.6 Building Bayesian Networks 
A BN can be built in two steps: 
1. Structure: The structure of the BN is defined in the first step. This involves 
identifying the set of variables that are important in the problem domain, and 
defining the set of states for each of these variables. Afterwards, the relations 
between the variables, and the directions of those relations are defined.  
2. Parameters: The parameters, representing the strength of the relations in the 
BN structure, are defined in the second step. If a variable and its parents are 
discrete, a probability is defined for each probability value in the NPT of the 
variable. If continuous variables are present, a statistical distribution and the 
necessary parameters are defined. 
Both BN structure and parameters can be learned from data, elicited from experts or 
estimated by a combination of them. In the remainder of this section, we review the 
existing methods for defining the structure and parameters of a BN. 
2.6.1 Knowledge Engineering Methods 
Structure 
The recommended way of modelling the correct probability distribution and CI is to 
model the causal relations in a BN structure (Fenton and Neil, 2012c; Koller and 
Friedman, 2009a). However, eliciting a causal structure can be challenging, and 
assistance can be required, especially when a large number of variables and complex 
relations need to be modelled. 
Neil et al. (2000) use specific BN fragments called idioms for representing common 
types of uncertain reasoning. Knowledge engineers and domain experts select the 
most appropriate idioms for their modelling problems and use these idioms as 
building blocks for their BN structure. Idioms are reused for the similar modelling 
tasks in order to develop BNs efficiently and consistently. 
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Koller and Pfeffer (1997) describe object-oriented Bayesian networks (OOBN) 
language that represents BNs with inter-related objects. OOBN are particularly 
useful for complex models that contain repeated fragments, where objects can be 
reused to decrease the modelling effort. Laskey and Mahoney (1997) also use object-
oriented concepts to construct a BN by using semantically meaningful fragments as 
basic building blocks. 
Nadkarni and Shenoy (2004) use a managerial tool, called causal maps, to capture 
causal information from domain experts. The causal map is transformed into a BN 
by assuming that it represents the dependency-map of the probability distribution. 
Laskey and Mahoney (2000) propose a system engineering approach that uses a 
spiral lifecycle model for BN development. Their approach starts by defining 
objectives and building initial prototypes with simple features. These prototypes are 
evaluated and rebuild. This process helps a knowledge engineer understand the 
domain and a domain expert understand the principles of BN modelling.  The 
systems engineering approach uses network fragments (Laskey and Mahoney, 1997) 
as basic elements of BN development.  
Heckerman (1990) describes similarity networks that can be used for diagnosing a 
single hypothesis that has mutually exclusive and exhaustive states. In this approach, 
each pair of similar hypotheses is connected in a similarity network. A separate BN 
network structure is elicited for each pair of these similar hypotheses. Then, the 
separate BN structures are merged to form the final BN structure. This approach 
divides the task of network building into pieces that are easier to manage. However, 
it can only be applied when the hypotheses are mutually exclusive and exhaustive, 
and the hypothesis variable has no parents. 
Abstraction methods for simplifying an expert elicited BN has also been proposed. 
However, most of the methods have been designed for a specific problem and are not 
generalisable to a wider range of problems. Srinivas (1994) proposes a hierarchical 
BN approach for fault diagnosis in engineering systems. In this approach, functional 
schematics are defined in multiple levels of abstraction between the inputs and 
outputs of the system. Shachter's topological operations (1986) are used to reach to 
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higher level schematics. The different abstraction levels of schematics must have the 
same inputs and outputs. 
Wu and Poh (2000) propose a set of operations that changes the abstraction level of a 
knowledge-based influence diagram. They propose the ‘extend’ and ‘retract’ 
operations to add and remove the parents of a variable. The ‘abstract’ operation 
merges a set of variables that shares a single parent and child. The ‘refine’ operation 
is the opposite of the ‘abstract’ operation. These operations can be applied to a 
limited variety of modelling tasks. For example, Wu and Poh (2000) do not discuss 
how to apply the ‘abstract’ operation to variables that do not share the same parent or 
that have multiple parents. 
Parameters 
The parameters of a BN can be elicited from domain experts without using any data. 
Several direct and indirect methods have been proposed to elicit probabilities 
including the use of probability scales and lotteries (Korb and Nicholson, 2004a; 
Renooij, 2001; Van der Gaag et al., 2002). Probability elicitation is a challenging 
task as domain experts display various kinds of biases while expressing probabilities 
(see Tversky and Kahneman (1974) and O’Hagan et al. (2006) for a detailed 
discussion of these issues). Methods to overcome these biases can take too much 
time and make it infeasible to elicit a large number of parameters from domain 
experts (Renooij, 2001). 
Parameters elicited from experts can be refined by sensitivity analysis methods 
(Coupé et al., 2000, 1999). In this approach, a knowledge engineer selects a target 
variable and examines the changes in the marginal probability distribution of this 
variable by systematically changing other parameters. This can be computationally 
expensive especially when the parameters of multiple variables are changed 
simultaneously (Coupé et al., 2000). Other types of sensitivity analysis exists for 
analysing the effects of observations and edge removals (Korb and Nicholson, 
2004b; Renooij, 2010). 
There are several techniques for decreasing the number of parameters in a BN. These 
techniques can be used to reduce the number of parameters that needs to be elicited 
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from experts. The parameter space of a variable grows rapidly as it has more parent 
variables. Adding an intermediate variable between the variable and its parents can 
reduce the size of its parameter space. This approach is known as ‘parent divorcing’ 
(Nielsen and Jensen, 2007). Canonical models, such as Noisy-OR and Noisy-Max 
gates, are also used for simplifying the elicitation task (Diez and Druzdzel, 2006; 
Henrion, 1987; Pearl, 1988; Pradhan et al., 1994). These models decrease the 
number of parameters in a NPT by assuming that the effect of each parent variable is 
independent from other parents. For example, Noisy-OR (Pearl, 1988) assumes that 
the presence of any of the causes is enough for the presence of the effect but there is 
a possibility that some of the causes may fail to produce the effect as indicated by the 
term ‘Noisy’. Parent divorcing and canonical models can be used together with 
parameter learning approaches when data is not large enough. 
Ranked nodes can simplify parameter elicitation for variables with ordinal scale 
(Fenton et al., 2007). A ranked node is an approximation of the truncated normal 
distribution to the multinomial distribution with ordinal scale. Fenton et al. (2007) 
provides a framework for using ranked nodes for parameter elicitation in BNs. In this 
approach, parameters are defined by 1) selecting a suitable ranked node function for 
modelling the relation between the variable and its parents, 2) eliciting the weights 
required for the ranked node function from domain experts, 3) eliciting the expert’s 
degree of confidence in these weights. The ranked nodes offer the possibility of 
modelling a wide range of relations for the variables with ordinal scale. Moreover, a 
ranked node requires fewer parameters compared to a complete NPT therefore the 
elicitation task requires significantly less effort (Fenton et al., 2007). However, 
selecting a suitable function for the elicited relation can be challenging as it demands 
thorough understanding of the behaviour of different ranked node functions. 
2.6.2 Data Based Methods 
Structure 
Structure learning algorithms for BNs can be divided into two categories: constraint-
based algorithms and score-based algorithms. Constraint-based algorithms aim to 
determine CIs in the dataset, and build a structure satisfying these CIs. The tests 
required for determining CIs may become computationally infeasible as the BN gets 
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larger. Therefore, these algorithms make several simplification assumptions such as 
limiting the maximum number of parents that a variable can have. 
A common statistical test for identifying CIs in data is the χ2 test. This test calculates 
the false-rejection probability of a CI hypothesis. The mutual information measure, 
which is mathematically related to the χ2 test, is also used for testing the same 
hypothesis. A more recent CI test for constraint-based learning is developed by Dash 
and Druzdzel (2003). A non-parametric test is proposed by Margaritis (2004). 
Constraint-based algorithms such as IC (Pearl and Verma, 1991) can learn a part of 
the causal relations from data. However, the true – complete – causal structure is not 
identifiable from the data. Even if a learning algorithm identifies all of the CIs in the 
probability distribution, it may not find the true causal structure as multiple BN 
structures can represent the same probability distribution (see Section 2.2). 
Moreover, since data is noisy, we may never be sure about the CIs identified by the 
learning algorithm. Notable constraint-based structure learning algorithms include IC 
(Pearl and Verma, 1991), LCD (Cooper, 1997), PC (Spirtes et al., 2001), Grow-
shrink (Margaritis, 2003) and TDPA (Cheng et al., 2002). 
Scored-based algorithms aim to find the BN structure that maximises a likelihood 
score. Adding edges to a BN increases the likelihood of representing the probability 
distribution but it can also reduce the quality of parameter estimation by dividing the 
data. Therefore, the scoring functions for these algorithms are often a combination of 
the goodness of fit and penalty for additional edges. Commonly used scoring 
functions include the Bayesian information criterion (Cruz-Ramírez et al., 2006; 
Schwarz, 1978), minimum description length (Lam and Bacchus, 1994), minimum 
message length (Wallace et al., 1996; Wallace and Korb, 1999) and BDe score 
(Heckerman et al., 1995). 
Based on the selected scoring function, a score-based algorithm searches the space of 
possible BN structures to find the structure with the maximum score. The search is 
done by removing, adding or reversing edges between the variables available in data. 
The algorithms can either search the space of singular BN structures or the space of 
equivalent structure classes. Notable search algorithms include Cooper and 
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Herskovits (1992), Glover and Laguna (1997), Chickering (2003; 1996), Chickering 
and Meek (2002), and Castelo and Kocka, (2003). 
Tsamardinos et al. (2006) proposed a combination of score-based and constraint-
based methods for structure learning. Their algorithm, called max min hill climbing 
(MMHC), defines a skeleton for the BN structure based on a constraint-based 
method, and orients the edges in the skeleton by maximising a scoring function.  
Structure learning is more complicated when missing values exist in the data. 
Calculation of the scoring functions becomes more difficult as these functions do not 
decompose when missing values exist. Daly et al. (2011) and Koller and Friedman 
(2009b)  provide a thorough review of structure learning methods for complete and 
incomplete data. 
Parameters 
A popular approach for parameter learning is to find the parameters that maximises 
the likelihood of the model given the data. For discrete variables, the maximum 
likelihood estimates can be found by calculating the related conditional probabilities 
in the data. Replacing zero probabilities with small values can increase the 
performance of the model in other datasets. Parameters can also be estimated by a 
Bayesian approach, which uses a prior distribution, representing the background 
knowledge, for the parameters and updates the prior based on data. Bayesian 
approach can provide better results especially for small datasets as it includes expert 
knowledge into parameter learning. 
Parameter learning becomes more difficult when data contains missing values. A 
simple way to deal with missing values is to complete the data by assigning values to 
them. The values can be assigned randomly, sampled from a distribution or 
estimated from the data. This approach is called imputation in statistics. After the 
missing values are assigned, standard parameter learning methods can be used. 
Expectation-maximisation (EM) is an iterative algorithm that uses the BN structure 
to deal with missing values (Lauritzen, 1995). EM starts with assigning initial values 
either to the BN parameters or to the missing values. In each iteration, EM calculates 
the parameters based on expected values of the missing values, and it updates the 
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expected values based on the new parameters. EM is guaranteed to converge to a 
local maximum. EM has also been applied to learn the parameters of canonical 
models such as noisy-OR (Meek and Heckerman, 1997).  
Bayesian learning can also be used for datasets with missing values. While 
calculating the posteriors in Bayesian learning is often trivial for complete datasets, 
it becomes computationally expensive, and sometimes infeasible, when missing 
values are present. In complete datasets, the parameters of different CPDs are 
independent of each other, and the posterior often has a compact form that can be 
solved analytically. However, the parameters become correlated when missing 
values exists. A thorough introduction to Bayesian parameter learning with complete 
and incomplete data is presented by Koller and Friedman (2009c; 2009d).  
2.6.3 Hybrid Methods that Combine Knowledge and Data 
Previous sections discussed several limitations of purely data and knowledge driven 
techniques. Methodologies that combine data and expert knowledge seek to 
overcome these limitations by using all available information in BN development. 
However, research in this area is still in early steps, and there are many challenges 
that need to be addressed.  
Structure 
Flores et al. (2011) proposes a method that integrates expert’s opinion about the 
presence and direction of the arcs into structure learning. In this method, experts can 
define the type of the relations between variables and assign a prior probability 
representing their confidence. For example, an expert can say that he is 80% 
confident that there is a direct relation between two variables but he is not sure about 
the causal direction of this relation. The expert can also define other types of 
relations including direct causal connection, causal dependence, temporal order, and 
correlation. Afterwards, the BN structure is learned based on these expert priors 
using a score-based method.  
Cano et al.'s method (2011) uses expert judgement during the learning process 
instead of using it as priors. A Bayesian score is used for the learning algorithm. The 
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arcs that have the most uncertainty, according to the learning algorithm, are shown to 
experts. Afterwards, the experts make the final decision about the presence and 
direction of these arcs. This approach can decrease the time spent by experts since 
their opinion is only used for the most uncertain BN elements. 
Velikova et al. (2013) uses structure learning methods as a complementary approach 
to evaluate and refine the BN structure built with experts. Antal et al. (2004) 
proposed a method for combining data and textual information from the medical 
literature to build BNs. They use information retrieval techniques to assist structure 
learning based on the textual information in medical literature.  
Parameters 
Bayesian learning methods can integrate expert knowledge into parameter learning 
by using informative priors. However, eliciting numbers for informative distributions 
can be difficult as experts often feel less confident in expressing quantitative 
statements (Druzdzel and Van Der Gaag, 2000). Therefore, using qualitative 
constraints, such as “value of A is greater than value of B”, can be more convenient. 
Zhou et al. (2013a, 2013b) proposed a technique for integrating expert knowledge as 
constraints when learning multinomial parameters from data. Similar approaches are 
also proposed by Feelders and Van der Gaag (2006) for binomial parameters, by 
Tong and Ji (2008) for a limited amount of constraints, and by Khan et al. (2011) for 
diagnostic BNs. 
2.6.4 Knowledge Gap 
The knowledge engineering and machine learning communities has focussed less on 
hybrid methodologies compared to purely knowledge or data driven approaches. 
Although the number of studies about hybrid methodologies has been increasing in 
recent years, many of these studies have addressed similar challenges. From the 
reviewed studies, the hybrid structure learning methods mainly focus on using 
knowledge to assist a data-based structure learning algorithms. The hybrid parameter 
learning studies mainly focus on using knowledge as constraints for parameter 
learning. Combination of knowledge and data also has potential benefits in other 
challenges of BN modelling that need to be addressed. For example, BNs that reason 
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consistent with knowledge often contains variables that cannot be directly measured 
and thus not available in the dataset. Hybrid methodologies that combine knowledge 
and data are required to deal with this task. In the following chapter, we discuss the 
application of knowledge and data driven techniques for medical models. In Chapter 
4, we introduce the medical case study and, by using the case study, we illustrate 
several modelling challenges that can be dealt with novel hybrid methodologies. 
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Clinical Decision Support 
The nature of medical decision making is inherently uncertain as the true state of a 
patient can almost never be observed (Sox and Higgins, 1988). A clinician can 
interview the patient, examine his physical conditions and conduct laboratory tests 
but these may not necessarily reveal the true state of the patient. The findings of 
these tests are often related to more than one disease therefore they can only help in 
ruling out some diseases and decreasing the uncertainty regarding the diagnosis. 
Selecting the best treatment is also not simple because of the uncertainty. The 
treatment options often have different benefits and disadvantages; an optimal 
decision, that is better in all aspects, may not exist. According to Sox and Higgins 
(1988), clinicians generate hypotheses about the patient’s problem often in early 
stages of patient care. They compare only a few hypotheses and gather more 
information to confirm or falsify them. In this regard, medical decision making 
follows the principles of Bayesian reasoning. 
There are systematic errors that clinicians, and other experts, make when they reason 
with uncertainty (Tversky and Kahneman, 1974). The classic study by Casscells et 
al. (1978) and the cases by Gigerenzer (2003) show examples of striking errors that 
clinicians make when calculating probabilities. Quantitative models, such as BNs, 
can be helpful in preventing these errors.  
In this chapter, we examine the potential benefits of quantitative models for 
providing clinical decision support. We review the pitfalls of the existing approaches 
to examine why many of these models have not been employed by clinicians.  
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3.1 Surgical Decision Making 
Most surgical decisions are made in challenging conditions. Surgeons often face 
uncertainty and strict time constraints when making decisions with critical and 
irreversible outcomes. A branch of decision science, called naturalistic decision 
making, studies decision making under such conditions (Klein, 2008; Lipshitz et al., 
2001). Other domains of naturalistic decision making include piloting and 
firefighting (Klein et al., 1986; Orsanu and Fischer, 1997).  
Flin et al. (2007) examined surgical decision making using concepts from other 
domains of naturalistic decision making. They defined surgical decision making in 
two stages. In the first stage, a surgeon focuses on situation awareness. He observes 
the overall situation of the patient, diagnoses the anatomical and physiological 
disorders, and evaluates the expected outcomes and risks. In the second stage, the 
surgeon adopts one of the following decision making strategies to select a treatment 
that maximises the expected outcomes:  
1. Recognition: The surgeon recognises the problem and recalls a treatment 
used in a similar problem. 
2. Rule-based: The surgeon selects the treatment recommended by the 
guidelines. 
3. Analytical: The surgeon evaluates multiple treatment options simultaneously 
and selects the one with maximum benefit.  
4. Creative: The surgeon uses a novel course of action for an unfamiliar 
situation. 
Surveys of experienced surgeons showed that they adopt the recognition and 
analytical decision making strategies more commonly than the rule-based and 
creative strategies (Pauley et al., 2011). The recognition strategy is preferred when 
the operation is familiar to the surgeon or when there is only one plausible option 
(Jacklin et al., 2008; Pauley et al., 2011). The analytical strategy is preferred when 
there are multiple treatment options with similar risks and benefits. The analytical 
strategy is more common in surgery than in other domains of naturalistic decision 
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making (Cristancho et al., 2013; Klein et al., 1993, 1986). The rule-based strategy is 
more commonly preferred by novice surgeons (Pauley et al., 2011); experienced 
surgeons occasionally adopt this strategy mainly for routine surgical operations 
(Jacklin et al., 2008). The creative strategy is not considered suitable for most 
surgical operations because of the risks and time constraints involved, and thus it is 
rarely adopted (Flin et al., 2007; Pauley et al., 2011). 
Quantitative models offer the potential to improve two areas of surgical decision 
making. First of all, the situation awareness stage can be improved by models that 
calculate risks and probabilities. Way et al. (2003) showed that misperception of 
risks leads to poor outcomes in many surgical operations even when the surgical skill 
and judgement is adequate. Experts make errors when reasoning with uncertainty 
(Casscells et al., 1978; Gigerenzer, 2003; Kahneman, 2011; Tversky and Kahneman, 
1974), and uncertainty is often abundant at the situation awareness stage (Flin et al., 
2007; Way et al., 2003). Quantitative models can be used at the situation awareness 
stage to quantify uncertainty when evaluating probabilities and risks.  Secondly, the 
analytical decision making strategy can be assisted by quantitative models. Experts 
who adopt this strategy need to calculate the expected outcomes of the available 
hypotheses.  The calculations have to be made iteratively as the observed state of the 
patient changes. Experts have to deal with the uncertainty regarding these 
calculations. Moreover, decision science research showed that experts can consider 
only a few hypotheses at a time (Kahneman, 2011; Sox and Higgins, 1988). 
Quantitative models can be used to assist analytical decision making strategy by 
enabling calculation of a larger number of hypotheses.  
3.2 Statistical Modelling Approaches in Medicine 
Models that predict the course of a disease or a medical condition, based on a single 
or multiple variables, are called prognostic models in the medical literature. 
Typically, the relation of the predictors to the model outcome is analysed by 
multivariate statistical models or similar approaches (Abu-Hanna and Lucas, 2001). 
The accepted way of selecting predictors is to adjust the variables and check their 
effects on the outcome in data. If an adjustment of a variable is connected to the 
outcome with statistical significance, the variable can be called an independent 
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predictor (Royston et al., 2009). The danger is that correlation is confused with 
causation. For example, grey hair is an independent risk factor for heart disease, 
however, if two men of the same age but different hair colours are considered, grey 
hair does not probably increase the heart disease risk (Brotman et al., 2005). 
Therefore, the independent predictors are not necessarily causal factors; they are the 
factors that are correlated with causal factors according to the available data and 
selected variables. The number and identity of the included variables is sometimes 
considered to be not important (Katz, 2003; Moons et al., 2009b). Consequently, the 
independent predictors and their relations to outcome can be completely different 
between studies. Jenks and Volkers (1992) shows more extreme examples about 
variable selection where electric-razors or owning refrigerators have been identified 
as risk factors for cancer.  
Although, a large number of prognostic models are developed and published, the 
majority are not adopted into clinical practice (Altman et al., 2009). The 
predominant reason for this are concerns regarding model accuracy. Accuracy alone, 
however, does not ensure use of a model. Predictors with different sets of variables 
can be statistically accurate but statistical accuracy of a model does not ensure its 
clinical acceptance (Moons et al., 2009a) and there are now widely accepted 
arguments against the use of statistical significance tests and their associated p-
values (Goodman, 1999; Ziliak and McCloskey, 2008). On the other hand, some 
models with mediocre performance are widely used in clinical practice (Moons et al., 
2009a). 
Clinicians tend to reject a prognostic model if they are not convinced that the 
model’s performance, for their patients, will be similar to its published performance 
in validation studies (Moons et al., 2009a; Wyatt and Altman, 1995). The clinical 
evidence supporting the model and its reasoning mechanism must be understood for 
clinicians to evaluate its prospective performance in their practice (Akhtar and Forse, 
2010; Wyatt and Altman, 1995). It may be necessary to modify an existing 
prognostic model because of the changes in clinical knowledge and practice. In this 
case, the model is often retrained from scratch with the new data. This approach 
discards all of the information in the previous model even though a part of the model 
may still be relevant (Moons et al., 2009a). This can be avoided by identifying the 
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obsolete parts of the model and refining only those parts. The link between clinical 
knowledge and the reasoning mechanism of the model must be clear for clinicians to 
identify and modify the obsolete parts. However, most statistical models are linear 
equations that represent the correlations in their training dataset. The structure of 
these models is often not intuitive to clinicians as they do not reflect causal relations. 
For example, it is difficult, if not impossible, to modify a regression model to include 
a new clinical factor that is known to affect the outcome and some of the 
independent variables through multiple causal pathways. 
Wyatt and Altman (1995) argue that useful prognostic models have 4 properties in 
common: clinical credibility, accuracy, generalisability, and ability to provide useful 
decision support. Traditional – purely data-driven – modelling approaches often 
target only one of these qualities: statistical accuracy. They disregard domain 
knowledge about the clinically relevant variables and their causal relations which is 
often available in abundance. As a result, evidence supporting the model becomes 
limited to its training data. Using knowledge from other sources, as well as data, can 
be an important step to achieve all four properties. In the following section, we 
review knowledge and data driven artificial intelligence (AI) approaches for 
developing clinical models.  
3.3 Artificial Intelligence and Bayesian Networks in 
Medicine 
Medicine has been a popular domain for applying AI techniques. The early 
applications tried to imitate decision making of clinicians using a set of rules defined 
in their system. MYCIN system was arguably the first successful application in 
medicine (Buchanan and Shortliffe, 1984; Shortliffe, 1976). It was developed in the 
1970s to recommend treatments for infectious blood diseases based on a knowledge 
base of about 500 rules. MYCIN performed better than most clinicians who were not 
specialised in infectious blood diseases (Yu et al., 1979).  Other notable expert 
systems include Internist (Miller et al., 1982), Casnet (Weiss et al., 1978) and ABEL 
(Patil et al., 1981). The early expert systems had two major disadvantages. First, by 
imitating the decision making of experts, these systems also imitated its undesirable 
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flaws (Druzdzel and Flynn, 2009). Second, their rule-based reasoning mechanism 
could not represent the uncertain nature of medicine. As a result, most expert 
systems have not been widely used in clinical practice. 
Machine learning (ML) is a branch of AI that focuses on learning systems purely 
from data. Following the advances in computing technology, ML applications have 
become increasingly popular. They have had successful results in some medical 
areas where data is available in large amounts. These include analysis of radiography 
images (Savage, 2012) and identification of the patterns between genes and diseases 
(Shipp et al., 2002). However, just like statistical models, ML methods have not 
always provided useful models for complicated clinical decisions even when a large 
amount of data is available. 
According to Buchan et al. (2009), this is because the complexity of clinical 
mechanisms is not taken into account by purely data-based approaches. Knowledge, 
from clinicians and published evidence, should be used to uncover the clinical 
mechanisms related with data, and the data should be used on top of this to reflect 
the complexity. Patel et al. (2009) confirmed this in a recent panel between the 
leading researchers of AI in medicine: combining knowledge and data offer the 
potential to be useful in areas that purely knowledge-based or data-based approaches 
fail (Holmes and Peek, 2007; Patel et al., 2009; Zupan et al., 2006).  
BNs are well-suited for combining knowledge and data (see Chapter 2 for a review 
of knowledge and data driven approaches for BNs). Complex clinical mechanisms 
with multiple pathways can be represented in the structure of BNs (Fenton and Neil, 
2010). Moreover, the probabilistic reasoning of BNs can effectively deal with 
uncertainty and unobserved variables, both of which are not rare in medical decision 
making. 
BNs have been a popular approach in medicine for more than 20 years (see Table 
3.1) (Abu-Hanna and Lucas, 2001; Lucas et al., 2004). Many of the early 
applications of BNs were built purely by knowledge. One of the first large-scale 
applications in medicine, the Pathfinder project, was aimed to diagnose 60 diseases 
of lymph nodes (Heckerman and Nathwani, 1992; Heckerman et al., 1989). Both the 
structure and parameters of Pathfinder were elicited from experts. It was 
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commercialised as a training tool, called IntelliPath, for junior pathologists 
(Nathwani et al., 1990). 
Alarm BN is one of the earliest applications in emergency medicine (Beinlich et al., 
1989). Its aim is to diagnose patient disorders and generate alarm messages based on 
the inputs from the patient monitoring devices. The BN structure and CPDs were 
elicited from experts. Data was used for learning the probability distributions of 
variables without parents. 
Table 3.1 Some Knowledge and Data Driven Applications of BN in Medicine 
Purely Data-Based Expert Knowledge Used in Modelling 
Arteriosclerosis (McGeachie et al., 2009) 
Breast Cancer (Cruz-Ramírez et al., 2007) 
Cardiac Surgery (Verduijn et al., 2007) 
Chronic Obstructive Pulmonary Disease 
(Himes et al., 2009) 
Clinical Therapeutics (Nordmann and 
Berdeaux, 2007) 
Colorectal Cancer Surgery (Nissan et al., 
2010) 
Head Injuries (Sakellaropoulos and 
Nikiforidis, 1999) 
Intensive Care (Celi et al., 2008; Crump et 
al., 2011) 
Malignant Skin Melanoma (Sierra and 
Larrañaga, 1998) 
Mortality Prediction (Celi et al., 2008) 
Radiography Interpretation (Maskery et al., 
2008; Neumann et al., 2010) 
Venous Thromboembolism (Kline et al., 
2005) 
Anticoagulant Treatment (Yet et al., 2013a) 
Breast Cancer (Wang et al., 1999) 
Chronic Obstructive Pulmonary Disease 
(van der Heijden et al., 2013) 
Echocardiography (Díez et al., 1997) 
Electromyography (Andreassen et al., 1989) 
Gastric Lymphoma (Lucas et al., 1998) 
Intensive Care (Beinlich et al., 1989) 
Infectious Diseases (Charitos et al., 2009; 
Lucas et al., 2000; Schurink et al., 2007, 
2005; Visscher et al., 2008) 
Liver Disorders (Onisko et al., 1998; 
Wasyluk et al., 2001) 
Multidisciplinary Team Meetings 
(Ogunsanya, 2012) 
Multiple morbidities (Lappenschaar et al., 
2013) 
Nasogastric Feeding Tube Insertion (Hanna 
et al., 2010) 
Oesophageal Cancer (Helsper and van Der 
Gaag, 2007; Van der Gaag et al., 2002) 
Pathologic Disorders (Heckerman and 
Nathwani, 1992) 
Prostate Cancer (Lacave and Díez, 2003) 
Pyloric Stenosis – Pediatric Surgery 
(Alvarez et al., 2006) 
Radiography Interpretation (Burnside et al., 
2006; Velikova et al., 2013, 2009) 
Trauma Diagnosis (Ahmed et al., 2009) 
Causality has been an important principle for representing expert knowledge in BN 
models as it is a natural way of expressing knowledge (Lucas, 1995) and it enables 
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development of less complex models (Koller and Friedman, 2009a). Even before the 
discovery of BNs, causality was employed by many AI approaches to model 
complex pathways between treatments and diseases (Patil et al., 1981; Weiss et al., 
1978). Many large scale applications of BNs, including MUNIN (Andreassen et al., 
1989) and Hepar II (Onisko et al., 1998), have causal structures based on domain 
knowledge. 
Many BN applications use domain knowledge in development of the BN (see Table 
3.1). Knowledge behind the BN, however, is often unclear to anyone else except the 
developers of the BN. The derivation of the BN structure, and supporting medical 
evidence, is often explained in a few paragraphs due to the space limitations in 
publications (for examples of inadequately described knowledge-based BNs see 
Ahmed et al., 2009; Burnside et al., 2006; Onisko et al., 1998; Wasyluk et al., 2001). 
The BN structure is often presented but the structure may not be descriptive enough 
as variable names often contain a limited amount of characters. As a result, the 
knowledge behind the BN may not be disseminated even when it is based on strong 
evidence. 
More recently, BNs have been used to synthesise published evidence for clinical 
guidelines (Ni et al., 2011). Hanna et al. (2010) used BNs to develop clinical 
guidelines for inserting nasogastric feeding tubes. They modelled the reliability of 
different tests of verifying the position of a nasogastric feeding tube using a BN 
model. The variables and states of the BN were selected based on expert opinion. 
Published statistics from relevant studies were used to define the parameters. The 
BN model was used to compare the performance of different measurements, and to 
prepare a clinical guideline showing the optimal measurements. Hanna et al’s study 
illustrates the power of BNs for combining evidence from different sources. 
BNs can also be used as a purely data-based ML approach by using the learning 
techniques described in Section 2.6.2. Such BNs, as well as other ML approaches, 
are well suited for pattern recognition and knowledge discovery from large datasets. 
For example, data-driven BNs have had successful results in revealing biological 
relations in genome datasets (Friedman, 2004; Needham et al., 2007). These BNs, 
however, share the same disadvantages with other purely data based methods when 
they are applied to complicated decision making problems.  
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Fenton (2012) shows a simple example where purely data based approaches fail even 
when data is available in large amounts. In this example, the sample size of the 
dataset is large but there is no data about some rare combination of events. 
Therefore, a purely data-driven approach cannot gather information about these 
events even though the dataset is large in overall. Yet, experts are able to provide 
knowledge about the rare events based on other sources of information. Fenton's 
example (2012) has been encountered in real medical problems: in Chapter 6 we 
describe a similar challenge about modelling of rare events in the trauma case-study. 
We address this challenge by combining the information from previous publications 
with domain knowledge and data.  
 
Figure 3.1 BNs for Head Injury Prognosis by Sakellaropoulos and Nikiforidis (1999) 
Despite these problems, many clinical BNs continue to ignore clinical knowledge 
regardless of its abundance. For example, Sakellaropoulos and Nikiforidis  (1999) 
built two, purely data-based, BNs to predict prognosis of head injuries by using two 
different learning methods on the same dataset (see Figure 3.1). Some the arcs 
between the same variables are in the opposite direction in these BNs, and some 
contradict with clinical understanding of the subject and common sense. For 
example, blood pressure is the parent of age in both models but the direction of this 
relation should be the opposite from a causal perspective as it makes sense to think 
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that old age causes increased blood pressure; not the other way around. Similarly, the 
result of the CT scan is the parent of delay in hospital admission in both models but 
this is confusing as CT scan is a measurement that is done after a patient is admitted. 
It may be more reasonable to think that delays in arrival to hospital made the 
patient’s condition worse therefore led to a worse result from the CT scan. Another 
possibility is to include a clinically relevant latent variable to make the BN more 
consistent with clinical knowledge. For example, a latent variable about the severity 
of injury can be included as the parent of ‘CT scan’ and child of ‘delays in arrival’ 
based on an expert statement such as: “the severity of injury is measured by CT scan, 
and delays in arrival may worsen the state of overall injury”.  
In summary, it is difficult to explain how these BNs reason to a clinician apart from 
saying that they predict the previous cases in their data. Moreover, the data may not 
produce consistent results alone, as in this example, the BN structure may change 
significantly depending on the learning method applied. The results of the BNs may 
be statistically accurate but, like many statistical models, they fail to satisfy the other 
three properties that useful prognostic models should have: clinical credibility, 
generalisability and ability to provide useful decision support (Wyatt and Altman, 
1995). The following chapter illustrates the challenges of building useful decision 
support models in the trauma case study. 
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Case Study: Trauma Care 
This chapter introduces the clinical case study which covers the treatment of 
mangled extremities in trauma care. We illustrate the challenges of building useful 
decision support models for the case study from two aspects. Firstly, we review the 
existing models for trauma care and discuss their limitations. Secondly, we describe 
the available datasets for the case study and discuss the need for expert knowledge to 
analyse the datasets. The chapter finishes with an overview of the novel 
methodologies proposed in the following chapters of the thesis. 
4.1 Overview of the Case Study 
One of the most difficult decisions for a clinician to make is whether to amputate or 
salvage a mangled extremity. This decision, with irreversible consequences for the 
patient, revolves around three possible adverse outcomes, which change prominence 
as the treatment progresses. 
1. Death. Many trauma patients arrive at hospital with severely deranged 
physiology. Their risk of death is high and most prominent during the early 
stage of treatment.  To reduce the risk of death, clinicians should resuscitate 
these patients, and allow their physiology to recover, before embarking on 
definitive limb reconstruction operations. Therefore, in the early stages of 
treatment, it is crucial to evaluate the physiological status and predict the risk 
of death before deciding to undertake a treatment. 
2. Limb tissue viability. If the limb loses its blood supply for too long, its 
tissues cease to become viable and surgical removal of these tissues is 
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inevitable. The viability of the limb tissues is evaluated as the extent of the 
injury is assessed. The limb may become unsalvageable if a large amount of 
its tissues become unviable and are removed. 
3. Non-functional limb. A salvaged limb may be more or less functional due to 
anatomical problems such as loss of muscle compartments or transected 
nerves. For some patients a prosthetic limb may be preferable to a non-
functional or painful limb.  
The clinician’s concerns about these three treatment outcomes changes as the 
treatment progresses. The probabilities of the adverse outcomes are both positively 
and negatively related with each other so it may not be possible to find a decision 
that minimises all of them. For example, lengthy reconstruction surgery can salvage 
the patient’s limb, but it can also put the patient’s life in danger when the patient is 
physiologically unwell. In later stages of the treatment, following correction of the 
initial physiology, infections of the damaged limb tissues may again threaten the 
patient’s life. Finally, the clinicians may decide to amputate the limb if it is not likely 
to be functional in the long run. Although the choice of treatment is the same, the 
underlying reasoning changes significantly through different stages of the treatment. 
The activity diagram in Figure 4.1 illustrates the decision making stages and 
changing priorities in treatment of mangled extremities. In the remainder of this 
section, we describe the activity diagram by an example of a patient who survived a 
motorcycle accident. The patient is physiologically unstable since he had lost a large 
volume of blood before arriving to the hospital. One of his lower extremities has a 
bleeding traumatic injury. At the emergency room, surgeons assess his physiological 
state, risk of death, and injury. Since the patient’s physiology is severely deranged, 
the surgeons decide to resuscitate the patient until his physiological state improves. 
His limb appears to be salvageable but the surgeons decide to delay any definitive 
reconstruction operations as such operations may put the patient’s life in danger due 
to his physiological state. The surgeons make quick preventive operations to stop the 
bleeding in the lower extremity until the patient’s physiology becomes stable enough 
for a definitive reconstruction operation. These preventive and lifesaving operations 
are also known as damage control surgery (DCS). 
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Figure 4.1 Activity Diagram for Treatment of Mangled Extremities 
After the patient’s physiology stabilises, the surgeons attempt to repair the vascular 
injuries on the lower extremity by a definitive reconstruction operation. The blood 
circulation in his lower extremity had been compromised as a result of the 
motorcycle accident and this lack of circulation caused a part of the soft tissue to 
become non-viable. The contamination and direct damage from the injury also 
caused a part of the soft tissue to become non-viable. At this stage, the surgeons 
assess the likelihood of successful limb salvage as they remove the non-viable tissue 
from the limb. Amputation may become inevitable if a large part of the soft tissue 
becomes non-viable since, without an adequate cover of soft tissue, his wounds may 
become infected, his limb may not function well and the vascular repair may fail. 
The surgeons also assess the projected functional outcome throughout the care. They 
evaluate whether an amputation followed by a prosthetic limb may lead to better 
outcomes than the reconstruction of his limb.  
4.1.1 Medical Collaborations 
This section describes the medical collaborations that provided clinical knowledge 
and datasets used in the trauma case study. 
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4.1.1.1 Domain Experts 
A trauma registrar at RLH, Mr Zane Perkins (ZP), provided clinical knowledge for 
analysing the case study and developing the decision support models presented in 
this thesis. ZP was closely involved in development of the BN models. His 
contribution included providing clinical knowledge, making systematic reviews of 
clinical literature and clinical verification of the developed models. 
A consultant trauma surgeon at RLH, Mr Nigel Tai (NT), was involved in clinical 
verification of the developed models. NT was ZP’s primary research supervisor. 
4.1.1.2 Trauma Unit at the Royal London Hospital 
The case study was done in collaboration with the trauma unit at RLH. RLH is an 
internationally recognised leader in trauma care and trauma research. The trauma 
unit is the busiest in the United Kingdom treating over 2000 injured patients in a 
year, a quarter of whom were severely injured. The hospital is also the lead for a 
network of trauma hospitals, the London Trauma System, which provides specialist 
trauma care for the millions of people living in London and the South-East of 
England. This trauma system is believed to be the largest of its kind in the world. As 
a major trauma centre, the hospital provides access to the latest technology, 
treatments and expert trauma clinicians around the clock. Evidence has shown that 
people who suffer serious injuries need the highest quality specialist care to give 
them the best chances of survival and recovery. The most common causes of injury 
seen at RLH are road traffic collisions, followed by stabbings and falls from a height. 
Nearly half of the trauma patients have an injury to an extremity or the pelvic girdle, 
and 1% of these patients end up having lower limb amputations. A large 
multidiscipline team manages those with severe limb injuries. These devastating 
injuries carry a high mortality and morbidity in a predominantly young population. 
The multidiscipline approach ensures the best possible outcome for these patients. 
The clinical datasets used for developing the ATC BN were provided by the RLH 
trauma unit and by their national and international collaborations with other hospitals 
(see Section 4.3.1 for a description of the ATC datasets). 
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4.1.1.3 United States Army Institute of Surgical Research 
United States Army Institute of Surgical Research (ISR) in San Antonio, Texas 
provided the dataset used for developing the lower extremity vascular trauma 
(LEVT) BN (see Section 4.3.2 for a description of the LEVT dataset). The author 
and ZP visited ISR to extract and refine the LEVT dataset, and to develop the LEVT 
BN model.  
ISR is one of the 6 research institutes within the United States Army Medical 
Research and Materiel Command. It is the leading research institute of combat 
casualty care for the United States Army. ISR focuses on a wide variety of research 
areas including extremity trauma, burn treatment, emergency medical monitoring 
and casualty care engineering. A diverse workforce of over 250 military and civilian 
personnel works at ISR to accomplish these research objectives. 
4.1.2 Decision Support Requirements 
Since the treatment of mangled extremities involves multiple decisions that affect 
multiple outcomes in multiple stages, it is crucial to define the scope of the decision 
support models according to the requirements of the clinicians. We conducted a 
series of interviews with the domain expert (ZP) in order to have a shared 
understanding of the areas where probabilistic models can provide useful decision 
support. The description of the case study and the activity diagram (see Figure 4.1) 
in Section 4.1 were also produced as a result of these interviews. The domain expert 
suggested that predictions of the following outcomes can potentially assist the 
decision making in treatment of traumatic lower extremity injuries: 
1. Death and ATC: One of the most critical physiological problems at the early 
stage of treatments is acute traumatic coagulopathy (ATC). ATC is the failure 
of the body’s protective mechanisms to limit bleeding. The patients with 
ATC have a considerably higher risk of bleeding and death. A model that 
accurately predicts ATC and the related risk of death can be used as the basis 
of a risk-benefit analysis for limb reconstruction operations during the early 
stages of treatment. 
57 
 
2. Limb Tissue Viability: The extremity may become unsalvageable if large 
amount of tissue becomes unviable and removed. Success of the vascular 
reconstruction is essential for the tissues to have adequate blood supply and 
remain viable. Predicting the outcome of a reconstruction operation and 
projected soft tissue viability would be useful in early decision making. Such 
prediction would allow informed treatment decisions and be helpful in 
assessing the risk of failure of a salvage attempt.  
3. Non-functional Limb: Since amputations followed by prostheses can 
sometimes lead to better functional outcomes than salvaged extremities, 
predicting the long-term function outcomes of a salvaged extremity would 
assist the decision making. 
We developed two BN models that aim to provide decision support for the first and 
second outcomes above. The first BN model predicts ATC and mortality using the 
observations that are available in the first 15 minutes of the treatment. The 
development methodology and results of this BN are described in Chapter 5. The 
second BN model predicts the short term outcomes of a vascular reconstruction 
operation by estimating the soft tissue viability. The development methodology and 
results of this BN are presented in Chapter 6. The third – non-functional limb – 
outcome was considered to be out of the scope of this thesis due to the issues 
discussed in Section 4.3.3.  
In the following section, we review the existing models that were built to provide 
decision support for the death, limb tissue viability and non-functional limb 
outcomes.  
4.2 Review of Existing Models in Trauma Care 
Most decision support models in trauma care are designed as scoring systems: they 
calculate a score for the situation of a patient using several inputs. Some scoring 
systems aim to summarise clinical conditions, leaving decisions to a clinician. For 
example, the Glasgow coma scale (GCS) summarises the level of consciousness after 
head injury (Teasdale and Jennett, 1974). The abbreviated injury scale (AIS) 
summarises the severity of anatomical injury in different parts of the body (Civil and 
58 
 
Schwab, 1988; Gennarelli and Wodzin, 2008), and the injury severity score (ISS) 
(Baker et al., 1974) summarises the severity of all injuries combined by using AIS 
scores. Other scoring systems aim to recommend a treatment by setting a threshold 
to the calculated score. For example, the mangled extremity scoring system (MESS) 
recommends amputation if the score is over a certain threshold value (Johansen et 
al., 1990). However, this adds little to an experienced clinician’s judgement 
especially when the score is close to the threshold. If there is a discrepancy between 
the model’s recommendations and clinician’s decisions, the model does not provide 
any useful decision support apart from implying that the recommended decision was 
the decision made in a similar circumstance in the model’s training data.  
Both kinds of scoring systems have been developed for trauma care. In the remainder 
of this section, we review the scoring systems related to the 3 main treatment 
outcomes in our case study: death, limb tissue viability and non-functional limb. 
4.2.1 Death 
The revised trauma score (RTS) is one of the earliest scoring systems about patient 
physiology (Champion et al., 1989, 1981). RTS was originally developed as a triage 
tool that assigns patients to trauma care if they score less than a predefined threshold 
value. However, RTS has been mainly used to predict mortality as it is found to be 
correlated with the rate of survival. RTS is calculated from three inputs: blood 
pressure, respiratory rate and GCS. Several studies indicate that RTS is overly 
simple and lacks important factors, such as those about anatomy, for predicting 
mortality (Gabbe et al., 2003; Russell et al., 2010). 
The trauma and injury severity score (TRISS) calculates the probability of death by 
combining the scores from RTS and ISS, and also adjusting for patient’s age and 
mechanism of injury (Boyd et al., 1987). TRISS cannot be used for decision support 
in early stages of care since acquiring the necessary injury descriptions for ISS may 
take several weeks. It has been mainly used for auditing and performance assessment 
(Russell et al., 2011). 
In a recent study, Perel et al. (2012) proposed a regression model, called the 
CRASH-2 prognostic model, to predict mortality specifically for bleeding trauma 
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patients. The independent variables in the model include injury characteristics, 
physiological variables and demographic factors such as the level of income. The 
variables were selected according to their p-values in a large international dataset. 
Limitations of using p-values for building clinical models are discussed in Section 
3.2. 
ATC is one of the most critical physiological problems in trauma care. The 
coagulopathy of severe trauma score (COAST) (Mitra et al., 2011) has been 
developed for predicting this condition but its performance were found inadequate 
for clinical use (Brohi, 2011). The COAST score had several erroneous assumptions 
about modelling of the latent variables; the limitations of the COAST score are 
examined further in Chapter 5.  
4.2.2 Limb Tissue Viability 
Many scoring systems have been developed to provide decision support for the 
treatment of traumatic lower extremities at the initial evaluation of a patient (see 
Table 4.1). These models calculate a score for the patient based on several physical 
and physiological factors, and recommend amputation if the score is above a certain 
threshold value. Table 4.2 shows the variables used for calculating scores in each of 
the scoring systems. 
Table 4.1 Scoring Systems for Traumatic Limb Injuries 
Scoring Systems for Traumatic Limb Injuries 
Mangled Extremity Syndrome Index (MESI) (Gregory et al., 1985) 
Predictive Salvage Index (PSI) (Howe et al., 1987) 
Hannover Fracture Scale (HFS) (Südkamp et al., 1989) 
Mangled Extremity Severity Score (MESS) (Johansen et al., 1990) 
Limb Salvage Index (LSI) (Russell et al., 1991) 
Nerve, Ischemia, Soft tissue, Skeletal, Shock, Age Score (NISSA) (McNamara et al., 1994) 
The scoring systems were developed based on the historical decisions in their 
training datasets. For example, the threshold for MESS, which is one of the most 
popular limb scoring systems, was defined with the score that discriminated all of 
the amputations and salvages in the training dataset of MESS (Johansen et al., 1990). 
MESS is likely to be overfitted to its training dataset as the dataset was small, 
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containing 39 patients. The initial performance of MESS was never repeated in 
external validations (see Table 4.3). 
Bosse et al. (2001) conducted a prospective multi-centre study that validated 5 of the 
scoring systems on 556 patients. This study concluded that the scoring systems are 
not good predictors of short term outcome and they should not be used for decision 
making in clinical practice. The sensitivity and specificity values in Bosse et al.'s 
study (2001) were substantially lower than the values reported by the models’ 
developers (see Table 4.4).  
Table 4.2 Variables Used in Scoring Systems for Traumatic Limb Injuries 
 MESI PSI HFS MESS LSI NISSSA 
Patient Age ▪   ▪  ▪ 
Bone Fracture ▪ ▪ ▪ ▪ ▪ ▪ 
Comorbidities ▪  ▪    
Nerve Injury ▪ ▪ ▪  ▪ ▪ 
Physiology/Shock ▪   ▪  ▪ 
Skin/soft tissue Injury ▪ ▪ ▪ ▪ ▪ ▪ 
Time until Treatment ▪ ▪ ▪    
Vascular Ischemia ▪ ▪ ▪ ▪ ▪ ▪ 
The scoring systems recommend a decision based on the historical decisions in their 
training dataset. In other words, they try to imitate the decisions that are made in 
similar circumstances in the training dataset without relating them to objective 
patient outcomes. This kind of approach is fundamentally flawed since some of the 
decisions, which were correct at the time, may become incorrect due to the changes 
in medical knowledge and practice. 
Table 4.3 Validations of MESS 
Study Participants Sensitivity Specificity 
Johansen et al. (1990) 26 100% 100% 
Robertson (1991) 154 43% 100% 
Bonanni et al. (1993) 89 22% 53% 
Durham et al. (1996) 51 79% 83% 
Bosse et al. (2001) 556 46% 91% 
Korompilias et al. (2009) 63 87% 71% 
Studies about the sensation in feet and amputation decisions illustrate the change of 
clinical practice and decision making in time. A limb cannot function without a 
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functional nerve therefore a permanent nerve dysfunction can make amputation 
inevitable. A nerve dysfunction in a lower limb can be diagnosed with the lack of 
sensation in the foot. A survey of orthopaedic surgeons showed that they considered 
insensate feet as an important factor for making amputation decisions (Swiontkowski 
et al., 2002). Several scoring systems also used insensate feet as a predictor of 
amputations (Johansen et al., 1990; McNamara et al., 1994). However, insensate foot 
is only an indicator of a more important decision factor: permanent nerve 
dysfunction. A few years after the Swiontkowski et al.’s survey, Bosse et al. (2005) 
showed that although insensate foot can indicate permanent dysfunction of nerves, it 
can also be related to long-term but temporary problems. They observed that some 
patients regain their sensation after several years. Bosse et al. (2005) concluded that 
surgeons should avoid making amputation decisions based on sensation in feet. 
Using sensation in feet, as a predictor, possibly increased the scoring systems’ 
accuracy for predicting historical amputations but it would have affected clinical 
outcomes negatively if these models were used for decision making. 
Swiontkowski et al.’s survey shows that some of the historical amputation decisions 
were possibly based on the sensation in the foot. If so, a data-driven approach would 
find correlation between the sensation and amputation, and would continue to build 
erroneous models. Such errors can be avoided if causal relations between sensation 
in the foot and permanent nerve function are modelled with domain experts. In this 
case, the experts would be able to indicate evidence from Bosse et al’s study and 
include other – temporary – causes of the loss of sensation in the model.  
Table 4.4 Internal and External Validation Results of Scoring Systems 
Scoring 
System 
Sensitivity Specificity 
Internal 
Validation* 
External 
Validation** 
Internal 
Validation* 
External 
Validation** 
PSI 0.78 0.46 1 0.87 
MESS 1 0.46 1 0.91 
LSI 1 0.46 1 0.97 
NISSA 0.81 0.33 0.92 0.98 
HFS 0.82 0.37 0.99 0.98 
*Results reported by authors, **Results from Bosse et al. (2001) 
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4.2.3 Non Functional Limb 
Following Bosse et al.'s study (2001), Ly et al. (2008) examined the performance of 
the scoring systems for predicting limb function. They showed that none of the 
scores reviewed by Bosse et al. (2001) are usefully correlated with function 
outcomes. 
Several survey based scores are available for summarising function outcomes. The 
short musculoskeletal function assessment (SMFA) score calculates multiple scores 
about function and emotional status based on 46 questions (Swiontkowski et al., 
1999).  Similarly, the short form – 36 – health survey (SF-36) calculates several 
outcome scores including a function score based on 36 questions (Ware and 
Sherbourne, 1992). 
4.3 Available Datasets 
This section describes the datasets used for the trauma case-study. The datasets were 
used to develop and validate the BN models presented in Chapter 5 and 6. 
4.3.1 ATC Datasets 
We used three datasets to develop and validate a decision support model that predicts 
physiological derangements and mortality at early stages of trauma care. 
The first of these datasets, called the training dataset, were used to build the ATC 
BN described in Chapter 5. The training dataset contains detailed information about 
600 trauma patients who were treated at RLH.  Table 4.5 summarises the available 
information in the dataset in different categories. 
The second dataset, called the test dataset, contains 300 patients who were treated at 
RLH at a later date than the first 600 patients in the training dataset. The test dataset 
was used for the temporal validation of the ATC BN. A temporal validation is the 
validation of a predictive model using data collected from the same population after 
the model was developed. 
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Table 4.5 Information in the ATC Datasets 
Data Section  Available Information 
Patient Characteristics Age, Gender and Comorbidities of the patient 
Injury Characteristics Mechanism and Energy of Injury, Injury Descriptions, ISS and 
AIS scores, result of the FAST* scan, presence of haemothorax, 
pelvic fractures and long bone injuries. 
Initial Observations Heart rate, systolic blood pressure, Glasgow coma score and 
body temperature of the patient measured shortly after 
admission to the hospital 
Initial Point of Care 
Results 
Blood pH, lactate and base excess values from the arterial blood 
gas test, ROTEM* test results including EXTEM A5* and A30* 
values measured shortly after admission to the hospital. 
Initial Laboratory 
Results 
INR*, PTR* and APTTR* values measured shortly after 
admission. 
Fluid Transfusions The amount of blood product and other fluid transfusions before 
and after admission.  
Later Point of Care and 
Laboratory Results 
Blood pH, lactate and base excess values, ROTEM EXTEM 
A5* and A30* values, INR*, PTR* and APTTR* values 
measured after 4th, 8th and 12th unit of blood is transfused to the 
patient. 
Outcome Survival outcome 
*FAST: Focused Assessment with Sonography for Trauma, ROTEM EXTEM A5 and A30: Amplitude 
of Rotational Thromboelastometry Extem tests at 5th and 30th minutes, INR: International Normalised 
Ratio, PTR: Prothrombin Ratio, APTTR: Activated Partial Thromboplastin Time Ratio.  
The third dataset, called the external dataset, contains 122 patients: 92 patients who 
were treated at a hospital in Oxford, UK, and 30 patients who were treated at a 
hospital in Cologne, Germany. This dataset was used for the external validation of 
the ATC BN. The variables in this dataset are exactly the same as the other two 
datasets from RLH since all datasets were collected as a part of a research 
collaboration led by RLH. Penetrating injuries, such as stabbings, were less 
common, and blunt injuries, such as traffic accidents, were more common in the 
external dataset compared to the datasets from RLH. A summary of the injuries in 
the training and validation datasets are shown in Table 4.6. 
All of the datasets contained missing variables mainly due to recording errors or 
missing laboratory tests. Apart from the missing values, two of the most important 
clinical variables about the physiological derangements, i.e. ATC and 
Hypoperfusion, were not available in any of the datasets. Lack of data for these 
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variables makes it challenging to build a model to predict physiological 
derangements and related mortality. In Chapter 5, we discuss these challenges and 
propose a methodology that systematically uses expert knowledge to overcome 
them. Using this methodology, a group of experts, including ZP, reviewed the 
categorical and free-text information in the data and extracted information about the 
Hypoperfusion and ATC variables. 
Table 4.6 Training and Validation Datasets for the ATC BN 
ATC BN Datasets Training Temporal Validation External Validation 
Patients 600 300 122 
Deaths 71 27 23 
Massive Blood Transfusion 37 21 7 
High Energy Injuries 202 78 42 
Low Energy Injuries 398 182 76 
Unknown Energy - 40 4 
Blunt Injuries 475 239 121 
Penetrating Injury 125 61 1 
4.3.2 LEVT Dataset 
We used a dataset of 521 lower extremity injuries of 487 patients to build a model 
that predicts the short term viability outcomes of lower extremities with vascular 
trauma (LEVT). All patients in the dataset had lower limb vascular injuries with an 
attempted salvage. Some of the patients had injuries on both limbs or vascular 
injuries at multiple levels on the same limb. The dataset contained a large amount of 
information recorded as free text descriptions. ZP reviewed these free text 
descriptions and extracted categorical information that was necessary for training the 
BN model. A summary of the dataset is shown in Table 4.7. 
Amputations that are performed after an attempt to reconstruct a lower extremity are 
called secondary amputations. Secondary amputations may indicate unsuccessful 
salvage outcomes in the dataset. The LEVT dataset contained 90 lower extremities 
that had secondary amputations. It is, however, crucial to identify the clinical reasons 
of the secondary amputations since some secondary amputations may have reasons 
other than short-term viability. For example, several patients in the dataset, who had 
successful limb repairs in terms of viability, decided to undergo amputation several 
years after the injury. The main reason for their amputation was the pain and limited 
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function of their lower extremity. Although these patients had secondary 
amputations, they are considered as positive outcomes in terms of short-term 
viability and negative outcomes in terms of long-term function. Since long-term 
function is out of the scope of our model, these patients were labelled as positive 
outcomes in our training data. ZP reviewed all of the secondary amputations in the 
dataset and identified the clinical reasons of these decisions based on the free-text 
descriptions of injuries and operations. Amputations due to the causes other than 
short-term viability were labelled as positive outcomes in the training data. A 
summary of the learning dataset is shown in Table 4.8.  
Table 4.7 Description of the LEVT Dataset 
Data Section Available Information 
Patient 
Background 
Id number, age, gender of the patient, and the laterality of the 
traumatic lower extremity   
Vascular Injury Location and type of the injured vessel,  
Vascular Repair Description and results of the vascular reconstruction operations 
Ischaemia Degree and duration of ischemia. 
Soft Tissue Injury Location and severity of soft tissue damage 
Associated Injuries Presence of associated bone, nerve and vein injuries.  
Physiology Degree of Shock 
Amputations The reason for amputation, the level of amputation (below the knee, 
through the knee, above the knee).  
Table 4.8 Summary of the LEVT BN Training Dataset 
LLVI BN Cross Validation Dataset 
Patients 487 
Lower Limb Vascular Injuries 521 
Secondary Amputations 90 
Secondary Amputations – Short Term Viability 54 
Above Knee Vascular Injuries 231 
Below Knee Vascular Injuries 290 
Patients with Bilateral Vascular Injuries 18 
Vascular Injuries at Multiple Levels at the Same Lower Limb 16 
Although the LEVT dataset had data for 521 injuries, there were not enough data for 
some severe but uncommon types of injuries. For example, the level of vascular 
injury, the type of repair operation and the presence of vascular injuries at multiple 
levels are important factors that are known to affect the outcome of reconstruction 
operations. Some combinations of these factors are uncommon but have significant 
consequences for the patient. The dataset contains a very small amount of 
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information for these combinations but their prediction is clinically important. In 
Chapter 6, we propose a methodology that combines results from previous research 
and expert knowledge with data to overcome these challenges. 
4.3.3 Limb Function Dataset 
The LEVT dataset also contained data about the function outcomes of 478 patients. 
This data was composed of the SMFA survey scores of 208 patients and SF-36 
survey scores of 278 patients. We built a prototype BN that aims to predict the 
functional components of SMFA and SF-36 scores using the injury and treatment 
variables available in the LEVT dataset. However, the accuracy of the prototype was 
not satisfactory. The domain experts indicated that factors related to life style, such 
as social and economic factors, are known to be affecting the function outcome 
reported by patients (Harris et al., 2008; MacKenzie et al., 2005; Wegener et al., 
2011). The lack of accuracy was possibly due to not including these factors in the 
prototype. Since we had neither data nor experts about the life style factors, we 
decided to leave decision support for the non-functional limb outcome out of the 
scope of this thesis. It would not be possible to identify this issue if we used a purely 
data-driven approach. Expert knowledge showed us the limitations of our resources 
and the requirements for developing a useful model for predicting limb function. 
4.4 Challenges of Developing Useful Decision 
Support Models 
Decision support models must be consistent with clinical knowledge to combine 
relevant evidence and provide evidence-based decision support. This could be 
achieved by models that reason with causal relations supported by clinical evidence. 
However, information about some of the clinically important causal relations is often 
not available in clinical datasets. The dataset described in Section 4.3.1 does not 
contain some of the most clinically important variables about physiological 
derangements. In this case, a decision support model must contain ‘latent’ variables 
in order to be consistent with clinical knowledge. The latent variables are not 
available in the dataset therefore their behaviour must be learned using expert 
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knowledge and other sources of information.  In other cases, data may exist but in 
small amounts for some clinically important variables. The dataset in Section 4.3.2 
also lacks some clinically important variables and it has only a limited amount of 
information for some severe and uncommon injury types. Therefore, the data needs 
to be supplemented by other sources of information to model the behaviour of these 
uncommon injuries.  
The previous trauma models reviewed in Section 4.2 were primarily based on the 
correlations learned from their training datasets. For example, the previous models 
for predicting limb tissue viability imitated the previous decisions in their datasets, 
and ignored factors that lack data. As a result, their predictions were overfitted to 
their training dataset, and failed to be useful in external datasets. 
BNs are well suited for modelling causal relations by combining evidence from 
experts, data and published research. Causal relations are often modelled based on 
expert knowledge as data-driven approaches have limited ability to identify causal 
relations (see Section 2.6.2). However, the elicitation of causal relations from experts 
is a challenging task requiring iterative steps of knowledge engineering to define the 
important variables and identify their relations. Moreover, evidence supporting the 
causal relations is often not presented in detail and is ambiguous to anyone else 
except the model’s developers. Consequently, knowledge and evidence supporting 
the BN becomes unclear even when the BN is based on reliable evidence. 
These challenges demonstrate the need of novel methodologies to develop and 
maintain evidence-based BN models for decision support. In the remainder of this 
thesis, we propose methodologies to address these issues. These novel 
methodologies are illustrated by two BNs developed for the trauma case study. 
In Chapter 5, we propose a methodology to build BNs that reason consistent with 
clinical knowledge without being limited by the observed variables in data. We use 
this methodology to develop a BN that predicts a potentially fatal physiological 
derangement, ATC, and death outcome using the training dataset described in 
Section 4.3.1. Some of the most important variables about this outcome are latent 
variables that cannot be directly observed and thus not present in the dataset. A 
purely data-driven model either ignores the existence of these variables or tries to 
68 
 
estimate them from the other variables available in the dataset. Both of these 
approaches ignore clinical knowledge about the latent variables.  Our methodology 
systematically combines clinical knowledge and data to learn the behaviour of latent 
variables, and to refine the BN model. The performance of the BN is evaluated in 
multiple datasets using a 10-fold cross-validation, a temporal and an external 
validation.  
In Chapter 6, we propose a methodology to build decision support models by 
combining evidence provided by meta-analysis of systematic reviews with expert 
knowledge and data. We use this methodology to develop a BN for predicting limb 
tissue viability outcome using the dataset described in Section 4.3.2. Although this 
dataset contains a total of 521 injuries, there is small amount of data for some 
uncommon injury types with potentially severe consequences. Therefore, a purely 
data-driven approach cannot uncover the relation between these uncommon injuries 
and outcomes due to the limitations of the data. We conducted a systematic literature 
review and meta-analysis of these factors, and combine the results of the meta-
analysis with expert knowledge and data to derive the structure and parameters of the 
BN decision support model. The accuracy of the BN is compared with purely data-
based learning methods and with existing models in a 10-fold cross validation. 
The BN models in Chapter 5 and 6 were developed with two trauma surgeons (Mr 
Zane Perkins and Mr Nigel Tai). Deriving BN structure from expert knowledge is a 
challenging task requiring iterative stages of knowledge engineering. The initial BN 
structures elicited from experts are often complicated with too many arcs and 
variables. The knowledge engineer and domain experts iteratively simplify the 
structure by removing some of the less relevant variables and relations. However, 
these modifications can lead to undesirable effects to knowledge encoded in the 
initial structure. When the derivation stages are not presented, knowledge behind the 
BN structure cannot be completely understood by anyone else except the developers 
of the BN. Knowledge engineering methodologies to systematically observe and 
present the effects of BN simplifications have not been thoroughly studied. Chapter 
7 proposes a method of abstracting a knowledge-based BN structure elicited from 
domain experts. The abstraction method shows the link between the initial and final 
BN structures by showing the effects of each abstraction step to underlying 
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probability distribution. A part of the ATC BN is used as a case study to illustrate the 
application of the abstraction method. 
In order to use a BN for EBM, evidence behind the BN should be explicitly 
presented to clinicians. The graphical structure of a BN shows the variables and 
relations included in the model but it does not present evidence supporting or 
conflicting with these elements. As a result, evidence behind the model becomes 
unclear to its users even when the model is based on substantial evidence. Chapter 8 
proposes a framework for representing the evidence behind clinical BNs. The 
evidence framework is composed of two parts: 1) an ontology that organises 
evidence regarding variables, relations and fragments in a BN 2) a web page 
generator that presents evidence in a web page without showing the technical details 
of the ontology. The ATC BN is used as a case study to illustrate the evidence 
framework.  
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Modelling Latent Variables with 
Knowledge and Data 
Many medical conditions are only indirectly observed through symptoms and tests. 
Developing predictive models for such conditions is challenging since they can be 
thought of as ‘latent’ variables. They are not present in the data and often get 
confused with measurements. As a result, building a model that fits data well is not 
the same as making a prediction that is useful for decision makers. Chapter 4 
illustrates these challenges based on the existing trauma models and available 
datasets. In this chapter, we present a methodology for developing BN models that 
predict and reason with latent variables, using a combination of expert knowledge 
and available data. The method is illustrated by the BN that aims to assist early 
stages of mangled extremity decision making by predicting acute traumatic 
coagulopathy (ATC), a disorder of blood clotting that significantly increases the risk 
of death following traumatic injuries. There are several measurements for ATC and 
previous models have predicted one of these measurements instead of the state of 
ATC itself. Our case study illustrates the advantages of models that distinguish 
between an underlying latent condition and its measurements, and of a continuing 
dialogue between the modeller and the domain experts as the model is developed 
using knowledge as well as data. 
5.1 Introduction 
Purely data-driven approaches are currently accepted as the primary, if not the only, 
way of developing predictive models. Because of the impressive results achieved 
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with such approaches by organizations like Amazon and Google, it is often assumed 
that this success is repeatable in other domains as long as a large enough amount of 
data is available. However, a purely data-driven approach can only predict the type 
of values recorded in a dataset, such as measurements made, decisions taken or 
outcomes recorded. Even when large volumes of data exist, purely data driven ML 
methods may not provide either accurate predictions or the insights required for 
improved decision-making. In this chapter, we consider the common real-world 
situation in which successful decision making depends on inferring underlying or 
latent information that is not – and can never be – part of the data. In such a situation 
a predictive model for decision support will contain latent variables representing this 
underlying state but the values of these variables will not be present in the data. We 
therefore need to depend on domain expertise to identify the important latent 
variables and to model relations between them and the observed variables.  
Domain experts do not just substitute guesswork for data. They may have access to 
information that is not machine-readable and they should back up any judgements by 
reference to published research whenever possible. Yet, such expert knowledge is 
usually avoided in data-driven approaches using arguments such as ‘avoiding 
subjectivity’ and ‘using facts based on the data’ (Gelman, 2008; Tonelli, 1999). The 
use of latent variables is also limited: some data-driven approaches, such as 
regression modelling, do not include latent variables at all. Other approaches contain 
latent variables but these are estimated only from data values, so that the use of latent 
variables in these methods does not escape the limits of the data. The objectivity of 
data-driven approaches holds only so far as the prediction of observed values really 
serves the needs of users. When this is not the case, erroneous results may follow. In 
this chapter, we show some examples of these errors and how they are avoided by 
appropriate and rigorous use of domain knowledge.  
We propose a pragmatic methodology to develop BN models with latent variables. 
Our method integrates domain expertise with the available data to develop and refine 
the model systematically through a series of expert reviews. We illustrate the 
application and results of this method with a clinical case study of a problem for 
which purely data-driven approaches have been tried but have not been considered to 
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be successful by clinicians. Our case study shows some possible reasons for these 
past failures. The details of the case study are provided in Chapter 4. 
The remainder of this paper is as follows: Section 5.2 presents the overview of our 
methodology. The case study is introduced in Section 5.3 and developed further in 
Sections 5.4 (learning and review), 5.5 (model refinement) and 5.6 (temporal and 
external validations). We present our conclusion in Section 5.7. 
5.2 Method Overview 
The limitations of data for making predictions useful to a decision-maker can be 
summarised in three points: 
1. Measurement errors: a dataset contains measurements of variables, but 
measurement errors mean that the true state of each variable differs from the 
measured data.  In some domains, including clinical diagnosis, this 
introduces significant uncertainty about the true value, so that a data-driven 
model cannot accurately predict the underlying state even if it can accurately 
predict the associated measurement values. 
2. Sub-optimal decisions: the objective of a decision-support model is to enable 
a decision-maker to determine the optimal decisions given the observed 
situation. A dataset may contain a ‘decision’ variable, that is, one that reflects 
the decision made (e.g. a treatment given by a clinician). A model that 
predicts the value of a decision variable can be useful if all the past decision-
makers had similar utilities and they were completely rational in evaluating 
utilities with their underlying uncertainties. However, there is usually no 
information about the utilities involved in past decisions, and the data may 
have records of some decisions that were incorrect at the time or, although 
correct at the time, were made on outdated understanding. A model that 
predicts the value of a decision variable is therefore limited in its 
performance even if the prediction is highly accurate. Moreover, a model can 
only be used for ‘what if’ analysis – exploring the consequences of decision 
alternatives – if it is causal; choosing one of the decision alternatives erases 
the factors that influenced past decisions (Pearl, 2000). Although these 
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problems are well known, models that are developed to fit past decisions are 
common in scientific literature (see Section 3.1). 
3. Causes of outcomes: an ‘outcome’ variable records what happened. But 
outcomes can have many causes, only some of which may be recorded in the 
dataset (for example, in medical applications not all interventions and 
treatments are recorded). A prediction based on only some causes may be 
useful – the missing causes simply add uncertainty – but understanding of the 
scope of the causes included is important to the correct application of the 
model. A purely data-driven approach does not resolve this problem; only an 
expert can detect if the data omits known causes of the outcome. If omitted 
causes can be identified, this information can be used either to improve the 
model or to clarify its scope and to assess its performance within the scope of 
the causes modelled. 
The main aim of our method (illustrated in the flow diagram in Figure 5.1) is to 
overcome these limitations. We show how to develop BNs that predict and reason 
with latent variables using a training dataset including measurements of these 
variables, but not including their true state. Domain expertise is used both at the start 
of the development to discover latent variables and then later to refine the model in a 
series of expert reviews; it is during these reviews that discrepancies between 
knowledge and data are revealed. Expert knowledge can be used in various degrees 
when deriving the structure of a BN (Korb and Nicholson, 2004a). In our method, 
the structure of the BN is developed with domain experts by using small BN 
fragments for commonly occurring reasoning types as building-blocks to form the 
complete BN structure (Neil et al., 2000). The advantage of experts deriving the 
model’s structure, rather than learning it from data, is to ensure causal coherence: 
latent variables influence measurements and decision variables influence outcomes. 
Hybrid approaches that combine expert knowledge and data can also be used at this 
stage for deriving the BN structure (Cano et al., 2011; Flores et al., 2011). Moreover, 
structure learning methods can be used as a complementary approach to evaluate and 
refine a BN structure developed by experts (Velikova et al., 2013). Of course, all 
causal assumptions need to be supported by the best available evidence, such as 
experimental results or expert consensus. Lack of knowledge of true causal 
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relationship is a problem and affects both expert and data-led modelling (aside from 
the limited capabilities of algorithms such as inductive causation (IC) (Pearl and 
Verma, 1991)) alike. Equally, not all causal relationships are uncertain: it is clear 
that an object’s temperature causes the thermometer reading rather than the other 
way around. 
 
Figure 5.1 Method for Learning BN with Latent Variables 
The next step is to label the latent variables in the training dataset, overcoming the 
problem that their values are unknown. The first label is derived from measurement 
data using deterministic (but not necessarily complete) rules defined by domain 
experts; the second uses data clustering. The experts’ rules can be of any form, but 
are typically derived from current practice. For example, if the related measurements 
are continuous, these rules are threshold values for the measurements.  For 
clustering, we use the standard Expectation-Maximisation (EM) for BNs with known 
structure (Lauritzen, 1995). EM is an iterative algorithm that is used for learning the 
parameters of a BN from a dataset with missing values. Each iteration of EM has two 
steps: the E-step completes the data by calculating the expected values of 
unobservable variables based on the current set of parameters; the M-step learns a 
new set of parameters from the maximum likelihood estimate of this completed data. 
When EM is used for parameter learning, the M-step of the final iteration calculates 
the BN parameters. When it is used for clustering, the unobserved variables are 
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labelled according to the values in the E-step of the final iteration. In our method, all 
of the values of the unobserved variable are missing from the dataset and we are 
using EM for clustering the unobserved values. Although EM can also be used for 
structure learning (Friedman, 1998, 1997) this is not required in our method as the 
BN structure is developed with domain experts. Extensions of EM that builds upon 
the information bottleneck (Elidan and Friedman, 2006), variational Bayesian 
(Attias, 1999) and hierarchical (Zhang, 2004) frameworks have been proposed for 
learning latent variables. Van Der Gaag et al. (2010) presents a similar approach to 
labelling with expert rules where they represent combinations of multiple 
observations with latent variables. 
We now have two labels for each latent variable: one from clinical measurements 
and the experts’ rules, the other from EM clustering. A final label is achieved by 
combining the two labels in cases where the labels are the same and by expert review 
of cases where there is a difference between the two labelling methods. We prepare a 
list of cases where the labels differ. Domain experts then decide the final label for 
each data record in this list. The experts can review other data including information 
that is not machine-readable and cite relevant research to support this decision. We 
also include a random subset of cases that were labelled consistently in the review to 
assess the experts’ consistency with the labelling by measurements and clustering 
approaches. This combination of expert review and data has a number of advantages. 
It allows for the possibility of errors in measurement, and it uses the experts 
efficiently. Expert review is a costly resource and using it for every single case in the 
data is usually not feasible, especially if the dataset is large. Therefore, our method 
aims to use it only for ambiguous cases, where the labels from measurements 
conflict with the results of the clustering on our data.  
After the expert review, we use the original dataset to which the latent variable labels 
have been added, to learn the BN’s parameters and to evaluate its performance. We 
again use the EM algorithm but this time to learn the parameters, since the dataset 
may still contain missing values of other variables for some patients. The second use 
of the EM algorithm in this step should not be confused with the previous use of the 
same EM algorithm to label latent variables in the step 2A (see Figure 5.1). Expert 
constraints (Helsper et al., 2005) in the form of parameter orders can also be used if 
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the available data is too small for learning a part of the parameters. We use k-fold 
cross-validation to evaluate the performance of the BN. In this approach, the data is 
divided into k equal sized groups. One of the k groups is used as test data while the 
remaining k-1 groups are used for training the BN. The learning and testing 
continues iteratively until the model is validated with all of the k groups. 
The inaccurate predictions of a predictive model offer useful lessons for improving 
the model and are the focus of the next stage of review. The BN modelling approach 
is well-suited for this kind of review since it concretely represents separate medical 
pathways leading to its predictions (Fenton and Neil, 2010; Lucas et al., 2004). 
When the BN model’s prediction in the cross-validation differs from the value 
recorded in the data, the domain experts investigate the reasons for this difference to 
look for potential improvements to the model or clarify its scope. The domain 
experts look at cases where the recorded values are what is expected in their 
experience even though it is different to what was predicted by the model. In some 
cases, the domain experts may agree with the prediction of the model, and they may 
consider the value recorded in the data as an error or simply as an unexpected 
outcome. For example, in a medical decision-support scenario, survival of a patient 
with a severe injury burden and high blood loss might be considered to be an 
unexpected outcome. The expert review can also clarify scope of the model: if the 
recorded outcome is explained by factors that have been excluded from the model 
then this should be made clear to the model’s users. For example, the experts might 
note that patient who unexpectedly survived did so as a result of a particular pre-
hospital treatment, and the model could not identify this as pre-hospital interventions 
were out of the scope of the model. Alternatively, additional latent variables and 
relations that are important for the predictions can be discovered and added to the 
model. Since the BN’s structure represents domain knowledge, any modifications 
must be supported by evidence. 
Differences between the available data and the target subpopulation of the BN must 
be examined as the knowledge from these two sources is combined in our method. 
Correlations, caused by these differences, must be analysed and modelled in the BN 
structure in order to avoid developing erroneous models (Druzdzel and Díez, 2003). 
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5.3 Case Study: Trauma Care 
We illustrate our methodology with the ATC BN which aims to provide decision 
support for the first outcome of the mangled extremity case study (see Section 4.1.2 
for a description of three main outcomes in the case study). The details of the case 
study and the development and validation datasets of the ATC BN are described in 
Chapter 4. In this section, we recap limitations of the data driven models. Next, we 
discuss the significance of ATC in trauma care and challenges of predicting ATC. 
The structure of the ATC BN is also presented in this section. 
5.3.1 Data-driven Models in Trauma Care 
Several data-driven prediction models have been developed for decision support in 
trauma care (see Section 4.2) but with little impact in clinical practice due to the 
limitations discussed in Section 5.2:  
1. Measurement errors: in the previous models to predict ATC, the presence of 
ATC is identified with a threshold value on a blood test called international 
normalised ratio (INR) (Mitra et al., 2011) despite the fact that this test has 
known limitations at identifying this condition. This approach has been 
criticised as it fails to produce useful clinical results (Brohi, 2011). 
2. Sub-optimal decisions: models that predict the decision values in data have 
been developed in other areas of trauma care. One example is decision 
support for injured extremities which encompasses knowledge of the 
presence of ATC. Several data-driven models have been developed to predict 
amputation decisions in this domain (see Section 4.2). Although some of 
these models have been used as research or evaluation tools, none of them 
have been recommended as a decision support tool in clinical practice (Bosse 
et al., 2001). The output of these models shows the percentage of clinicians 
that made amputation decision in similar circumstances. However, 
recommending an amputation without relating it with patient outcomes 
makes it difficult to assess the model or to understand its reasoning. 
Moreover, recent advances in trauma care may have made some of the 
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decisions in the training data inappropriate for current use.  A more useful 
prediction for the decision-maker would be to compare the function expected 
from a salvaged versus an amputated extremity, given the characteristics of 
the injury factors. 
3. Causes of outcomes: Variables about sensation in the foot has been included in 
previous trauma models as a predictor of amputation even though this variable 
is known to indicate temporary nerve problems, therefore not recommended as 
a decision factor (see Section 4.2.2). Yet, some clinically important factors, 
such as nerve recovery and causes of nerve dysfunction, were ignored in the 
data-driven models as the data were not available. Considering the irreversible 
outcomes of amputation decisions, all relevant factors should be examined. 
5.3.2 Acute Traumatic Coagulopathy 
Acute traumatic coagulopathy (ATC) is one of the most critical risks regarding 
patient physiology in early stages of trauma care. Up to a quarter of trauma patients 
develop ATC soon after their injury. These patients have a considerably higher risk 
of bleeding and death since the body’s protective mechanisms to limit bleeding are 
deranged. Several effective treatment options are available if ATC can be identified 
early. Immediate treatment is most effective however; standard laboratory tests to 
identify ATC take over an hour to produce results. The primary aim of the BN model 
is therefore to predict ATC with the information normally available within the first 
10 minutes of care. It should be noted that the variables included in the BN are not 
limited to the ones that are available in the first 10 minutes; the predictions of the BN 
are generated by instantiating only those variables that can be observed in 10 
minutes of care. The methodology we have described is relevant to this problem: the 
values of both ATC and of its causal factors are measured but none of the 
measurements are perfectly accurate. 
5.3.3 ATC Bayesian Network 
The initial structure of the BN, shown in Figure 5.2, was developed with domain 
experts using the AgenaRisk software (Agena Ltd, 2013). The BN structure contains 
two latent variables: ATC and Hypoperfusion. In addition, several other variables are 
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available in the training dataset but are usually unobserved in the first 10 minutes of 
treatment when the model is designed to be used. Each of these unobserved and 
latent variables is modelled with their measurements as naïve BN fragments or 
‘measurement idioms’ (Neil et al., 2000). These naïve BN fragments were used as 
building blocks to form the BN structure, connected using causal relations elicited 
from experts. Table 5.1 shows the variables modelled with measurement idioms. 
 
Figure 5.2 ATC BN 
Table 5.1 Measurement Idioms in the ATC BN 
Latent Variables Measurements / Markers 
ATC ROTEMA5*, ROTEMA30*, INR*, PTR*, APTTR*  
Hypoperfusion Lactate, BE*, pH, SBP*, HR* 
Variables Unobserved at 
First 10 Minutes 
Measurements / Markers 
Chest Injury Haemothorax (HT) 
Abdomen Injury FAST* Scan 
Pelvic Injury Long Bone Injury (LB), Unstable Pelvis (UP) 
Head Injury Glasgow Coma Score (GCS) 
*APTTR: Active partial thromboplastin time ratio, BE: Base excess, FAST: Focused assessment 
with sonography for trauma HR: Heart rate, INR: International normalised ratio, PTR: 
Prothrombin ratio, ROTEMA5 and A30: Amplitude of rotational thromboelastometry extem test 
at 5th and 30th minute, SBP: Systolic blood pressure 
The model is divided into four components, corresponding to the four boxes shown 
in Figure 5.2. The remainder of this section explains the variables and relations in 
each of these components briefly: 
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 Coagulopathy: the ATC variable has two states: ‘Present’ and ‘Absent’, and 
it can be estimated from 5 measurements. None of these measurements are 
available within the first 10 minutes but the variables are useful for model 
development. The main drivers of ATC are the degree of tissue injury and 
hypoperfusion. This may be aggravated by the infusion of large volumes of 
fluid (PreHosp). 
 Shock: The hypoperfusion variable represents inadequate oxygen delivery to 
tissues as a result of blood loss, and it has three states: ‘None’, Compensated’ 
and ‘Uncompensated’.  It can be estimated by 5 measurements: base excess 
(BE), lactate, pH, systolic blood pressure (SBP) and heart rate (HR). BE, 
lactate and pH are all relevant to the acidity of blood and they can be 
measured by a single, point-of-care, blood gas test. Blood gas test results are 
available within a few minutes. SBP and HR are continuously measured after 
admission to the hospital.  
 Injury: The degree of overall tissue injury may not be known at the early 
stages of care. Overall tissue injury is estimated from the mechanism and 
energy of injury, and the number of severely injured body regions in the BN. 
Injury in each body part is estimated by mechanism and energy of injury, and 
also by clinical or radiological markers that would be expected to be 
available within 10 minutes of care: haemothorax (HT), FAST scan, long 
bone injuries (LB), unstable pelvic fracture (UP) and Glasgow coma score 
(GCS). 
 Death: The model predicts death caused by physiological derangements, i.e. 
ATC and hypoperfusion. Age is an established independent predictor of 
death and has important effects on the physiological response to injury. Head 
injury is also a major cause of trauma deaths and thus the BN is refined to 
predict this (see Section 5.2.2).   
Table 5.2 shows a brief description and the state-space of each variable in the ATC 
BN. The training and validation datasets of the ATC BN are described in Section 
4.3.1. 
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Table 5.2 Variable Definitions and States in ATC BN  
Variable Description States 
ATC* Acute Traumatic Coagulopathy {Present, Absent} 
ROTEM A30 Amplitude of ROTEM 
EXTEM at 30th minute 
Continuous 
ROTEM A5 Amplitude of ROTEM 
EXTEM at 5th minute 
Continuous 
INR International normalised ratio Continuous 
PTR Prothrombin ratio Continuous 
APTTr Activated Partial 
Thromboplastin time 
Continuous 
PreHosp Amount of liquids infused 
before admission to hospital. 
{≥ 500ml, <500ml} 
Hypoperfusion* Decrease in the volume of 
blood perfusion to tissues. 
{Uncompensated, Compensated, 
None} 
BE Base excess in blood Continuous 
pH pH of blood Continuous 
Lactate Amount of lactate in blood Continuous 
HR Heart Rate Continuous 
SBP Systolic Blood Pressure Continuous 
Bleeding Parts Number of bleeding main body 
parts 
{0, 1, 2, 3, 4} 
Death Risk of death in 48 hours {Yes, No} 
Age Patient’s age {≥ 65, <65} 
Tissue Injury Severity of the overall tissue 
injury defined by injury 
severity score (ISS) 
{Profound (ISS ≥ 45), Severe (45 > 
ISS ≥ 30), Moderate (30 > ISS ≥ 15), 
Mild (ISS < 15)} 
Injured Parts Number of severely injured 
main body parts 
{0, 1, 2, 3, 4} 
Chest Severe chest injury {Present (AIS ≥ 3), Absent (AIS < 
3)} 
Abdomen Severe abdomen injury  {Present (AIS ≥ 3), Absent (AIS < 
3)} 
Pelvis & 
Extremity 
Severe pelvis and extremity 
injury 
{Present (AIS ≥ 3), Absent (AIS < 
3)} 
Head Severe head injury {Present (AIS ≥ 3), Absent (AIS < 
3)} 
Energy Energy of Injury. {Low, High} 
Mechanism Mechanism of Injury {Penetrating, Blunt} 
HT Haemothorax {Present, Absent} 
UP Unstable pelvis {Present, Absent} 
LB Long bone injury {Present, Absent} 
GCS Glasgow coma scale Integer between [3,15] 
FAST FAST scan result {Positive, Negative} 
*ATC and Hypoperfusion variables were not available in the datasets. 
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5.3.4 Issues with ATC Measurements 
The true state of ATC, which is the main outcome of our model and a crucial factor 
in trauma care, cannot be directly observed in practice, even after all the laboratory 
measurements have been completed. The ATC state is estimated using laboratory 
measurements such as the clotting time of a blood sample. However, none of these 
measurements can estimate the underlying ATC state with complete certainty. One 
measurement is the INR which is the normalised ratio of the clotting time of a 
patient’s blood plasma to the clotting time of a healthy person. INR, and its clinically 
interchangeable measure prothrombin ratio (PTR), are the clinically accepted 
standard for diagnosing ATC (Frith et al., 2010). A normal INR value is 1, meaning 
that a patient has the same clotting time as a healthy person, and higher INR values 
indicate coagulation problems. However, there is not a clear borderline to distinguish 
normal coagulation from coagulopathy. Given that the actual mechanism of 
coagulation is complex and incompletely understood, INR and similar measurements 
have limitations that lead to uncertainty in the diagnosis of coagulopathy: 
1. INR only tests blood plasma, disregarding other components essential to 
clotting such as the contribution made by platelets and the blood vessel wall. 
2. INR does not measure the strength of a formed clot, the primary abnormality 
in ATC. It only measures the time it takes to form a clot. 
3. INR is designed to monitor the effects of the drug Warfarin; it is not 
specifically designed for trauma. 
Developing and validating a model that predicts INR values is convenient, but 
predicting INR is quite different from predicting the underlying coagulopathy state. 
For example, Mitra et al. (2011) used an INR of 1.5 as a threshold value for 
classifying ATC. However, a patient with an INR of 1.3 may have serious 
coagulation problems. 
Consequently, the true underlying coagulopathic state of some patients cannot be 
known with certainty until a completely accurate way of measuring coagulopathy is 
discovered. Until then, clinicians will continue to estimate coagulopathy using their 
clinical judgement together with available measurements and observations. These 
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clinical judgements are not recorded in the hospital database. Only the data about 
INR and similar measurements are recorded in the dataset. The situation is similar 
for ‘Hypoperfusion’ which is the other latent variable in our model. 
5.4 Learning 
5.4.1 Initial Labelling with Expert Thresholds and 
Clustering 
The latent variables were labelled twice using two different methods: first using 
measurement thresholds that reflect current clinical understanding (Brohi et al., 
2003; Davenport et al., 2011; Frith et al., 2010), and then by clustering using the EM 
algorithm (2A and 2B of Figure 5.1). The thresholds used for labelling the ATC and 
Hypoperfusion variables are shown in Table 5.3. As a result of missing data, a 
number of patients could not be labelled. The labelling criteria for Hypoperfusion 
(see Table 5.3) are not complete so this state could not be labelled for several 
patients.  Clustering was performed using the EM algorithm on the BN structure 
shown in Figure 5.2. EM uses all of the observed values and the BN structure to 
classify the data into coherent groups based on the maximum likelihood estimate of 
the latent variables. We used EM to classify the data into two coherent ATC states 
and three coherent hypoperfusion states. 
Table 5.3 Criteria for Labelling ATC and Hypoperfusion from Measurements in Data 
ATC 
No Yes 
INR≤ 1.2 INR> 1.2 
Hypoperfusion 
None Compensated Uncompensated 
BE≥-2 & Lactate≤2 & 
SI<0.9 
SBP<90 & BT>4 BE<-4 & Lactate>4 & 
BT>0 
Alive & BT in 12 Hours=0 -4≤ BE<-2 & 2<Lactate≤4 & 
BT>0 
Pre-hospital cardiac arrest 
Died in > 48 hours & 
BT=0 
 Death from haemorrhage 
BT= Blood Transfusion in 12 Hours, SI = Shock Index, BE= Base Excess, SBP= Systolic 
Blood Pressure 
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5.4.2 Expert Review of the Labelling Differences 
We compared the labels given by the measurement threshold and clustering 
approaches and prepared a list of the patients with differing labels, no label and a 
random subset of other cases. Three domain experts independently reviewed these 
cases and provided an expert label. All clinical information was available to the 
experts to assist labelling. The experts were blind to the labels assigned by the 
measurement threshold and EM clustering methods. The consensus between the 
experts’ labels was assigned as the final label. Table 5.4 shows the number of cases 
reviewed for the two latent variables. 
Table 5.4 Number of Cases Reviewed by Domain Expert 
Hypoperfusion ATC 
Label Differs No Label Label Same Label Differs No Label Label Same 
114 57 17 27 10 17 
Total: 188 Total: 54 
This method required the domain experts to review 188 (31%) and 54 (9%) of the 
600 cases respectively to label the hypoperfusion and ATC categories. Table 5.5 and 
Table 5.6 show the number of measurement threshold labels changed after the 
review: for example Table 5.5 shows that 6 patients classified as coagulopathic on 
the basis of the INR threshold were re-classified to non-coagulopathic by the expert 
review. At the end of this step, each latent variable had a single set of labels that 
were obtained from the combination of measurement threshold and clustering 
approaches, and the expert review of the differing labels. 
Table 5.5 Measurement Threshold ATC Labels Changed by Expert 
ATC Label Review -  Measurements 
 After Review 
Measurements Yes No Unlabelled 
Yes 57 6 - 
No 3 524 - 
Unlabelled 1 5 4 
Total: 600 
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Table 5.6 Measurement Threshold Hypoperfusion Labels Changed by Expert 
Hypoperfusion Label Review – Measurements 
 After Review 
Measurements Uncomp. Comp. None Unlabelled 
Uncomp. 62 9 4 - 
Comp. 1 52 5 - 
None 1 6 403 - 
Unlabelled - 17 35 5 
Total: 600 
5.4.3 Learning and Cross-Validation 
The result of the expert review (step 3 of Figure 5.1) is a dataset now including 
values for the latent variables for almost all patients. The ATC value of 4 patients 
and Hypoperfusion value of 5 patients remained unlabelled after the expert review 
because the expert was not confident about the correct value. We used the standard 
EM algorithm to learn the parameters of the model. The performance of the model 
trained on the RLH data was tested by 10-fold cross validation. Only the variables 
that can be observed in the first 10 minutes of treatment are instantiated for 
generating the predictions in 10-fold cross validation. 
Performance of a model can be measured in terms of its discrimination, calibration 
and accuracy. Discrimination measures whether the model can distinguish the 
patients with the event. A model that has well discriminatory performance gives 
higher probabilities to the patients with the event, and lower probabilities to the 
patients without the event. Calibration measures whether the predicted probability 
represents the correct probability on average. For example, when a model predicts 
10% chance of survival for a group of patients, 10% of these patients are expected to 
survive if the model is well calibrated. Accuracy measures whether the predicted 
outcomes are close to the actual outcomes by combining features of discrimination 
and calibration. Medlock et al. (Medlock et al., 2011) recommends using multiple 
performance measures to quantify different aspects of the model performance. 
We used multiple performance measures to assess the discrimination, accuracy and 
calibration of the ATC BN as recommended by the Medlock framework (Medlock et 
al., 2011). The discrimination of the ATC BN was evaluated with receiver operating 
characteristic (ROC) curves, sensitivity and specificity values. The area under the 
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ROC curve (AUROC) is 0.90 and 0.81 for the prediction of ATC and death 
respectively. Brohi (2011) argues that a useful prediction model for coagulopathy 
must operate with at least 90% sensitivity: the BN achieves specificities of 71% for 
ATC and 44% for death when operating with 90% sensitivity. The initial 
performance of the model on the cross-validation dataset can be seen in Table 5.7. 
Table 5.7 Initial Cross Validation Results 
 ATC Death 
AUROC 0.90 0.81 
Specificity* 71% 44% 
Specificity** 83% 67% 
Brier Score 0.06 0.09 
Brier Skill Score 0.32 0.15 
*At 0.90 sensitivity **At 0.80 Sensitivity 
The accuracy of the BN was evaluated with the Brier score (BS) and Brier skill score 
(BSS) (Brier, 1950; Weigel et al., 2007). BS is the mean squared difference between 
the predicted probability and actual outcome. The score can take values between 0 
and 1; 0 indicates a perfect model and 1 is the worst score achievable. BSS measures 
the improvement of the model’s prediction relative to a reference prediction which is 
often the average probability of the event in the data. BSS can take values between 
negative infinity and 1; a negative value indicates a worse prediction than the 
average probability and 1 indicates a perfect model. The BN has BS of 0.06 and BSS 
of 0.32 for ATC predictions, BS of 0.09 and BSS of 0.15 for death predictions. 
The calibration of the BN was assessed with the Hosmer-Lemeshow test (Hosmer 
and Lemeshow, 1980). This test divides the data into 10 subgroups, and calculates a 
chi-square statistic comparing the observed outcomes to the outcomes expected by 
the model in each subgroup. Low p-values indicate a lack of calibration. Hosmer-
Lemeshow test is strongly influenced by the sample size. In large datasets, small 
differences between the expected and observed outcomes can lead to low p-values 
but the visual representation of this test provides a concise summary of the model 
calibration. 
The BN was well calibrated for both ATC and death predictions with Hosmer-
Lemeshow statistics of 9.7 (p=0.29) and 6.7 (p=0.57) respectively. Figure 5.3 is a 
visual representation of the model’s calibration for ATC predictions. The similarity 
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between the expected and true outcomes in each subgroup shows that the model was 
well calibrated. 
 
Figure 5.3 Model Calibrations for ATC Predictions 
5.4.4 Inaccurate Predictions and Unexpected Clinical 
Outcomes 
After the learning and cross-validation steps, we reviewed the inaccurate predictions 
of the model with the domain experts (step 5 of Figure 5.1). We divided the 
predictions, given by cross validation of the model, into ten bins according to the 
predicted probability, and prepared a contingency table that compares the predictions 
of the model to the outcome values in data for each bin as shown in Table 5.8. 
Table 5.8 Predictions and Recorded Outcomes 
ATC 
Prediction 
Outcome in Data 
P ATC=Yes ATC=No 
1.0 > P ≥ 0.9 0 0 
0.9 > P ≥ 0.8 1 1 
0.8 > P ≥ 0.7 5 1 
0.7 > P ≥ 0.6 15 5 
0.6 > P ≥ 0.5 7 8 
0.5 > P ≥ 0.4 7 8 
0.4 > P ≥ 0.3 1 8 
0.3 > P ≥ 0.2 7 25 
0.2 > P ≥ 0.1 6 40 
0.1 > P ≥ 0.0 12 440 
Total 61 535 
The negative outcomes with ATC prediction over 0.1, and the positive outcomes 
with ATC prediction less than 0.1 (shown in bold in Table 5.8) were considered as 
the possibly inaccurate predictions since 10% of the patients were initially labelled 
with ATC and thus 0.1 was our prior probability. A clinician reviewed the data and 
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patient notes for each of these 108 cases and analysed the possible causes of each 
unexpected prediction: 
a. Expert agrees with the prediction: The actual outcome is unexpected, 
possibly requiring further clinical investigation. Another possible 
explanation is incorrectly recorded data.  
b. Expert expects the recorded outcome: The model was considered to be 
making inaccurate predictions for these cases.  The clinician decided that 
the outcome value in the data is clinically expected and analysed the 
causes of the inaccurate predictions. These inaccuracies could be caused 
by an error in the model structure.  
Table 5.9 gives a summary of this review: the domain experts agreed with about a 
third of the apparently inaccurate predictions. During the review, domain experts 
explained why they agreed with the individual predictions or recorded outcomes 
which led to a number of refinements to the model and to the clinicians’ 
understanding of the data. Death predictions were also reviewed by the same 
approach. We describe these issues and the way the model was refined in the 
following section. 
Table 5.9 Inaccurate Predictions and Expert Review 
ATC 
Prediction P 
Prediction 
differs from the 
recorded 
outcome 
Expert agrees 
with the 
prediction 
0.9 > P  ≥ 0.8 1 0 (0%) 
0.8 > P  ≥ 0.7 1 1 (100%) 
0.7 > P  ≥ 0.6 5 5 (100%) 
0.6 > P  ≥ 0.5 8 4 (50%) 
0.5 > P  ≥ 0.4 8 5 (63%) 
0.4 > P  ≥ 0.3 8 6 (75%) 
0.3 > P  ≥ 0.2 25 8 (32%) 
0.2 > P  ≥ 0.1 40 6 (15%) 
0.1 > P  ≥ 0.0 12 2 (17%) 
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5.5 Model Refinement 
Three issues were found from the review of inaccurate predictions: 
1. ATC may develop in some patients soon after the blood test used for INR 
and other measurements was taken. 
2. Some of the deaths recorded in the dataset were most likely due to conditions 
other than ATC. 
3. There are mechanisms of coagulopathy other than ATC that may be 
occurring in patients in the dataset. 
These issues all challenge the supposed objectivity of data and reinforce the need to 
combine data with expert review. The following sections describe these issues in 
more detail.  
5.5.1 Incipient Coagulopathy 
A group of patients who had normal values for their initial ATC measurements (see 
Table 5.1) showed significant signs of ATC in a second set of measurements that 
were conducted soon after. Moreover, these patients had severe injury burden and 
poor perfusion; they were therefore at high clinical risk of developing ATC. The 
ATC model predicts high risk of coagulopathy for these patients but the value in the 
data is negative since only the initial measurements were considered while labelling 
the ATC state of patients with measurement thresholds and clustering approaches. 
Coagulopathy is a dynamic phenomenon that develops in time, so the results of 
measurements are dependent on the time they are carried out. Variations in the 
interval between the injury and the arrival at the hospital add further uncertainty. 
Therefore, the domain experts considered the prediction of those patients with 
‘incipient coagulopathy’ as a clinically useful feature of the BN. 
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Figure 5.4 Predictions with Incipient Coagulopathy 
We relearnt the ATC BN and recalculated its performance in a cross validation when 
patients with incipient ATC were also considered as positive outcomes. The structure 
of the ATC BN was not changed in this analysis. Figure 5.4 compares the ROC 
curves for ATC prediction based on only the initial measurements with the one for 
patients with incipient ATC. The AUROC is 0.92, and the model achieves specificity 
of 79% with sensitivity of 90%, BS of 0.06 and BSS of 0.39. 
Prediction of incipient coagulopathy shows the difference between the clinically 
useful models and the models that predict measurements in data well. The patients 
with incipient coagulopathy would count as incorrect predictions for a purely data-
based approach, and such an approach would try to change the parameters to 
‘correct’ these predictions. In contrast, the expert was able to explain the apparent 
anomaly and show that predicting incipient coagulopathy was useful; this was not 
obvious at the beginning of the model development. 
5.5.2 Other Causes of Death 
The review revealed that a large proportion of deaths that could not be predicted by 
the BN were the result of head injuries and thus these deaths were expected by the 
domain experts. The ATC model is designed to predict risk of death relevant to 
bleeding and coagulopathy, so the initial model does not predict deaths related to 
head injuries. However, the model structure is easily modified to predict these deaths 
since we already have a head injury variable in the model which is used to estimate 
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the overall tissue injury burden of patients. By adding an arc between head injury 
and death variable, we increase the accuracy of the model for death prediction. 
Although death might be considered to be the least ambiguous outcome in a clinical 
dataset, our experience shows that this is not the case when there is a mismatch 
between the modelled and actual cause of death. 
This simple modification increased the accuracy of death predictions significantly. 
The AUROC increased from 0.81 to 0.88 as shown in Figure 5.5. The specificity of 
the BN is increased from 44% to 72% when it is operated at 90% sensitivity level. 
BS and BSS also indicated an increased accuracy in the death predictions: BS of the 
BN decreased from 0.09 to 0.08; and BSS increased from 0.15 to 0.23. This change 
had no impact on ATC prediction. 
 
Figure 5.5 Predictions with Head Injury Modification 
5.5.3 Unmodelled Mechanisms of Coagulopathy 
The aim of this BN is to predict ATC, which is driven by a combination of the 
degree of tissue injury and hypoperfusion following traumatic injuries. The scope of 
the model has to be clearly defined since other forms of coagulopathy exist. For 
example, the anticoagulation medicine Warfarin makes a person coagulopathic 
without any traumatic injury, and predicting drug induced coagulopathy is out of 
scope for this model. 
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Another important cause of traumatic coagulopathy is a catastrophic brain injury. 
These injuries seem to effect coagulation via a different mechanism to ATC.  The 
review of unexpected predictions showed that 9 of the 12 coagulopathic patients that 
the BN model could not accurately predict had severe head injuries, and in 7 of these 
patients brain injury was fatal. It is likely that these patients were suffering from a 
coagulopathy caused by brain injury (BIC) rather than ATC. 
BIC is now documented as being outside the scope of our BN. This issue was not 
clear at the beginning of the model development even though the clinicians were 
aware of the phenomenon; it was identified as a result of the review of inaccurate 
predictions with the domain expert. If prediction of the BIC is required by the users, 
the model structure can be adapted accordingly by adding two variables ‘BIC’ and 
‘Coagulopathy’ as shown in Figure 5.6. In this model fragment, ‘Coagulopathy’ 
variable represents the overall coagulopathy risk that sums the risk of ‘BIC’ and 
‘ATC’ variables. 
 
Figure 5.6 BN Structure Refined for Brain Injury Induced Coagulopathy 
5.6 Temporal and External Validation 
Further validation of the model, with the head injury and incipient coagulopathy 
modifications, was done on the test and external datasets (see Section 4.3.1 for a 
description of these datasets). These datasets are composed of exactly the same 
variables as the training dataset as all datasets were collected as a part of an 
international collaboration. The ATC states in the test and external datasets were 
labelled using the methodology described in Section 5.2. 
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A temporal validation of the ATC BN was done using the test dataset. In the 
temporal validation, the AUROC is 0.94 for the ATC predictions, and 0.92 for the 
death predictions. At 90% sensitivity level, the BN achieves 92% specificity for 
predicting ATC, and 79% specificity for predicting death (see Table 5.10). The ATC 
BN was well calibrated for both ATC and Death predictions at the temporal 
validation (see Figure 5.7a and Figure 5.7b) 
 
Figure 5.7 Calibration of a) ATC b) Death predictions at Temporal Validation 
An external validation of the ATC BN was done using the external dataset. In the 
external validation, the AUROC is 0.90 for ATC predictions, and 0.91 for death 
predictions. The BN achieves 88% specificity and 90% sensitivity for ATC 
predictions; 84% specificity and 90% sensitivity for death predictions (see Table 
5.10). The calibration for ATC and Death predictions on the external data is shown 
in Figure 5.8a and Figure 5.8b respectively. The model was well calibrated for ATC 
predictions. For death predictions, the discrimination of the model was accurate but 
there were more deaths in the external data than it was expected by the model. A part 
of these deaths were caused by factors such as neck and chest injuries which are 
outside the scope of the ATC BN. 
Table 5.10 Temporal and External Validation Results 
 Temporal Validation External Validation 
 ATC Death ATC Death 
AUROC 0.94 0.92 0.91 0.90 
Specificity* 92% 79% 88% 81% 
Specificity** 94% 87% 90% 84% 
Brier Score 0.05 0.06 0.07 0.10 
Brier Skill Score 0.48 0.30 0.27 0.30 
*At 0.90 sensitivity **At 0.80 Sensitivity 
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Figure 5.8 Calibration of a) ATC b) Death predictions at External Validation 
5.7 Conclusion 
This chapter proposed a method for developing and refining BNs with latent clinical 
conditions, using a combination of expert knowledge and data. The method is 
successfully applied to a clinical case study about the prediction of ATC in trauma 
care. Our method addresses the problems related to measurement errors and causes 
of outcomes by: 
1. Making a clear distinction between a latent variable that we wish to predict 
for decision support and any measurements of this variable that may be 
recorded in a dataset; both latent and observed variables are represented 
explicitly in the BN model. 
2. Using iterative expert review of the model to refine the model and to 
understand the relationship between the data and the real decision problem. 
Our methodology systematically integrated domain expertise into model 
development at two stages. Firstly, the ‘true’ but unobserved state was added to a 
dataset by combining labelling by observed measurements with data clustering in an 
expert-elicited BN structure. Focussing the detailed expert review on the cases 
labelled differently in these two steps saves time compared to a review of all cases. 
Secondly, the experts examined differences between the model’s predictions and the 
data. 
In our case study, this examination revealed several issues initially neglected by our 
experts and emphasised the difference between useful predictions for the decision-
maker and an accurate prediction of measurements in data. Other latent and observed 
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causes of predicted outcomes, which were not clear at the beginning, were modelled 
during the review. These issues were resolved either by refining the model or by 
acknowledging the scope of its applicability, which were not obvious at the initial 
stages of model development. 
The case study demonstrates significant improvements in predictions from the 
iterative expert reviews and refinements. Identifying and including the other causes 
of death increased the specificity for death predictions from 44% to 72% when the 
model is operated at 90% sensitivity. Similarly, identifying the clinically important 
patient subgroup with incipient coagulopathy increased the specificity for ATC 
predictions from 72% to 79% at 90% sensitivity. The ATC BN performed well in the 
temporal and external validations. 
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Building Bayesian Networks 
using the Evidence from  
Meta-analyses 
Meta-analysis is an important statistical tool for EBM as it combines evidence from 
multiple studies to infer the overall effect and variation. By combining the results 
from individual datasets, meta-analysis can provide evidence based on a larger 
number of patients compared to the size of the individual datasets. This is beneficial 
especially for uncommon medical conditions, such as mangled extremities, where 
data is typically available in small amounts. Chapter 4 illustrated the need for 
combining evidence from different sources to develop useful decision support 
models in this domain. 
However, many medical studies report ‘univariate’ relations between a single factor 
and a single outcome. RCTs, for example, analyse the effect of a single treatment by 
using randomisation to decrease the confounding effect of other variables. Similarly, 
many observational studies report the relation between individual risk factors and 
outcomes even when the dataset contains information about multiple factors. 
Moreover, medical studies rarely present their raw data (Vickers, 2006).  
Meta-analysis can effectively combine evidence about univariate relations but 
decision support from such evidence is limited in most circumstances. Clinical 
decisions are often complex (Buchan et al., 2009). They require decision maker to 
evaluate multiple factors that may interact with each other. For example, separate 
meta-analyses can be conducted to combine the evidence about the individual effect 
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of a treatment and a comorbidity factor. However, if the treatment and comorbidity 
factor interacts with each other, their joint effect may be completely different from 
their individual effects. In this case, decision support provided by the meta-analysis 
of individual effects may be invalid for a patient who is exposed both to the 
treatment and the comorbidity factor (see Marshall  (2006) and Rawlins (2008) for a 
discussion of generalisation of clinical evidence). More useful decision support can 
be provided by combining the evidence about all plausible causes and interaction 
effects. Statistical techniques, such as multivariate meta-regression, are available for 
combining evidence about multivariate relations, but clinical studies rarely publishes 
information detailed enough to use for these techniques (Vickers, 2006).  
In this chapter, we present a methodology for building decision support models that 
reason consistent with the best available evidence and accounts for the complexity of 
clinical decisions. Our methodology aims to build BNs based on the evidence from 
meta-analysis, expert knowledge and data. As discussed in Chapters 2, 3 and 5, BNs 
offer a powerful framework for providing decision support by combining different 
sources of evidence. However, a systematic methodology to build a BN by using 
meta-analysis results has not been proposed. Our methodology combines the 
evidence from meta-analysis with expert knowledge and data to define the structure 
and parameters of a BN. Our methodology uses auxiliary BNs to learn the 
parameters of the BN used for decision support. We apply this methodology to 
develop a BN that predicts the short-term viability outcomes of lower extremities 
with vascular trauma. 
In the remainder of this chapter, Section 6.1 summarises the meta-analysis 
techniques. Section 6.2 describes our methodology for defining BN structure and 
parameters based on the results of a meta-analysis. Section 6.3 and 6.4 present the 
application and results of this method for the case-study, and Section 6.5 presents the 
conclusions. 
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6.1 Meta-analysis 
Meta-analysis is a statistical method for combining evidence from different RCTs or 
observational studies. It is often used as a part of systematic literature reviews to 
combine the statistics from reviewed studies. 
A RCT or an observational study may compare the outcome of patients who were 
exposed to a treatment or a risk factor against those who were not exposed to this 
factor. For example, a researcher, who aims to investigate the effects of bone 
fractures to the outcomes of lower extremity surgery, examines the fractured lower 
extremities 𝑁𝑃 in the data. He records the number of fractured extremities that had a 
successful operation 𝑆𝑃, and the number of extremities that had a failed operation 𝐹𝑃. 
Afterwards, he examines the lower extremities that were not fractured 𝑁𝐴, and 
records the number of successful 𝑆𝐴 and failed outcomes 𝐹𝐴 among these extremities 
(see Table 6.1). 
Table 6.1 Numbers Presented in the Example about Mangled Extremity 
 Success Fail Total 
Fracture - Present 𝑆𝑃  𝐹𝑃 𝑁𝑃 =  𝑆𝑃 + 𝐹𝑃 
Fracture - Absent 𝑆𝐴 𝐹𝐴 𝑁𝐴 = 𝑆𝐴 +  𝐹𝐴 
The results of this study can be presented in several ways including counts, 
conditional probabilities and odds ratios. Perhaps the crudest way is to present the 
counts. The counts must be transformed into conditional probabilities or other forms 
of ratios in order to compare and combine results from multiple studies. The results 
can be presented by two conditional probabilities: the probability of a successful 
outcome given a fractured lower extremity 𝑃(𝑆|𝑃) = 𝑆𝑃/ 𝑁𝑃 and the probability of a 
successful outcome given a non-fractured lower extremity 𝑃(𝑆|𝐴) = 𝑆𝐴/𝑁𝐴. Rather 
than presenting two conditional probabilities, the effect of a bone fracture can also be 
summarised as a single odds ratio. The odds ratio can be calculated by dividing the 
odds of having a successful outcome with a fractured extremity by the odds of 
having the same outcome with a non-fractured extremity: 
𝑂𝑑𝑑𝑠 𝑅𝑎𝑡𝑖𝑜 =
𝑆𝑃/𝐹𝑃
𝑆𝐴/𝐹𝐴
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Meta-analysis can be used to combine various statistics including conditional 
probabilities and odds ratios. Since BN parameters are composed of conditional 
probabilities, we focus on the meta-analysis of conditional probabilities in the 
remainder of this chapter.  
6.1.1 Fixed and Random Effects Meta-analysis 
Evidence can be combined based on either a fixed effect or a random effects model 
in a meta-analysis. The fixed effect model assumes that all of the individual studies 
in the analysis share the same true effect and that there is no variation between the 
studies (see Figure 6.1a). Therefore, the individual studies are expected to be centred 
on the true effect value, and the only source of variation is dependent on the sample 
size of the studies. However, it is often implausible to assume, especially for 
observational studies, that a single effect is common to all studies. The random 
effects model assumes that several known or unknown factors may cause variations 
(heterogeneity) in the true effect size between the studies. The random-effects model 
accounts for variation between the studies as well as variation within the studies (see 
Figure 6.1b).  
 
Figure 6.1 Illustration of a) Fixed Effects b) Random Effects Models in Meta-analysis 
The assumptions behind the fixed effects model are not realistic in most real-world 
cases. Observational studies, for example, are likely to be heterogeneous. Besides, 
large observational studies are not necessarily preferable to smaller ones as their data 
may contain less detail and more errors (Egger et al., 2001). In the fixed effect 
model, the contribution of each study to the pooled estimate is weighted by their 
sample sizes: the studies with larger sample size accounts for most of the combined 
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evidence whereas small studies may practically have no effect. The random-effects 
meta-analysis is more conservative in allocating weight to sample sizes as it also 
takes heterogeneity into account. 
6.1.2 Bayesian meta-analysis 
Meta-analysis can be conducted using either a frequentist or a Bayesian approach. 
Computation of the frequentist approach is simpler and readily implemented in 
popular statistical software such as SPSS and R. The Bayesian approach has several 
advantages over the frequentist approach including the following (Sutton and 
Abrams, 2001): 
1. It offers a unified modelling framework to model the variation between and 
within the studies. 
2. The results of the meta-analysis can be presented in a predictive distribution 
that takes both heterogeneity and the uncertainty of the pooled estimate into 
account. 
3. Individual study effects do not necessarily follow the normal distribution in 
Bayesian meta-analysis models. 
4. Prior information can be included into the analysis. Priors must be chosen 
with care: it is often useful to conduct a sensitivity analysis for different prior 
alternatives. 
6.1.3 A Bayesian meta-analysis model for combining 
probabilities 
Conditional probabilities from multiple studies can be combined using the Bayesian 
meta-analysis model shown in Figure 6..  This model takes the variation between the 
studies into account, and it does not assume normality for the distribution of 
individual studies.  
The binomial distribution is the probability distribution of the number of positive 
outcomes in 𝑛 independent experiments where the probability of a positive outcome 
is 𝑝 for every experiment. In this model, the result of each individual study 𝑖 is 
modelled with the binomial distribution: 
101 
 
𝑟𝑖~𝐵𝑖𝑛𝑜𝑚𝑖𝑎𝑙(𝑝𝑖 , 𝑛𝑖) 
Where 𝑟𝑖 is the number of positive outcomes observed in the study 𝑖, 𝑝𝑖 is the true 
study probability of the study 𝑖, and 𝑛𝑖 is the sample size of the study 𝑖. 
When combining estimates from different studies, a transformation can be used to model 
the pooled estimates with the normal distribution. For probability values, the logit 
transformation can be used for this purpose. The normal distribution is convenient for 
modelling the pooled estimate and variation between studies. In our model, the logit 
transformation of the true study probability 𝑝𝑖 follows the normal distribution. The 
mean 𝜇 of this distribution represents the transformed pooled estimate, and the 
variance 𝜏2 represents the variation between studies. 
𝑙𝑜𝑔𝑖𝑡(𝑝𝑖) = 𝜃𝑖  
𝜃𝑖 ~𝑁𝑜𝑟𝑚𝑎𝑙(𝜇, 𝜏
2) 
The predictive distribution of the conditional probability for a future study can also 
be calculated by a logit transformation. 
𝜃𝑛𝑒𝑤~𝑁𝑜𝑟𝑚𝑎𝑙(𝜇, 𝜏
2) 
𝑙𝑜𝑔𝑖𝑡(𝑝𝑛𝑒𝑤) = 𝜃𝑛𝑒𝑤 
Finally, priors need to be chosen for the mean and variance of the normal 
distribution. The ignorant priors shown below can be used if informative priors are 
not available. 
𝜇~𝑁𝑜𝑟𝑚𝑎𝑙(0,1000) 
𝜏~𝑈𝑛𝑖𝑓𝑜𝑟𝑚(0,2) 
In order to calculate the posteriors of 𝜇, 𝜏2 and 𝑝𝑛𝑒𝑤, we enter the observed number 
of positive outcomes 𝑟𝑖 and sample sizes 𝑛𝑖 from each reviewed study. The 
posteriors can be calculated by using the dynamic discretisation algorithm (Neil et 
al., 2007) in the AgenaRisk software (Agena Ltd, 2013) or the Markov Chain Monte 
Carlo (MCMC) sampling technique in the OpenBUGS software (Lunn et al., 2009). 
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Figure 6.2 Bayesian Meta-analysis model for pooling proportions 
6.2 Building BNs based on Meta-analysis 
Previous section described a Bayesian meta-analysis technique for pooling 
proportions. In this section, we present a methodology that uses the evidence from a 
meta-analysis of proportions to define the structure and parameters of a BN decision 
support model. Our methodology integrates the evidence from meta-analysis with 
data and clinical knowledge to build the BN. Our methodology assumes that expert 
knowledge, a meta-analysis of univariate relations from a relevant systematic review 
and some data about multivariate relations is available. However, the data is not 
large enough to learn the behaviour of some of the relations in the BN.  
6.2.1 Structure 
Development of a BN structure can be defined in two stages: selecting variables, and 
identifying the relations between those variables. Our aim is to use clinical evidence 
in both of these stages. 
In our method, domain experts use the meta-analysis as a guide for selecting the 
important variables for the BN. They review every variable that is found to have a 
clinically significant effect in the meta-analysis. During the review, they define the 
mechanistic relations between each of these variables and the outcome, and describe 
how these variables clinically affect the outcomes. Expert knowledge about the 
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mechanistic relations allows us to 1) build a causal BN structure based on clinical 
knowledge 2) examine whether each variable is within the scope of the model. 
The mechanistic relations between the observed factors and outcomes often depend 
on several clinical factors that cannot be observed. In this case, latent variables may 
be required to represent the clinical knowledge in the BN. For example, a meta-
analysis may show that a complicated surgery has worse outcomes than its 
alternatives. A decision support model, with only the surgery and outcome variables, 
may therefore never recommend this surgery. However, the reason for the worse 
outcomes can be that the surgery is only applied to patients with more severe 
conditions. Even though its outcomes are worse compared to the average, it may 
perform better in patients with severe conditions. Such knowledge can only be 
provided by domain experts as the meta-analysis contains only the univariate effects. 
Moreover, a latent variable representing the severity of injury is required to model 
this knowledge in the BN structure.  
Knowledge about mechanistic relations also allows knowledge engineers to 
understand whether each variable is within the scope of the BN. Some variables may 
be irrelevant considering the aims and scope of the model even though they have 
significant effects in the meta-analysis. For example, although the complicated 
surgery performs well for severe conditions, it may not be included in the BN if such 
patients are outside its scope.  
6.2.2 Parameters 
Since most studies, especially in the medical domain, publish the results about 
univariate relations, the meta-analysis of such studies provides a probability 
conditioned on a single variable, such as 𝑃(𝑌|𝑋1). Such probability distributions can 
be used for the parameters of BN variables with a single parent but BNs often 
contain variables with multiple parents. The parameters of these variables require 
probabilities conditioned on multiple variables such as 𝑃(𝑌|𝑋1, … , 𝑋𝑛). The 
probability distributions from a meta-analysis of univariate relations cannot be used 
for such BNs.  
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In this section, we present a parameter learning method for combining the results of 
a meta-analysis with data to learn the parameters of a BN variable with multiple 
parents. The Bayesian framework of this method assumes that the data generating 
process of the reviewed studies is similar, but not necessarily the same as the 
available data. The differences between the subpopulations of the data and the 
previous research must be evaluated before applying this method in order to avoid 
developing erroneous BNs (Druzdzel and Díez, 2003). In the remainder of this 
section, we illustrate the proposed method by a simple example in Section 6.2.2.1, 
and we present the generalisation of the method in Section 6.2.2.2. 
6.2.2.1 Illustration of the Parameter Learning Method 
In this section, we illustrate our parameter learning method with the simple BN 
shown in Figure 6.3.  
 
Figure 6.3 Simple BN for Illustrating the Parameter Learning Method 
This BN has 3 variables and each of the variables has 2 states: 
𝑋1 = {𝑥1
1, 𝑥1
2} 
𝑋2 = {𝑥2
1, 𝑥2
2} 
𝑌 = {𝑦1, 𝑦2} 
Table 6.2 NPT of the Variable Y 
 𝑋1 = 𝑥1
1 
 𝑋2 = 𝑥2
1  
𝑋1 = 𝑥1
1 
 𝑋2 = 𝑥2
2  
𝑋1 = 𝑥1
2 
 𝑋2 = 𝑥2
1 
𝑋1 = 𝑥1
2  
𝑋2 = 𝑥2
2  
𝒀 = 𝒚𝟏 𝑃(𝑦1|𝑥1
1 , 𝑥2
1) 𝑃(𝑦1|𝑥1
1 , 𝑥2
2) 𝑃(𝑦1|𝑥1
2 , 𝑥2
1) 𝑃(𝑦1|𝑥1
2 , 𝑥2
2) 
𝒀 = 𝒚𝟐 1 − 𝑃(𝑦1|𝑥1
1 , 𝑥2
1) 1 − 𝑃(𝑦1|𝑥1
1 , 𝑥2
2) 1 − 𝑃(𝑦1|𝑥1
2 , 𝑥2
1) 1 − 𝑃(𝑦1|𝑥1
2 , 𝑥2
1) 
Table 6.2 shows the NPT of the variable 𝑌. We require 4 parameters for this NPT: 
𝑃(𝑦1|𝑥1
1, 𝑥2
1), 𝑃(𝑦1|𝑥1
1, 𝑥2
2), 𝑃(𝑦1|𝑥1
2, 𝑥2
1) and 𝑃(𝑦1|𝑥1
2, 𝑥2
2). 
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The parameters of the variable 𝑌 can be learnt from data using the maximum 
likelihood estimate (MLE) approach. For example, 𝑃(𝑦1|𝑥1
1, 𝑥2
1) can be estimated by 
dividing 𝑀[𝑦, 𝑥1
1, 𝑥2
1] to 𝑀[𝑥1
1, 𝑥2
1], where 𝑀[𝑦, 𝑥1
1, 𝑥2
1] represents the count of data 
instances where 𝑌 = 𝑦1, 𝑋1 = 𝑥1
1 and 𝑋2 = 𝑥2
1, and 𝑀[𝑥1
1, 𝑥2
1] represents the count 
of data instances where 𝑋1 = 𝑥1
1 and 𝑋2 = 𝑥2
1. 
𝑃(𝑦1|𝑥1
1, 𝑥2
1) =
𝑀[𝑦1, 𝑥1
1, 𝑥2
1]
𝑀[𝑥1
1, 𝑥2
1]
 
Suppose we have a dataset with a sample size of 𝑀 = 250 to learn the parameters of 
the BN in Figure 6.3. Table 6.3 shows a part of the relevant counts from this 
imaginary dataset. There is only 3 data instances where 𝑌 = 𝑦1, 𝑋1 = 𝑥1
1 and 𝑋2 =
𝑥2
2 as shown by the first row of this table. 
Table 6.3 Some Relevant Counts from the Data 
Counts in the 
Data 
𝑴[𝒚𝟏, 𝒙𝟏
𝟏, 𝒙𝟐
𝟏] 3 
𝑴[𝒚𝟏, 𝒙𝟏
𝟏, 𝒙𝟐
𝟐] 25 
𝑴[𝒙𝟏
𝟏, 𝒙𝟐
𝟏] 10 
𝑴[𝒙𝟏
𝟏, 𝒙𝟐
𝟐] 160 
𝑴[𝒙𝟐
𝟏] 230 
𝑴[𝒙𝟐
𝟐] 20 
𝑴 250 
Our aim is to estimate the parameters of the BN. Although the overall sample size of 
the data is not small, there is not an adequate amount of data for learning some of the 
parameters. For example, there are only a few data instances to learn the probability 
of 𝑃(𝑦1|𝑥1
1, 𝑥2
1) since  𝑀[𝑦1, 𝑥1
1, 𝑥2
1] = 3 and M[𝑥1
1, 𝑥2
1] = 10. 
As well as the data, suppose we have the results of a meta-analysis that analyses the 
relation between 𝑌 and 𝑋1. This meta-analysis pools the conditional probabilities 
𝑃(𝑦1|𝑥1
1) reported in multiple studies. The result of the meta-analysis is reported by 
the mean, 𝜇𝑝𝑛𝑒𝑤(𝑦
1|𝑥1
1), and variance, 𝜎𝑝𝑛𝑒𝑤
2 (𝑦1|𝑥1
1), of the predictive distribution 
of the pooled conditional probability (see Table 6.4). The way that these statistics are 
calculated is described in Section 6.1.3.  
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Table 6.4 Predictive Distribution Parameters from the Meta-analysis 
Meta-analysis of 𝑷(𝒚𝟏|𝒙𝟏
𝟏) 
Predictive Distribution Parameters 
𝝁𝒑𝒏𝒆𝒘(𝒚
𝟏|𝒙𝟏
𝟏) 0.2 
𝝈𝒑𝒏𝒆𝒘
𝟐 (𝒚𝟏|𝒙𝟏
𝟏) 0.005 
The results of the meta-analysis cannot be directly used for the BN parameters since 
the variable 𝑌 is conditioned on both 𝑋1 and 𝑋2 in the BN model whereas it is 
conditioned only on 𝑋1 in the meta-analysis. In other words, there is no parameter to 
use 𝑃(𝑦1|𝑥1
1) directly in the NPT of the variable 𝑌 (see Table 6.2).   
In the remainder of this section, we present a novel technique that combines the data 
shown in Table 6.3 and the meta-analysis results shown in Table 6.4 to learn the 
parameters 𝑃(𝑦1|𝑥1
1, 𝑥2
1) and 𝑃(𝑦1|𝑥1
1, 𝑥2
2) for the NPT of the variable 𝑌. The 
generalisation of this method for a larger number of parents and states is described in 
Section 6.2.2.2. 
Figure 6.4 shows a BN representation of the implemented technique. The BN 
representation is divided into five components that are described in the remainder of 
this section:  
1. Data: This part uses the binomial distribution to model the relation between 
the CPDs that we aim to estimate and the observed counts in the data. For 
example, the number of data instances where 𝑋1 = 𝑥1
1, 𝑋2 = 𝑥2
2 and 𝑌 = 𝑦2, 
shown by 𝑀[𝑦1, 𝑥1
1, 𝑥2
1], has a binomial distribution where the probability 
parameter is 𝑃(𝑦1|𝑥1
1, 𝑥2
1) and the number of trials parameter is 𝑀[𝑥1
1, 𝑥2
1]. 
The binomial distributions used in this part are shown below: 
𝑀[𝑦1, 𝑥1
1, 𝑥2
1] ~ 𝐵𝑖𝑛𝑜𝑚𝑖𝑎𝑙(𝑀[𝑥1
1, 𝑥2
1], 𝑃(𝑦1|𝑥1
1, 𝑥2
1)) 
𝑀[𝑦1, 𝑥1
1, 𝑥2
2] ~ 𝐵𝑖𝑛𝑜𝑚𝑖𝑎𝑙(𝑀[𝑥1
1, 𝑥2
2], 𝑃(𝑦1|𝑥1
1, 𝑥2
2)) 
𝑀[𝑥2
1] ~ 𝐵𝑖𝑛𝑜𝑚𝑖𝑎𝑙(𝑀, 𝑃(𝑥2
1)) 
𝑀[𝑥2
2] ~ 𝐵𝑖𝑛𝑜𝑚𝑖𝑎𝑙(𝑀, 𝑃(𝑥2
2)) 
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Figure 6.4 BN Representation of the Auxiliary Parameter Learning Model 
2. Probability Distributions for NPT: This part contains the CPDs that we 
aim to estimate for the NPT of 𝑌. We assign a uniform prior for these 
distributions:  
𝑃(𝑦1|𝑥1
1, 𝑥2
1) ~ 𝑈𝑛𝑖𝑓𝑜𝑟𝑚(0,1) 
𝑃(𝑦1|𝑥1
1, 𝑥2
2) ~ 𝑈𝑛𝑖𝑓𝑜𝑟𝑚(0,1) 
3. Marginalisation of NPT Distributions: Since the variable 𝑌 is conditioned 
only on 1 variable in the meta-analysis and 2 variables in the BN, we model 
the probability distribution from the meta-analysis, 𝑃(𝑦1|𝑥1
1), as the 
marginalisation of the probability distribution from the BN parameters 
𝑃(𝑦1|𝑥1
1, 𝑥2
1) and 𝑃(𝑦1|𝑥1
1, 𝑥2
2): 
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𝑃(𝑦1|𝑥1
1) = ∑(𝑃(𝑦1|𝑥1
1, 𝑋2) ∗ 𝑃(𝑋2))
𝑋2
= 𝑃(𝑦1|𝑥1
1, 𝑥2
1)𝑃(𝑥2
1) + 𝑃(𝑦1|𝑥1
1, 𝑥2
2)𝑃(𝑥2
2) 
4. Probabilities Required for Marginalisation: In order to calculate the 
marginalisation in part 3, we need the probability distributions of 𝑃(𝑥2
1) and 
𝑃(𝑥2
2). We assign a uniform prior for these variables. We also assign a 
constraint to ensure that sum of 𝑃(𝑥2
1) and 𝑃(𝑥2
2) equals to 1.  
𝑃(𝑥2
1) ~ 𝑈𝑛𝑖𝑓𝑜𝑟𝑚(0,1) 
𝑃(𝑥2
2) ~ 𝑈𝑛𝑖𝑓𝑜𝑟𝑚(0,1) 
∑ 𝑃(𝑋2)
𝑋2
= 𝑃(𝑥2
1) + 𝑃(𝑥2
2) = 1 
5. Values from Meta-analysis: The pooled estimate 𝜇𝑝𝑛𝑒𝑤(𝑦
1|𝑥1
1)  from the 
meta-analysis is modelled with the normal distribution centred on the 
marginalisation shown in part 3. We use 𝜎𝑝𝑛𝑒𝑤
2 (𝑦1|𝑥1
1) from the predictive 
distribution as the variance of this normal distribution. The normal 
distribution is truncated to a unit interval as it represents a probability value, 
denoted by 𝑇𝑁𝑜𝑟𝑚𝑎𝑙[0,1](𝜇, 𝜎
2). The values from the meta-analysis are 
modelled as: 
𝜇𝑝𝑛𝑒𝑤(𝑦
1|𝑥1
1) ~ 𝑇𝑁𝑜𝑟𝑚𝑎𝑙[0,1] (𝑃(𝑦
1|𝑥1
1), 𝜎𝑝𝑛𝑒𝑤
2 (𝑦1|𝑥1
1)) 
After the observations from the data and meta-analysis is entered to the BN (see 
Figure 6.4), the posteriors for 𝑃(𝑦1|𝑥1
1, 𝑥2
1) and 𝑃(𝑦1|𝑥1
1, 𝑥2
2) can be calculated. Note 
that, the NPT of 𝑌 requires point estimates for 𝑃(𝑦1|𝑥1
1, 𝑥2
1) and 𝑃(𝑦1|𝑥1
1, 𝑥2
2) 
whereas our model calculates the entire probability distribution of these parameters. 
Therefore, we take the mean of these distributions for the point estimates required 
for the NPT. 
In the following section, we describe the generalisation of this technique for 
estimating parameters of variables with more parents or states.  
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6.2.2.2 Generalisation of the Parameter Learning Method 
Let 𝑌 be a BN variable that has 𝑛 parents, and ?̅? = {𝑋1, 𝑋2, … , 𝑋𝑛} be the set of 
parents of 𝑌 (see Figure 6.5). Both 𝑌 and its parents have multiple states: 
𝑌 = {𝑦1, … , 𝑦𝑘} 
𝑋𝑖 = {𝑥𝑖
1, … , 𝑥𝑖
𝑘} 
 
Figure 6.5 BN Model 
Our dataset contains a total of 𝑀 data instances about ?̅? and 𝑌 (see Table 6.5). We 
also have pooled conditional probability and variance estimates of the predictive 
distribution of 𝑃(𝑌|𝑋𝑖) from a meta-analysis (see Table 6.6). The way that these 
statistics are calculated is described in Section 6.1.3. The predictive distribution is a 
recommended way of presenting the results of a meta-analysis as it represents the 
uncertainty from both pooled estimate and heterogeneity (Higgins et al., 2009). 
However, the meta-analysis only provides us with the univariate conditional 
probability estimates; conditional probabilities such as 𝑃(𝑌|𝑋1, 𝑋2) are not available.  
Table 6.5. Sample Learning Dataset 
 Y X1 … Xn 
1 𝑦4 𝑥1
3 … 𝑥2
2 
2 𝑦2 𝑥1
2 … 𝑥2
1 
: 
: 
: 
: 
: 
: 
 : 
: 
M 𝑦1 𝑥1
1 … 𝑥2
4 
Figure 6.6 shows an abstract graphical illustration of the generalised auxiliary 
parameter learning model. This model is a generalisation of the model shown in 
Figure 6.4. This illustration is not a BN; it is a schema for building an auxiliary 
parameter learning BN for any number of states and parent variables. The size of the 
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auxiliary parameter learning BN grows rapidly with increasing number of parents 
and states. 
Table 6.6 Sample Meta-analysis Results 
 𝝁𝑷𝒏𝒆𝒘 𝝈𝑷𝒏𝒆𝒘
𝟐
 
𝑷(𝒀|𝑿𝟏). 0.13 0.007 
𝑷(𝒀|𝑿𝟐). 0.21 0.025 
: 
: 
: 
: 
: 
: 
𝑷(𝒀|𝑿𝒏). 0.19 0.001 
In Figure 6.6, the variables shown by circles are unknown variables that will be 
estimated by the model. The variables shown by rounded rectangles are observed 
with the values from the meta-analysis, and the variables shown by rectangles are 
observed from the dataset. The constraints that sum probabilities to 1 are not 
included in this figure to simplify the illustration. By running this auxiliary model, 
we estimate probability distributions for the parameters 𝑃(𝑌|?̅?) required by the NPT 
of 𝑌. Since the BN requires only a point estimate of the parameter, not the whole 
distribution; we use the mean of this distribution as the BN parameter. 
 
Figure 6.6 Graphical Illustration of the Generalised Auxiliary Parameter Learning Model 
According to our model, the data related to 𝑌, i.e. 𝑀[?̅?, 𝑌], is generated by the 
binomial distribution with the probability of success 𝑃(𝑌|?̅?) and the number of trials 
𝑀[?̅?].  
𝑀[𝑌, ?̅?]~𝐵𝑖𝑛𝑜𝑚𝑖𝑎𝑙(𝑀[?̅?], 𝑃(𝑌|?̅?)) 
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𝑀[?̅?, 𝑌] represents the count of data instances for specific values of 𝑋1, … , 𝑋𝑛 and 𝑌. 
For example, 𝑀[𝑥1
1, 𝑥2
3, … , 𝑥𝑛
4 , 𝑦2] represents the number of data instances where 
𝑋1 = 𝑥1
1, 𝑋2 = 𝑥2
3, … , 𝑋𝑛 = 𝑥𝑛
4 and 𝑌 = 𝑦2. Similarly 𝑀[?̅?] represent the number of 
data instances where 𝑋1, … , 𝑋𝑛 have certain values. 
Our aim is to estimate the CPD of 𝑃(𝑌|?̅?). We assign a uniform prior for this 
distribution; informative expert priors can also be used when available. 
𝑃(𝑌|?̅?)~𝑈𝑛𝑖𝑓𝑜𝑟𝑚(0,1) 
The meta-analysis results are conditioned on a fewer variables than the CPD in the 
BN. Therefore, the expected values of the meta-analysis results are modelled as a 
marginalisation of the CPD. The meta-analysis provided the pooled conditional 
probability estimates about 𝑃(𝑌|𝑋𝑖) that are marginalisations of P(𝑌|?̅?) 
𝑃(𝑌|𝑋𝑖) = ∑ 𝑃(𝑌|?̅?)𝑃(?̅? ∖ {𝑋𝑖})
?̅?∖{𝑋𝑖}
 
𝑃(?̅? ∖ {𝑋𝑖}) is also estimated by the following binomial distribution.  
𝑀[?̅? ∖ {𝑋𝑖}]~𝐵𝑖𝑛𝑜𝑚𝑖𝑎𝑙(𝑀, 𝑃(?̅? ∖ {𝑋𝑖})) 
Where 𝑀 denotes the total number of data instances, and 𝑀[?̅? ∖ {𝑋𝑖}] denotes the 
counts of data instances with ?̅? ∖ {𝑋𝑖}. 𝑃(?̅? ∖ {𝑋𝑖}) has a uniform prior 
𝑃(?̅? ∖ {𝑋𝑖})~𝑈𝑛𝑖𝑓𝑜𝑟𝑚(0,1) 
The pooled estimates from the meta-analysis 𝜇𝑃𝑛𝑒𝑤(𝑌|𝑋𝑖) are modelled with a normal 
distribution that is centred on the marginalisation of the CPD. The normal 
distribution is truncated to a unit interval, i.e. [0 – 1], as it represents a probability. 
The variance of the truncated normal distribution 𝜎𝑃(𝑌|𝑋𝑖)
2  represents the degree of 
uncertainty we assign to the meta-analysis results. We enter the mean and variance 
of the predictive distribution in meta-analysis as observations for 𝜇𝑃𝑛𝑒𝑤(𝑌|𝑋𝑖) and 
𝜎𝑃𝑛𝑒𝑤(𝑌|𝑋𝑖)
2 . We use the truncated normal distribution as it is convenient to define the 
expected value and variance parameters for it but 𝜇𝑃𝑛𝑒𝑤(𝑌|𝑋𝑖) may not be normally 
distributed as it represents a probability value between 0 and 1.  
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𝜇𝑃𝑛𝑒𝑤(𝑌|𝑋𝑖)~𝑇𝑁𝑜𝑟𝑚[0,1](𝑃(𝑌|𝑋𝑖), 𝜎𝑃𝑛𝑒𝑤(𝑌|𝑋𝑖)
2 ) 
Finally, we introduce constraints to ensure that probability distributions sum up to 1.  
∑ 𝑃(𝑌|?̅?) = 1
𝑌
 
∑ 𝑃(?̅? ∖ {𝑋𝑖}) = 1
?̅?∖{𝑋𝑖}
 
∑ 𝑃(𝑌|𝑋𝑖) = 1
𝑌
 
6.3 Case-study 
The method described in Section 6.2 was used for developing a BN that aims to 
predict the short term outcomes of a traumatic lower extremity with vascular injury.  
The LEVT BN is designed for the limb-saving stage of the treatment: it estimates the 
risk of a failure of a salvage attempt, which makes amputation inevitable due to 
inadequate blood supply and nonviable soft tissue in the lower extremity.  
The BN is built in collaboration with the Trauma Sciences Unit at the RLH and the 
ISR. Two trauma surgeons (ZP and NT) were involved in development of the LEVT 
BN. The LEVT dataset (see Section 4.3.2) and a meta-analysis of a systematic 
review were used for developing the LEVT BN. The remainder of this section 
describes the meta-analysis and development methodology of the LEVT BN.  
6.3.1 Meta-analysis for Lower Extremity Vascular Trauma 
Our first step was to conduct a systematic review and meta-analysis of the factors 
affecting outcomes of lower extremity vascular injuries. The systematic review was 
conducted by ZP. The studies published between 2000 and 2012 were searched using 
Medline, EMBASE and CINAHL databases. Another trauma registrar followed the 
same search procedure to evaluate the consistency of the inclusion criteria. Forty-
four articles, containing information about 3054 lower extremity repairs, were 
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included in the systematic review. The protocol for systematic review is published in 
the PROSPERO register of systematic reviews (Perkins et al., 2012).  
Meta-analysis of the systematic review was conducted by the author. The complete 
meta-analysis included pooling of conditional probabilities, odds ratios and risk 
differences regarding 23 variables in 44 studies reviewed in the systematic review. In 
this section, we use a part of the pooled conditional probabilities that are relevant to 
the LEVT BN as pooled conditional probabilities are naturally suited for learning 
BN parameters. We used the model described in Section 6.1.3 to pool the conditional 
probabilities and calculate the predictive distributions. The calculations were done in 
AgenaRisk (Agena Ltd, 2013). Table 6.7 shows the means and variances of these 
predictive distributions. In the following sections, we describe how these results 
were used for defining the BN structure and parameters. 
Table 6.7 Mean and Variances of the Predictive Distributions from the Meta-analysis 
Clinical Factor Predictive Distribution 
 𝜇𝑃𝑛𝑒𝑤 𝜎𝑃𝑛𝑒𝑤
2  
Arterial Repair 
  Graft 
  Primary Repair 
Anatomical Site 
  Femoral 
  Popliteal 
  Tibial 
Associated Injuries 
  MAI* - present 
  MAI* - absent 
  Soft tissue - present 
  Soft tissue - absent 
  Fracture - present 
  Fracture - absent 
  Nerve - present 
  Nerve - absent 
Complications 
  Shock - present 
  Shock – absent 
  Ischaemia time > 6 hrs. 
  Ischaemia time ≤ 6 hrs. 
  CS+ - present 
  CS+ - absent 
 
0.11 
0.05 
 
0.04 
0.14 
0.10 
 
0.22 
0.10 
0.28 
0.09 
0.14 
0.02 
0.12 
0.05 
 
0.12 
0.06 
0.24 
0.05 
0.31 
0.06 
 
0.009 
0.002 
 
0.004 
0.005 
0.018 
 
0.045 
0.006 
0.066 
0.009 
0.013 
0.001 
0.022 
0.016 
 
0.047 
0.030 
0.050 
0.009 
0.008 
0.002 
*MAI= Arterial Injuries at Multiple Levels, +CS: Compartment Syndrome 
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6.3.2 Deriving the BN structure 
The structure of the BN was defined using the methodology described in Section 
6.2.1. A domain expert (ZP) identified the variables that are found to have clinically 
significant effect in the meta-analysis. ZP described the mechanistic relation between 
each of the variables and the predicted outcome, which were modelled in a causal 
BN structure. Knowledge about the mechanistic relations helped us to identify the 
variables that are outside the scope of the BN. For example, nerve injuries were not 
included in the model even though it is found to increase the probability of 
amputation in the meta-analysis. The domain expert indicated that the outcomes 
related to limb function are outside the scope of the LEVT BN, and the amputations 
related to nerve injuries are often caused by pain and poor function outcomes. 
Table 6.8 Observed and Latent Variables in LEVT BN 
Observed Variables Latent Variables 
Arterial Repair 
Anatomical Site 
Multiple Levels (MAI) 
Soft Tissue Injury 
Associated Fracture 
Shock 
Ischemic Time 
Ischemic Degree 
Compartment Syndrome 
Repair Failure 
Number of Injured Tibials 
Nonviable Extremity 
Blood Supply 
Ischemic Damage 
Microcirculation 
Soft Tissue Cover 
 
Several latent variables were introduced while the domain expert identified the 
mechanistic relations between the observed clinical factors and outcomes. These 
variables were clinically important but neither the dataset nor the reviewed studies 
contained them as they cannot be directly observed. For example, both graft repairs 
and soft tissue injuries have higher probabilities of amputation in the meta-analysis. 
However, each of these factors is related to amputation through a different pathway. 
Graft repairs can lead to amputation when the repaired artery bleeds or gets blocked, 
and thus cannot deliver enough blood to the lower extremity. A variable about the 
degree of blood supply is required to model this relation. Although the degree of 
blood supply can be estimated by several measurements, the precise state of this 
variable is difficult to observe and therefore is not in the dataset. Soft tissue injuries 
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can lead to amputation if there is not enough viable soft tissue to cover the injuries 
and to repair the wounds. Similarly, a latent variable about the degree of soft tissue 
cover is required to model this relation into the BN model. Table 6.8 shows a list of 
the observed and latent variables in the LEVT BN structure. These variables are 
described in the remainder of this section. 
The information in our dataset was more detailed, for some variables, compared to 
the information reported in the meta-analysis. For example, soft-tissue injuries were 
modelled with more detailed states in the BN as the dataset had more information 
about this variable. Similarly, information about the degree of ischemia were present 
in the dataset but not in the meta-analysis. Therefore, the BN contains more detail 
about some variables compared to the information obtained from the meta-analysis. 
Model Structure 
The LEVT BN is divided into 5 components, corresponding to the 5 boxes shown in 
Figure 6.7. The remainder of this section describes the LEVT BN by summarising 
the meanings of the variables and relations in each of these components: 
 
Figure 6.7 LEVT BN Structure 
 Lower Extremity Outcome: The aim of the LEVT BN is to predict the risk 
of failure of an attempted salvage for a lower extremity with vascular injury. 
The ‘Nonviable Extremity’ variable represents extremities that are amputated 
as a result of nonviable tissue. A lower extremity can sustain life if there is 
adequate blood flow from the vessels and enough viable soft tissue to cover 
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the vessels. ‘Nonviable Extremity’ is the main outcome variable that the 
LEVT BN aims to predict. 
 Ischaemia: Ischaemia is the deficiency of blood supply as a result of an 
arterial injury or obstruction. Ischaemia causes permanent damage to tissues 
if it continues for a prolonged time. Since our model is built for lower 
extremities with vascular injuries, most of the extremities within the scope of 
our model will be partly or completely ischemic until the vascular injury is 
repaired. The severity of ischaemic damage depends on the time elapsed 
since the beginning of ischemia (Ischaemic Time) and the degree of 
obstruction (Ischaemic Degree). A major cause of ischemia is a compartment 
syndrome, which causes complete obstruction of blood flow due to increased 
pressure in the muscle compartments of a lower extremity.  
 Soft Tissue Damage: This part of the model predicts the projected amount of 
viable soft tissue cover in the lower extremity. Adequate amount of soft 
tissue cover is necessary to repair the tissues and protect them from infection. 
Therefore, soft tissue cover is one of the main factors affecting the viability 
outcome. Our model estimates the amount of soft tissue cover based on the 
amount of non-viable tissue due to the direct damage from the injury (Soft 
Tissue Injury) and ischemia (Ischaemic Damage). 
 Success of Arterial Repair: This part of the model predicts the success of a 
vascular repair operation. ‘Arterial Repair’ variable represents the type of the 
repair operation, and have two states: ‘Graft’ and ‘Primary Repair’. ‘Graft’ 
represents bypassing of the injured artery by a vein harvested from the 
patient. ‘Primary repair’ represents a simpler repair operation such as 
stitching of a small laceration in the artery.  ‘Graft’ repairs have higher rate 
of failure compared to ‘Primary Repair’ as this operation is more complicated 
and applied to more severe cases. Injury characteristics often define the type 
of the arterial repair. For example, an arterial injury cannot be treated by 
primary repair if a significant part of the artery has been torn apart and thus a 
graft is necessary. 
The ‘Multiple Levels’ variable represent whether vascular injuries are present 
at multiple levels of the same extremity. Repair of such injuries have a higher 
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probability of failure as clots are more likely to form when the artery is 
injured at multiple levels.  
‘Anatomical Site’ variable represents the location of the main arterial injury. 
The injury can be at above the knee (femoral artery), at the knee (popliteal 
artery) or below the knee (tibial artery). Reconstruction of a femoral artery 
often has better outcomes compared to a popliteal or a tibial artery.  
 Blood Circulation: ‘Blood Supply’ variable represents the degree of blood 
supply to the lower extremity. This variable essentially depends on the 
‘Repair Failure’ variable. If the vascular repair fails, the extremity will not 
have adequate blood supply; so there is a deterministic relation between the 
negative repair failure and inadequate blood supply. However, a successful 
arterial repair may not guarantee adequate blood supply throughout the lower 
extremity; side factors including ‘Shock’ and ‘Microcirculation’ can also 
affect the outcomes. The ‘Shock’ variable represents an overall deficiency of 
blood supply throughout the body. ‘Microcirculation’ represents the severity 
of injury in the smaller vessels of the lower extremity. 
 
Figure 6.8 LEVT BN Modification for Below the Knee 
The main branch of artery that carries blood to the lower extremity divides 
into three branches below the knee. In other words, a single main branch of 
artery supplies blood for the tissues above the knee whereas three branches, 
called tibial arteries, supply blood for the tissues below the knee. In order to 
model this difference, we modified the BN structure for injuries below the 
knee by adding a variable about the number of injured tibial arteries. This 
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modification is shown by the variable with dashed lines in Figure 6.8. 
Modelling of tibial arteries is important since the extremity is more likely to 
survive if all of the tibial arteries are not injured, even when the arterial repair 
fails. Apart from this difference, the BN models for above the knee and 
below the knee injuries are exactly the same. Table 6.9 shows the description 
and states of each variable in the LEVT BN. 
Table 6.9 Description and States of Variables in LLVI BN 
Variable Description States 
Anatomical Site Level of arterial injury {Femoral, Popliteal, Tibial} 
Arterial Repair Surgical method for treating 
arterial injury 
{Primary, Graft, Ligation} 
Associated Fracture Associated fracture at the 
level of arterial injury 
{True, False} 
Blood Supply Predicted degree of blood 
supply after repair 
{Low, Medium, High} 
Ischaemic Damage Degree of soft tissue damage 
caused by ischaemia 
{Low, Medium, High} 
Ischaemic Degree Degree of obstruction in 
blood supply 
{None, Partial, Complete} 
Ischaemic Time Duration of obstructed blood 
supply 
{<1hr, <3hr, <6hr, ≥6hr} 
Microcirculation Degree of microcirculation 
problems at the level of 
arterial injury 
{Normal, Severe, 
Deranged} 
Multiple Levels Presence of arterial injuries 
at multiple levels 
{True, False} 
Nonviable Extremity Presence of a non-survivable 
lower extremity 
{True, False} 
Number of Injured Tibials Number of tibial arteries 
injured 
{0, 1, 2, 3} 
Shock Presence of uncompensated 
shock 
{True, False} 
Soft Tissue Cover Degree of soft tissue damage 
due to injury and ischaemia 
{Low, Medium, High} 
Soft Tissue Injury Degree of soft tissue damage 
cause by injury 
{None, Mild, Moderate, 
Severe, Profound} 
Repair Failure Failure of arterial repair due 
to occlusion or bleeding 
{True, False} 
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6.3.3 Learning Parameters 
We examined the amount of data available for learning each parameter in the BN. 
Data were too small, or not available, to learn the parameters for some relations.  In 
this section, we describe the techniques used for learning the parameters when they 
have 1) small amount of data, 2) no data at all (latent variables) and 3) adequate 
amount of data. 
Variables with Small Data 
We learned the parameters that had less than 20 data instances from a combination of 
meta-analysis and data using the technique described in Section 6.2.2. Table 6.10 
shows the data available for learning the NPT of the ‘repair failure’ variable. There 
was small amount of data to learn some of these parameters (shown by bold in Table 
6.10) therefore we learned these parameters by combining the meta-analysis results 
with the data. We used the mean and variance of the predictive distributions from the 
meta-analysis (see Table 6.7) as observations to 𝜇𝑃𝑛𝑒𝑤 and 𝜎𝑃𝑛𝑒𝑤
2  variables in the 
Bayesian learning model (see Figure 6.6). 
The meta-analysis provides us the pooled probabilities of an unsuccessful outcome 
conditioned on each individual clinical factor (see Table 6.7). The variable 
equivalent to an unsuccessful outcome is ‘nonviable extremity’ in the LEVT BN. 
However, the meta-analysis results could also be used for the NPT of the ‘repair 
failure’ variable as 1) our model assumes a deterministic relation between an 
unsuccessful outcome and repair failure 2) the parents of ‘repair failure’ can 
influence ‘nonviable extremity’ through only one pathway. For example, the ‘arterial 
repair’ variable can affect ‘nonviable extremity’ through the following pathway in 
our model: 
𝐴𝑟𝑡𝑒𝑟𝑖𝑎𝑙 𝑅𝑒𝑝𝑎𝑖𝑟 → 𝑅𝑒𝑝𝑎𝑖𝑟 𝐹𝑎𝑖𝑙𝑢𝑟𝑒 → 𝐵𝑙𝑜𝑜𝑑 𝑆𝑢𝑝𝑝𝑙𝑦 → 𝑁𝑜𝑛𝑣𝑖𝑎𝑏𝑙𝑒 𝐸𝑥𝑡𝑟𝑒𝑚𝑖𝑡𝑦 
        (𝐴𝑅)                                (𝑅𝐹)                           (𝐵𝑆)                         (𝑁𝐸) 
The probability provided by the meta-analysis, 𝑃(𝑁𝐸 = 𝑇𝑟𝑢𝑒|𝐴𝑅 = 𝐺𝑟𝑎𝑓𝑡), is 
equivalent to marginalisation of ‘repair failure’ and ‘blood supply’ from this 
pathway: 
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𝑃(𝑁𝐸 = 𝑇𝑟𝑢𝑒|𝐴𝑅 = 𝐺𝑟𝑎𝑓𝑡) = ∑ 𝑃(𝑁𝐸 = 𝑇𝑟𝑢𝑒|𝐵𝑆)𝑃(𝐵𝑆|𝑅𝐹)𝑃(𝑅𝐹|𝐴𝑅 = 𝐺𝑟𝑎𝑓𝑡)
𝐵𝑆,𝑅𝐹
 
In our model, a repair failure always leads to inadequate blood supply, and 
inadequate blood supply always leads to a nonviable extremity: 
𝑃(𝐵𝑆 = 𝐿𝑜𝑤|𝑅𝐹 = 𝑇𝑟𝑢𝑒) = 1, 𝑃(𝑁𝐸 = 𝑇𝑟𝑢𝑒|𝐵𝑆 = 𝐿𝑜𝑤) = 1 
𝑃(𝐵𝑆 = 𝐿𝑜𝑤|𝑅𝐹 = ¬𝑇𝑟𝑢𝑒) = 0, 𝑃(𝑁𝐸 = 𝑇𝑟𝑢𝑒|𝐵𝑆 = ¬𝐿𝑜𝑤) = 0 
By using these values in the marginalisation equation above, we get: 
𝑃(𝑁𝐸 = 𝑇𝑟𝑢𝑒|𝐴𝑅 = 𝐺𝑟𝑎𝑓𝑡) = 𝑃(𝑅𝐹 = 𝑇𝑟𝑢𝑒|𝐴𝑅 = 𝐺𝑟𝑎𝑓𝑡). Consequently, we can use 
the probabilities from the meta-analysis for learning the relation between ‘repair 
failure’ and its parents. 
The meta-analysis does not provide any information about the multiplicity of tibial 
arteries (see Section 6.3.2 how the multiplicity of tibial arteries is modelled in the 
BN). Therefore, we model the number of injured tibial arteries as a risk modifier. 
Our model assumes that a repair failure leads to a non-viable extremity if all 3 tibial 
arteries are injured. However, there is a chance of a successful outcome, which is 
learned from data, if only 1 or 2 tibial arteries are injured. 
Table 6.10 Amount of Data Available for Learning Parameters of Repair Failure Variable 
AR* Graft 
True 
Femoral 
Graft 
True 
Popliteal 
Graft 
True 
Tibial 
Graft 
False 
Femoral 
Graft 
False 
Popliteal 
Graft 
False 
Tibial 
Primary 
True 
Femoral 
Primary 
True 
Popliteal 
… MAI* 
AS* 
RF*          
Data 14 
 
6 
 
2 
 
71 
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38 
 
1 
 
3 … 
*AR: Arterial Repair, MAI: Multiple Levels, AS: Anatomical Site, RF: Repair Failure 
We used the OpenBUGS software (Lunn et al., 2009) to calculate the posteriors of 
the auxiliary learning model for this case study. Since OpenBUGS uses MCMC 
sampling, it is necessary to assess the convergence of the Markov chain to ensure 
that sampled values cover the entire distribution. We used Gelman and Rubin (1992) 
diagnostic technique, sample plots and autocorrelation plots to assess the 
convergence. None of the diagnostic techniques can prove convergence but they can 
assist detecting the lack of convergence. We discarded the first 10,000 samples in 
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MCMC as the burn-in samples, and calculated the posterior distributions based on 
the next 70,000 samples. 
Table 6.11 shows extracts of the NPTs of the ‘Repair Failure’ and the amount of data 
available for learning its parameters. The values in bold and italic fonts are the 
parameters learned by combining the results of the meta-analysis with the data, and 
the values in normal fonts are the parameters learned purely from the data. The 
parameters learned from two approaches differ substantially for smaller amounts of 
data. The effects of this difference to the model performance are discussed in Section 
6.4.1. 
Table 6.11 Learning from Data, and from Combining Data and Meta-Analysis Results 
AR*: Graft 
True 
Femoral 
Graft 
True 
Popliteal 
Graft 
True 
Tibial 
 
… 
 
Primary 
True 
Femoral 
Primary 
True 
Popliteal 
… MAI*: 
AS*: 
RF*:       ….      
True 0.17 0.17 0.39 0.41 0.99 0.49 0.01 0.14 0.01 0.29 … 
False 0.83 0.83 0.61 0.59 0.01 0.51 0.99 0.86 0.99 0.71  
Data: 14 6 2  1 3  
*AR: Arterial Repair, MAI: Multiple Levels, AS: Anatomical Site, RF: Repair Failure 
Latent Variables 
The BN contained several latent variables as described in Section 6.3.2 (see Table 
6.8 for a list of these variables). Ranked nodes were used to model the NPT of these 
variables (Fenton et al., 2007). A ranked node is an approximation of the truncated 
normal distribution to the multinomial distribution with ordinal scale (see Section 
2.6.1 for a more detailed description of ranked nodes). We used the framework 
proposed by Fenton et al. (2007) to elicit the parameters of ranked nodes. 
For each of the latent variables we first asked the domain experts to describe the 
relation between the variable and its parents. Afterwards, we selected a suitable 
ranked node function and elicited initial weights that imitate the described relation. 
We presented the behaviour of the ranked node under various combinations of 
observations to the domain experts, and refined the weights based on their 
comments. 
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Adequate Amount of Data 
After the parameters with small or no data were defined, the remainder of the 
parameters were learned purely from the data. The EM algorithm was used to learn 
the parameters as the dataset contained missing values. The parameters that were 
already defined from the experts or meta-analysis were kept fixed while EM was 
applied. 
6.4 Results 
The performance of the LEVT BN for predicting the ‘Nonviable Extremity’ variable 
was tested by a 10-fold cross-validation in the LEVT dataset. The AUROC was 0.90. 
The BN had 80% specificity when operated at 80% sensitivity, and 70% specificity 
when operated at 90% sensitivity. The LEVT BN had a BS of 0.06 and a BSS of 
0.33. Hosmer-lemeshow test was used to assess the calibration of the BN. The BN 
was well calibrated with a Hosmer-lemeshow statistic of 12.7 (p-value: 0.13, see 
Figure 6.9). 
 
Figure 6.9 Calibration of the LEVT BN 
6.4.1 Parameters from Pure Data vs. Hybrid Approach 
The LEVT BN was learned by a hybrid approach that reinforces the data with the 
meta-analysis results when there is small amount of data to learn a parameter (see 
Section 6.3). We compared the results of this approach to a purely data-based 
parameter learning algorithm. We learned the parameters of the same BN structure 
purely from data and compared it with the LEVT BN learned by the hybrid 
approach. Note that, the parameters of the ranked nodes, which were elicited from 
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the experts, were kept the same in both models. The purely data-based parameter 
learning had poor results in all measures. The AUROC was 0.48, the specificity was 
13% at 80% sensitivity, and the Hosmer-lemeshow test indicated poor calibration (p-
value: 0.01). Both BS and BSS indicated poor performance for the purely data-based 
parameter learning as well (see Table 6.12).  
The LEVT BN has a quite complicated structure compared to the data available for 
learning some of its parameters. As a result, the purely data-based approach overfits 
the data, which leads to poor results in the cross-validation. 
Table 6.12 Results of Parameter Learning from Data and Hybrid Approach 
 Hybrid Approach Data 
AUROC 0.90 0.48 
Specificity (at 90% Sensitivity) 70% 7% 
Specificity (at 80% Sensitivity) 80% 13% 
Hosmer-Lemeshow Test 12.7 (p=0.13) 20 (p=0.01) 
Brier Score 0.06 0.10 
Brier Skill Score 0.33 0.02 
6.4.2 Mangled Extremity Severity Score 
MESS (Johansen et al., 1990) is a well-known scoring system developed for 
providing decision support in treatment of mangled extremities. MESS calculates a 
score based on the injury mechanism, the degree of shock, the ischemic status and 
the patient’s age. If the score is above a certain threshold value MESS recommends 
an amputation (see Section 4.2.2 for the results of MESS in different validation 
studies). In the LEVT dataset, MESS had an AUROC of 0.75 for predicting the 
‘Nonviable Extremity’ variable (Figure 6.10). Its specificity was 40% when operated 
at 90% sensitivity and 60% when operated at 80% sensitivity. Both the accuracy and 
calibration of MESS were worse than the predictions of the LEVT BN as shown in 
Table 6.13. BS and BSS could not be calculated for MESS since the outputs of 
MESS are not probabilities. 
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Table 6.13 Results of LEVT BN and MESS 
 LEVT BN MESS 
AUROC 0.90 0.75 
Specificity (at 90% Sensitivity) 70% 40% 
Specificity (at 80% Sensitivity) 80% 60% 
Hosmer-Lemeshow Test 12.7 (p=0.13) 20 (p=0.01) 
 
 
Figure 6.10 ROC Curves for LEVT BN and MESS 
6.4.3 Learning BN Purely From Data vs. LEVT BN 
Clinical knowledge was an essential factor in development of the LEVT BN. In 
order to assess the effects of using knowledge in modelling, we compared the 
performance of the LEVT BN to 3 other BNs that were developed purely from the 
data using 3 different structure learning algorithms. We used a score based learning 
algorithm (hill climbing (HC) algorithm with BIC score (Korb and Nicholson, 
2004b; Margaritis, 2003; Schwarz, 1978)), a constraint based learning algorithm 
(grow shrink (GS) algorithm (Margaritis, 2003)), and a hybrid algorithm that 
combines the score and constraint based approaches (max-min hill climbing 
(MMHC) algorithm (Tsamardinos et al., 2006)) to learn each of these BNs. Expert 
knowledge was not used in development of these BNs, and the BNs do not contain 
any latent variables. 
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Table 6.14 Results of LEVT BN and Structure Learning Methods 
 LEVT BN HC MMHC GS 
AUROC 0.90 0.83 0.83 0.84 
Specificity 
(at 90% Sensitivity) 
70% 37% 41% 54% 
Specificity 
(at 80% Sensitivity) 
80% 71% 80% 69% 
Hosmer-Lemeshow Test 12.7 (p=0.13) 11.5 (p=0.17) 15.3 (p=0.05) 8.5 (p=0.39) 
Brier Score 0.06 0.07 0.07 0.07 
Brier Skill Score 0.33 0.22 0.21 0.23 
We first imputed the missing values in the dataset using the Amelia package 
(Honaker et al., 2013) in the R statistical software (R Core Development Team, 
2013) as all of the structure learning algorithms require complete datasets. 
Afterwards, we learned a separate BN structure using each of the learning 
algorithms. These algorithms are readily implemented in the BNLearn package 
(Scutari, 2010) of the R statistical software.  
 
Figure 6.11 ROC Curves for LEVT BN and Structure Learning Methods 
We assessed the performance of each BN for predicting the ‘Nonviable Extremity’ 
variable in a 10-fold cross validation. The LEVT BN has a larger AUROC than the 
BNs learned purely from the data (see Figure 6.11). The LEVT BN had substantially 
better performance at operating points with higher sensitivity levels. At the 90% 
sensitivity level, the predictions of the LEVT BN have over 70% specificity which 
is, on average, 27% more than the BNs learned from the data. Both BS and BSS also 
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indicated better performance for the LEVT BN (see Table 6.14). The Hosmer-
lemeshow test indicated that the LEVT BN, HC and GS were calibrated at 95% 
confidence level. 
Figure 6.12 shows the BN structures learned by MC (Figure 6.12a), MMHC (Figure 
6.12b) and GS (Figure 6.12c) methods. In Section 6.4.1, we observed that a purely 
data-driven approach overfits the data for the LEVT BN as the BN structure is too 
complicated for the available data. In order to avoid overfitting, the structure 
learning methods learned simpler BN structures. Consequently, their predictions 
were better than the purely data-based parameter learning algorithm in Section 6.4.1. 
 
Figure 6.12 BN Structures Learned by a) HC b) MMHC c) GS methods 
One of the disadvantages of a purely data-driven structure learning method is that the 
learnt structure is often not meaningful to domain experts (see Section 3.3). In this 
case study, the structure learning methods built different, and sometimes 
contradicting, BN structures. For example, while the ‘Shock’ variable is a cause of 
the ‘Nonviable Extremity’ variable in the GS model (see Figure 6.12c); the same 
variable is the consequence of the ‘Nonviable extremity’ variable in the HC and 
MMHC models (see Figure 6.12a and Figure 6.12b).  
The potential use of the model for evidence based medicine may be limited if the BN 
structure is not meaningful to experts. First of all, the BN cannot be supported by the 
evidence from the clinical literature if its structure does not make sense to domain 
experts (see Chapter 8). The relations defined in the BN must be consistent with 
clinical knowledge in order to identify the relevant evidence for them.  
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The predictions of a BN can also be explained if its structure is consistent with 
clinical knowledge. If causal pathways in the BN are aligned with clinical 
knowledge, its predictions can be explained in a way that makes sense to domain 
experts. However, it is not possible to explain the predictions of some machine 
learned BN apart from saying that the input variables are correlated with the 
outcome. 
6.5 Conclusion 
This chapter presented a methodology to build BNs for decision supports based on 
clinical evidence from meta-analyses, expert knowledge and data. Meta-analysis 
results were used to identify the BN variables based on the evidence from previous 
research. We proposed a Bayesian learning technique that can combine the meta-
analysis results with data to learn the BN parameters. Our method was successfully 
applied to the trauma case-study, in which we developed an accurate model for 
predicting short-term outcomes of lower extremities with vascular injuries. The 
techniques presented in this paper can be applied to a wider scope of problems than 
trauma care. A meta-analysis is an important source of evidence but it is often used 
to analyse simple relations, conditioned on a few variables, therefore it does not 
account for the complexity of disease mechanisms. By combining evidence from the 
meta-analysis with data and knowledge, our method enables evidence to be used in 
more complicated decisions by taking causal pathways and interaction effects into 
account.  
In our case study, we developed an accurate model for a clinical problem where the 
previous modes have not been successful. The case study demonstrated the benefits 
of integrating meta-analysis results and expert knowledge into BN development. The 
BN built by our approach performed better than the structure learning techniques and 
the scoring system compared: the AUROC was 0.90 for our BN, 0.84 for the best 
performing structure learning method and 0.75 for the MESS scoring system.  
The LEVT BN contained latent variables that were modelled by ranked nodes. The 
parameters of these variables were elicited from domain experts. It would also be 
possible to estimate the parameters of these variables using the methodology 
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presented in Chapter 5. In this case, each step of the EM algorithm would estimate 
the parameters of a ranked node rather than a normal NPT. The EM algorithm has 
not been implemented to learn ranked nodes.  Such implementation would be useful 
for domains with limited data as ranked nodes require fewer parameters than 
complete NPTs. 
As further research, the parameter learning method described in this Chapter could 
be expanded with qualitative expert constraints (see Section 2.6.3 for a review of the 
Bayesian parameter learning methods with qualitative expert constraints). This 
expansion would allow expert knowledge to be integrated with meta-analysis results 
and data when learning parameters. In Bayesian parameter learning methods, such as 
the one we described in Section 6.2.2, we estimate the entire distribution of the 
parameters. This gives us both expected value of the parameter and a variance 
showing the degree of uncertainty for this estimate. Usually, the expected value of 
this distribution is used as the BN parameter, and the variance is ignored. However, 
if the BN structure is meaningful and aligned with knowledge, the variance could be 
used to show our degree of understanding about the parameters. Ways of integrating 
this variance to the parameter estimation techniques could be investigated. 
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Abstractions in Bayesian 
Networks 
The graphical structure of a BN makes it a technology well-suited for developing 
evidence-based decision support models from a combination of domain knowledge 
and data. However, the available data seldom match the variables in the structure 
that is elicited from experts, whose models may be quite detailed; consequently, the 
structure needs to be abstracted to simplify parameter estimation. Up to now, this 
abstraction has been informal, loosening the link between the final model and the 
experts’ knowledge. In this chapter, we propose a method for abstracting the BN 
structure by using four ‘abstraction’ operations: node removal, node merging, state-
space collapsing and edge removal. Approximations introduced by the abstraction 
operations can be identified from changes in the conditional independence (CI) 
assertions of a BN. 
7.1 Introduction 
A knowledge-based BN aims to model the data-generating process of a problem 
domain by encoding knowledge about influences and independences between the 
important variables of the domain. They are often developed through multiple stages 
as the knowledge engineers and the domain experts refine the model iteratively 
(Laskey and Mahoney, 2000). The initial knowledge model is often large and 
detailed, and some elements of the model may need to be simplified or abstracted as 
data is lacking or the parameters are too difficult to elicit. However, even simple 
abstraction operations, such as removing a node, can result in numerous and 
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complicated alternative BNs which are difficult for the knowledge engineers to 
evaluate without a structured method. The effects of these abstractions must be 
carefully examined by the domain experts to prevent any unwanted changes in the 
modelled knowledge of the data generating process. Moreover, the way that the final 
BN has been derived needs to be presented thoroughly so that the knowledge base of 
the model and its derivation is understandable. 
Our aim is to present a method of abstracting a BN structure. The method is 
developed for knowledge engineers building a BN structure with domain experts. 
The method provides a set of abstraction operations which together: 
1. Allow a BN to be simplified by removing and merging nodes, removing 
edges and reducing the number of states 
2. Distinguish abstractions that add to the knowledge base from those 
compatible with the knowledge elicited so far, so that the added knowledge 
can be confirmed by domain experts  
3. Provide a way to show the link between the initial and abstracted models, in 
the form  of a derivation that captures the complete sequence of abstraction 
operations 
The method can be used to help knowledge engineers select the most suitable model 
refinements by evaluating alternative abstractions, in consultation with domain 
experts. The selection may also be guided by considering the availability of data or 
compatibility with causal relationships.  
Our knowledge engineering method is based on well-known techniques mainly used 
for learning and inference problems (Choi and Darwiche, 2006; Shachter, 1986; Van 
Engelen, 1997; Wellman and Liu, 1994). Our main contribution is to explore the 
knowledge engineering aspect of these operations. 
The remainder of this chapter is organised as follows: Section 7.2 gives an overview 
of the relation between knowledge and conditional independencies (CI) in BNs. 
Section 7.3 introduces abstraction as a knowledge engineering method and Section 
7.4 describes the abstraction operations of this method and examines their 
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compatibility properties. These operations are illustrated by a medical case-study in 
Section 7.5. Section 7.6 shows the graphical representation of the abstraction 
operations. Finally, Section 7.7  discusses the motivation from ABEL (Patil et al., 
1981), and Section 7.8 presents the conclusions. 
7.2 Knowledge and Conditional Independencies 
The aim of a knowledge-based BN is to model the data-generating process of a 
domain by encoding knowledge about influences and independences in the BN 
structure. A satisfactory modelling of this knowledge is when a BN 𝐺𝑋 is able to 
represent the joint probability distribution 𝑃𝑋 of the data-generating process (see 
Figure 7.1).   
 
Figure 7.1 Knowledge-based Bayesian Network 
A BN structure encodes a set of CIs; therefore its ability to represent the data-
generating process depends on the CIs the BN asserts. Consequently, compatibility 
of the BN abstractions can be evaluated by their effect on the CI assertions of the 
BN. The preliminaries regarding CIs and BNs are provided in Section 2.4. 
7.3 Abstraction as a Knowledge Engineering Method 
In this section, we present an overview of our abstraction method for knowledge-
engineered BNs. Our approach is to construct the BN structure based on expert 
knowledge before using data, statistics from relevant studies, and numbers elicited 
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from domain experts to parameterise the BN. The first step of our method is to elicit 
the BN structure about the domain. The initial structure should be considered as a 
knowledge-model of the domain so it should include all relevant variables and 
relations without being limited by issues such as availability of data or complexity of 
the model. Knowledge engineering techniques for eliciting the BN structure are 
discussed in Section 2.6.1. 
When the initial structure of the BN is complete, we compare it with the resources 
available for parameterising the BN. The data and the statistics from relevant studies 
may not be enough to learn the parameters for all of the variables in the BN. For 
example, information about some of the variables may not be observed in practice, 
or they may not be recorded in the data. Moreover, the NPTs of some variables may 
be too large to elicit from the domain experts or to learn from the data. 
Consequently, the initial BN structure has to be abstracted in order to have a 
parameterised and working BN. 
 
Figure 7.2 Overview of abstraction as a method of model development 
We propose 4 abstraction operations that are classified as compatible or 
incompatible as shown in Table 7.1. Node removal and node merging are 
‘compatible’ abstractions meaning that these operations can always be applied 
without adding new CI conditions to the variables shared between the initial and the 
abstracted BN. State-space abstraction and edge removal are ‘incompatible’ 
abstractions that bring additional CI conditions to the BN structure. The probability 
distribution of the data-generating process that factorises on the initial BN structure 
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may not factorise after incompatible abstractions are applied. Therefore, the domain 
experts should review the effects of the incompatible abstractions on the knowledge-
base of the BN. The compatibility properties of the abstraction operations are 
defined in Section 7.4.1. Figure 7.2 illustrates the overview of our method. In 
summary: 
 We use compatible abstraction first to reduce the number of variables in the 
model  
 We then make approximations with incompatible abstractions to improve 
learning and elicitation, often to complement the compatible abstractions 
However, the order of the abstraction operations is not restricted to this pattern; any 
operation can be applied to any network. 
Table 7.1 Abstraction Operations 
Operation Compatibility 
Node removal Compatible 
Node merging Compatible 
State-space abstraction Incompatible 
Edge removal Incompatible 
The purpose of the BN must be considered when removing variables: some variables 
may have primary importance, and they should not be removed even when no data is 
available; whereas other variables may be removed without affecting the reasoning 
mechanism of the model significantly. The node removal operation is described in 
Section 7.4.2. 
Node merging can be used for a set of variables that together represent an abstract 
concept. Each of the merged variables is described as a part of the definition of the 
abstract concept. The node merging operation is demonstrated in Section 7.4.3. 
The states of a variable can be collapsed in order to decrease the size of its NPT 
thereby making it easier to learn or elicit the parameters with available resources. 
Domain experts should review the CI conditions that are added as a result of state-
space abstraction. The state-space abstraction operation is described in Section 7.4.4. 
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Edge removal can also be used to simplify the parameter-space of a BN. Edge 
removal is an incompatible abstraction; therefore, its effects on the CI conditions 
should be reviewed by domain experts. Data, if available, can be used to assess the 
effects of edge removals by statistical independence tests or model selection scores. 
The edge removal operation and approaches for reviewing its effects are described in 
Section 7.4.5. 
7.4 Abstraction Operations 
7.4.1 Compatibility of Abstractions 
A BN structure has fewer variables, states or relations than the initial – knowledge – 
model after the abstraction operations are applied. A crucial factor to consider is 
whether the abstracted BN 𝐺𝐴 is a compatible abstraction that is able to represent the 
probability distribution of the remaining variables. In this section, we present the 
definition of compatible abstractions in the case where some variables are removed 
from the model1. In the following sections we will expand this definition for the 
node merging operation, and discuss the compatibility of the state-space abstraction 
and edge removal operations. 
A compatible node removal operation is able to represent the probability distribution 
of the remaining variables in the BN. Let 𝐺𝑋 be a BN structure where the probability 
distribution 𝑃𝑋 of the set of variables 𝑋 factorises. When a set of nodes are removed 
from this BN, the abstracted BN structure 𝐺𝐴 must be able to represent the 
probability distribution of the set of remaining variables 𝐴. Since 𝐴 ⊆ 𝑋, the 
probability distribution 𝑃𝐴 of the set of variables 𝐴 is simply a marginalisation of 𝑃𝑋, 
and the compatible abstraction 𝐺𝐴 is able to factorise  𝑃𝐴 = ∑ 𝑃𝑋𝑋−𝐴 . This is possible 
if the abstraction operation does not introduce additional independence assertions to 
the BN structure so that 𝐺𝐴 asserts the subset of the d-separations in 𝐺𝑋. 
                                               
1 This section uses the concepts of d-separation, active trails and CI to define the compatibility of 
abstractions, see Section 2.4 for the definition of these concepts. 
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Compatible Abstraction: 𝐺𝑋 is an compatible abstraction of 𝐺𝐴 if  
𝑑𝑠𝑒𝑝𝐺𝐴 (𝐷; 𝐸|𝐹) → 𝑑𝑠𝑒𝑝𝐺𝑋(𝐷; 𝐸|𝐹) and ¬𝑑𝑠𝑒𝑝𝐺𝑋(𝐷; 𝐸|𝐹) → ¬𝑑𝑠𝑒𝑝𝐺𝐴(𝐷; 𝐸|𝐹) 
where 𝐷, 𝐸, 𝐹 three sets of variables in 𝐴. 
When an abstraction operation adds a CI assertion, therefore is incompatible, the 
knowledge engineers must carefully evaluate the differences brought by the 
additional CI comparing it to the initial knowledge-based model (see Figure 7.3). 
 
Figure 7.3 Compatible and Incompatible Abstraction 
In the remainder of this section, we present each of the abstraction operations and 
discuss their compatibility properties. 
7.4.2 Node Removal 
Any node in a BN can be removed without adding independence assertions using 
Shachter’s topological operations (Shachter, 1988, 1986). The node removal 
operation is based on the concepts of barren nodes, covered edges and edge 
reversals: 
1. Barren Nodes: Nodes that do not have any descendants in the BN are called 
barren nodes. Removing barren nodes does not add independence 
assumptions for the rest of the BN: 𝑑𝑠𝑒𝑝𝐺𝐴(𝐷; 𝐸|𝐹) = 𝑑𝑠𝑒𝑝𝐺𝑋(𝐷; 𝐸|𝐹) 
where (𝑋 − 𝐴) are barren nodes and 𝐷, 𝐸, 𝐹 are three sets of variables in 𝐴. 
2. Covered Edge and Edge Reversal: An edge 𝑌 → 𝑍 in a graph 𝐺 is covered 
if 𝑃𝐴𝑌
𝐺 = 𝑃𝐴𝑍
𝐺 − {𝑌} that is if the set of parents of 𝑌 and set of parents of 𝑍 
excluding 𝑌 are equivalent. Covered edges can be reversed without adding 
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any independence assertions to the BN structure. This is useful since the 
outgoing edges from a node can be reversed to make the node barren, and to 
remove the node without adding CIs, when these edges are covered. 
3. Adding Edges: Adding edges to a BN structure do not add CI assertions to 
𝐺𝑋, but they remove CI assertions, since all the previously active trails are 
still present and the added edges may add further active trails: 𝐼(𝐺𝐸) ⊆ 𝐼(𝐺𝑋) 
where 𝐺𝐸 is derived from adding some edges to 𝐺𝑋. As a result, any edge in a 
BN can be covered, without introducing CIs, by adding edges between the 
variables that share the edge and their parents. 
In summary, we can cover any edge in a BN by adding more edges to the BN 
structure, and this will not add more independence assertions. We can reverse any 
edge and make any node barren as we can cover any edge in the BN structure. 
Consequently, we can remove any node as a compatible abstraction without adding 
independence assertions to the BN (Shachter, 1988). 
Removing a node can increase the parameter-space and computational complexity of 
a BN especially if the removed node has many children. As the number of children 
of a variable increases, more edges are required to cover the outgoing edges from the 
variable. For example, we need to add 4 edges in order to remove the node 𝑅 from 
the BN structure in Figure 7.4a with a compatible abstraction. As a result, the 
number of parents that 𝐶, 𝐷 and 𝐸 have is tripled (Figure 7.4c). 
Suppose that we need to reverse an edge 𝐴 → 𝐵 so that A becomes a barren node. If 
another directed path exists from 𝐴 → ⋯ → 𝐵 then reversing the edge 𝐴 → 𝐵 would 
introduce a cycle. However, in this case the node 𝐵 has another parent ‘𝑋’ on this 
path; since 𝑋 is a descendant of 𝐴 and the BN is acyclic we can be sure that there is 
no directed path from 𝑋 to 𝐵 via 𝐴. In general, since the BN is acyclic, the set 𝑃𝐴𝐵
𝐺  
must contain at least one node that does not have an additional directed path leading 
to 𝐵. This node is not greater than the other parents of 𝐵 in the partial order on edges 
defined by the BN’s graph. It is therefore always possible to select a node from 𝑃𝐴𝐵
𝐺  
so that its edge to 𝐵 can be reversed without introducing a cycle and is therefore 
possible to make any node in a BN barren without introducing a cycle. 
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Figure 7.4 (a) R with multiple children (b) Making R a barren node (c) R removed 
Since the BN’s graph defines only a partial, not total order, on nodes, we may have 
to choose the order in which the edges leading from a node 𝑅 are reversed as we 
transform the BN to make 𝑅 a barren node. Changing the order of edge reversal can 
change the structure of the final BN. For example, we have to reverse 𝑅 → 𝐷 and 
𝑅 → 𝐶 in order to remove 𝑅 from the BN shown in Figure 7.5a. If we start by 
reversing 𝑅 → 𝐷 the resulting structure has a total of 6 edges as shown in Figure 
7.5b. However, if we start by reversing 𝑅 → 𝐶, the resulting structure has 7 edges as 
shown in Figure 7.5c. 
The order of edge reversals can be selected in a way to minimise either the number 
of edges added or the size of the final state space. Having the least number of 
additional edges does not guarantee that the state-space is minimised. A BN with 
fewer edges can have a larger state-space due to the state-space of its individual 
variables. 
Making an exhaustive search for possible equivalent abstractions gets increasingly 
difficult as the number of children of the removed node increases. The outgoing 
edges from a node that has 𝑛 children can be reversed in 𝑛! possible orders. 
However, an exhaustive search can be unnecessary from a knowledge engineering 
perspective. A relation in a BN can represent causality or association. Edges added 
between the children of a removed node are assumed to represent association due to 
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the missing parent, therefore they can be modelled in any direction. However, some 
of the directions can make more sense to the domain experts even though these 
variables are assumed to be independent when the state of missing parent is known. 
 
Figure 7.5 (a) Initial BN (b) Equivalent Abstraction (c) Equivalent Abstraction 
If the domain experts have no preference about the directions of edges, following 
heuristics can be useful to choose the order of removing nodes without making an 
exhaustive search: 
 In order to add the minimal number of edges, start reversing from the edge 
𝑅 → 𝑋 where 𝑋 has the least number of parents. When multiple edges must 
be reversed to remove 𝑅, an edge is added from 𝑋 and 𝑃𝐴𝑋
𝐺 − {𝑅} in order to 
cover edges directed to other children of 𝑅 that are reversed later. Therefore, 
if we start from reversing the node that has the smallest number of parents, 
fewer edges will be added to cover the edges that are reversed later. 
 Similarly, in order to have a minimal increase in the size of the state-space, 
start reversing from the edge 𝑅 → 𝑋 where 𝑋 has the smallest number of 
parameters.  
Node removal is a well-known technique that has been primarily used for inference 
problems (Shachter, 1990, 1988, 1986). It is a crucial operation for knowledge 
engineering of BNs as it explicitly shows the number and possible direction of edges 
that must be added for abstraction. A node removal operation is straightforward 
when the removed node has a single or no child. In this case, no edges are added and 
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the edge directions are maintained. However, removing a node with multiple 
children can result in multiple equivalent BN structures with many additional edges 
as shown in Figure 7.5. The additional edges are necessary for compatibility but, if 
further simplifications are required, incompatible abstractions may follow. 
Using Edge Removal with Node Removal  
The edge removal operation (see Section 7.4.5) can complement node removal when 
a large number of edges are added due to node removal. Rather than making ad-hoc 
approximations, the domain experts should evaluate the CIs modelled by each of the 
new edges, and remove the ones that are considered to be trivial. An example of a 
node removal followed by edge removals is shown by the case-study in Section 7.5. 
7.4.3 Node Merging 
The second of the compatible abstraction operations is merging multiple nodes 
𝑇1, … , 𝑇𝑛 into a single node 𝑀. Two nodes 𝑇𝑖 and 𝑇𝑗 can be merged into a single node 
𝑀 when an edge can be added between 𝑇𝑖 and 𝑇𝑗 and this edge is reversible by 
adding extra edges to cover it. The network with the merged variable combines the 
networks with this edge in both directions. The merging operation is a compatible 
abstraction since covering and reversing the edge between 𝑇𝑖 and 𝑇𝑗 does not add CI 
conditions to the BN structure (see Section 7.4.2). When we merge the nodes 𝑇𝑖 and 
𝑇𝑗 into 𝑀, the state-space of 𝑀 becomes the Cartesian product of the state-spaces of 
𝑇𝑖 and 𝑇𝑗.  
Node merging does not change the probability distribution that factorises on the BN. 
The main difference is that 𝑇i and 𝑇j  cannot be observed separately, they must be 
observed or unobserved together. Therefore, while comparing the CI conditions 
between 𝐺𝑋 and 𝐺𝐴 observing 𝑀 is equivalent to observing 𝑇i and 𝑇j together. 
An example of the merging operation is shown in Figure 7.6 where the nodes 𝑋 and 
𝑌 are merged into 𝑋𝑌. The first step is to add an edge between 𝑋 and 𝑌 as shown in 
Figure 7.6b. Next, this edge is covered and reversed as shown in Figure 7.6c. The 
final BN with the merged variable 𝑋𝑌 (see Figure 7.6e), can be seen as equivalent to 
the BNs with edges in both directions (see Figure 7.6d).  
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Multiple nodes can be merged into a single node by repeating the merging operation 
pairwise. For instance, the nodes 𝑋, 𝑌 and 𝑍 in Figure 7.6a can be merged pairwise 
by first merging 𝑋 and 𝑌 to 𝑋𝑌 (see Figure 7.6e), then merging 𝑋𝑌 and 𝑍 to 𝑋𝑌𝑍 as 
shown in (see Figure 7.7). 
 
Figure 7.6 (a) Initial BN (b) 𝑿 → 𝒀 added (c) 𝑿 → 𝒀 reversed (d) BNs with 𝑿 → 𝒀 and 𝑿 ← 𝒀 
combined (e) 𝑿𝒀 merged 
A BN with merged nodes has the same or fewer CI assertions than the initial BN. 
The edges added after edge reversal and covering operations may remove some CIs. 
Moreover, some of the CI encoded in the initial BN disappears after merging since 
the merged variables cannot be observed separately. For example, 𝐴 and 𝐵 is 
independent given that 𝑋 and 𝑌 is observed in Figure 7.8a, but this independence 
disappears after merging 𝑋 and 𝑌 as shown in Figure 7.8b. 
 
Figure 7.7 𝑿𝒀 and 𝒁 merged 
 
Figure 7.8 (a) Initial BN (b) 𝑿 and 𝒀 Merged 
The merging operation introduces a cycle if there is a directed path between the 
nodes to be merged, 𝑇𝑖 and 𝑇𝑗, that includes some other node. These cycles have to 
141 
 
be eliminated since BNs are acyclic graphs. Our solution is to reverse some of the 
edges in these directed paths until none of the directed paths remain between 𝑇𝑖 and 
𝑇𝑗. In other words, if there is a directed path between 𝑇𝑖 and 𝑇𝑗 that includes other 
nodes, we break this directed path by reversing some of the edges in it. There are two 
issues to consider while reversing these edges: 
 The reversed edges must not introduce a cycle as well. 
 The edges must be covered before reversing (see Section 7.4.2). 
For example, we cannot immediately merge 𝑋 and 𝑌 in Figure 7.9 since there is a 
directed path 𝑋 → 𝐵 → 𝐷 → 𝑌 between 𝑋 and 𝑌 that includes the nodes 𝐵 and 𝐷. 
We have to reverse one of the edges between 𝑋 → 𝐵, 𝐵 → 𝐷 or 𝐷 → 𝑌 to prevent 
the merging operation from introducing a cycle. 
 
Figure 7.9 BN before 𝑿 and 𝒀 are merged 
We consider whether any of 𝑋 → 𝐵, 𝐵 → 𝐷 or 𝐷 → 𝑌 are covered or not. If one of 
them is covered, it can be reversed. In this case, none of these edges are covered 
therefore we need to add more edges to cover and reverse them:  
 Parents of 𝐵 = {𝐴, 𝑋}, parents of 𝑋 = { } therefore the edge 𝑋 → 𝐵 is not 
covered. The edge 𝐴 → 𝑋 has to be added in order to make this edge covered 
(see Figure 7.10a). 
 Parents of 𝐷 = {𝐶, 𝐵}, parents of 𝑌 = {𝐷, 𝑋, 𝐸}; therefore the edge 𝐷 → 𝑌 is 
not covered. The edges 𝐶 → 𝑌, 𝐵 → 𝑌, 𝑋 → 𝐷 and 𝐸 → 𝐷 must be added 
(Figure 7.10b). 
 Parents of 𝐵 = {𝐴, 𝑋}, parents of 𝐷 = {𝐶, 𝐵}; therefore the edge 𝐵 → 𝐷 is 
not covered. The edges 𝐴 → 𝐷, 𝑋 → 𝐷 and 𝐶 → 𝐵 must be added (Figure 
7.10c). 
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Figure 7.10 (a) 𝑿 → 𝑩 reversed (b) 𝑫 → 𝒀 reversed (c) 𝑩 → 𝑫 reversed 
Figure 7.10a, Figure 7.10b and Figure 7.10c shows the model structure when the 
edges 𝑋 → 𝐵, 𝐷 → 𝑌 and 𝐵 → 𝐷  are covered and reversed respectively. The edges 
that were added are shown by dashed lines, and the reversed edges are shown by 
bold lines in these figures. The BN in Figure 7.10a does not have a directed path 
between 𝑋 and 𝑌 therefore the nodes 𝑋 and 𝑌 can be merged. The BNs in Figure 
7.10b and Figure 7.10c, on the other hand, still have directed paths 𝑋 → 𝐵 → 𝑌 and 
𝑋 → 𝐷 → 𝑌 respectively. We need to reverse more edges in order to merge 𝑋 and 𝑌 
in these BNs. Since we already have a structure without a directed path between 𝑋 
and 𝑌 (Figure 7.10a), we will continue with this structure. 
The BN in Figure 7.11 is a compatible abstraction of the BN shown in Figure 7.9. 
The probability distribution 𝑃(𝐴, 𝐵, 𝐶, 𝐷, 𝑋𝑌, 𝐸) can be represented in the same way 
in these two BNs assuming that observing 𝑋𝑌 is equivalent to observing 𝑋 and 𝑌 at 
the same time in the initial BN. 
The BN in Figure 7.11 has one more edge compared to the initial BN. It is possible 
to select the sequence of reversals that leads to the fewest number of additional edges 
or to the smallest state-space. In our example, reversing 𝑋 → 𝐵 (Figure 7.10a) added 
the least number of edges compared to reversing 𝐷 → 𝑌 (Figure 7.10b) or 𝐵 → 𝐷 
(Figure 7.10c). 
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Figure 7.11 Compatible Merging of 𝑿 and 𝒀 
In general, it is possible to merge any pair of nodes in a BN. In the worst case the 
process described above will lead to a fully connected BN, with no CI conditions. 
Since all fully connected BNs that are formed by the same set of nodes have 
equivalent CI conditions (i.e. none), any (acyclic) combination of edge directions can 
be reached by an appropriate sequence of reversals of covered edges. Therefore, any 
edge can be reversed in a fully connected network, and any pair of nodes can be 
merged. 
Although possible, not all merging operations are sensible from a knowledge 
engineering perspective. In Figure 7.9, 𝑋 is a cause of 𝑌, and 𝐵 and 𝐷 are the 
intermediate variables between the cause and effect. Merging the cause and effect, 
and leaving the intermediate variables in the model would not be sensible in most 
knowledge engineered BNs. One would prefer to merge an intermediate variable 
with either its cause or its effect in order to simplify a causal BN. 
Using Node Merging with State-Space Abstraction 
Abstraction by merging variables is suitable when multiple variables in the model 
are parts of the definition of a more abstract concept. For example, one option to 
model an engine fault in a BN is to represent it with a single variable with ‘Yes/No’ 
states. Alternatively, the same concept can be modelled in detail with multiple 
variables each representing faults in different components of the engine such as 
faults in pistons, alternators and crankshaft. The merging operation makes it possible 
to show the link between the abstracted and detailed representations in this case. The 
variables about the individual engine components can be merged into the abstract 
variable about overall engine fault. After node merging the state-space of the abstract 
variable becomes the Cartesian product of the states of the merged variables. 
However, we would expect the abstract variable to have more abstract states as well. 
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State-space abstraction will follow node merging operation in such cases (see 
Section 7.4.4). An example of a node merging followed by state-space abstraction is 
shown in the case-study in Section 7.5. 
7.4.4 State-space Abstraction 
State-space abstraction collapses multiple states of a variable into a single state. For 
example, suppose a variable has 4 states named {None, Moderate, Severe, 
Profound}. We can collapse ‘Moderate’, ‘Severe’ and ‘Profound’ states into a single 
state called ‘Present’, as a result, the variable will have 2 states named {None, 
Present}. Consequently, the NPT of the variable requires fewer parameters and its 
learning, or elicitation, becomes simpler. This operation is often used in combination 
with node merging (See Section 7.4.3).   
State-space abstraction is an incompatible abstraction although it makes no change in 
the BN structure (Chang and Fung, 1990; Wellman and Liu, 1994). The changes in 
the CI and their effects to the domain representation should be discussed with the 
experts before making state-space abstractions.  
7.4.5 Edge Removal 
Edge removal is an incompatible abstraction that always adds CI assertions to the 
BN structure (see Section 7.2). Therefore, an edge should not be removed if it is not 
recommended by experts or statistical evidence. By adding CIs, edge removal 
decreases the parameter space and computational complexity of the BN. Edges 
added after the node removal and merging operations, and weak relations 
represented in the BN structure are suitable candidates for edge removal. The 
remainder of this section presents knowledge and data driven approaches for 
assisting edge removal. 
Using Domain Knowledge for Selecting Edges to be Removed 
Before removing an edge, the effects of removing the edge should be reviewed with 
domain experts. The review focuses on the strength of the relation modelled by the 
edge, and the CI conditions introduced due to removing it. It may not be feasible to 
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review the CI conditions between all subsets of variables especially if the BN is 
large. In this case, the domain experts can identify the important variables in the 
domain, and limit the review to these variables. 
Edge removal can be used with node removal and node merging as these operations 
can add many edges to the BN structure (see Section 7.4.2 and 7.4.3). For example, 
when the node 𝑅 is removed from the BN in Figure 7.12a 3 edges are added between 
the variables 𝐵, 𝐶 and 𝐷 as shown in Figure 7.12b. Removing these edges simplify 
the BN but it also adds CIs that are not present in the initial BN. For example, 
removing 𝐶 → 𝐷 and 𝐵 → 𝐶 as in Figure 7.12c adds two new CI conditions: 
(𝐵 ⊥ 𝐶|𝐴) and (𝐶 ⊥ 𝐷|𝐴). The knowledge engineers should discuss with the 
domain experts whether these CIs are acceptable in the domain. 
 
Figure 7.12 (a) Initial BN (b) Node R removed (c) Edges 𝑩 → 𝑪 and 𝑪 → 𝑫 removed 
Using Data for Selecting Edges to be Removed 
If data is available, statistical tests, including χ2, Margaritis (2004) and Dash and 
Druzdzel (2003), can be used to assist edge removal. These tests can identify the 
statistically significant CI assertions between variables. Alternatively, model 
selection scores, such as Bayesian Information Criterion (Schwarz, 1978), can be 
used to compare the effects of removing edges. Another possible approach is to 
assess the sensitivity of certain variables to edge removals (Renooij, 2010). 
7.5 Case-Study: Shock 
In this section, we use the ATC BN as a case study to illustrate the abstraction 
methodology. We apply the abstraction methodology to derive the shock fragment of 
the ATC BN from a more complicated BN structure elicited from the domain experts 
(see Section 5.3.3 for a description of the ATC BN). In the remainder of this section, 
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Sections 7.5.1 and 7.5.2 describe clinical knowledge modelled in the shock fragment 
and the initial BN structure elicited from the experts. Sections 7.5.3 – 7.5.6 applies 
each of the abstraction operations to the initial BN.  
7.5.1 Background 
Blood is the medium through which oxygen, which is vital for metabolism, is 
delivered to tissues. Patients with significant blood loss are unable to adequately 
perfuse their tissues with blood and thus unable to adequately deliver oxygen to the 
tissues. The body tissues start to die if starved of oxygen for a prolonged time. The 
body responds in several ways to compensate for the effects of blood loss. First, the 
heart rate increases in order to maintain normal perfusion and blood pressure. 
However, as the blood loss increases the increased heart rate cannot compensate and 
the blood pressure decreases. Second, as oxygen delivery to the tissues decreases, 
less efficient (anaerobic) metabolism takes over to compensate for the lack of 
oxygen. The by-products of anaerobic metabolism increase the acidity of blood and 
tissues, which in turn causes the respiration rate to increase. A patient in whom these 
mechanisms are operating as a result of bleeding is said to be in a state of 
haemorrhagic shock. 
Table 7.2 Definitions of Variables in the Shock fragment 
Variable Definition 
Bleeding 
Body Parts 
The number of bleeding body compartments. 
Hypovolemia Decrease in the volume of blood in circulatory system. Heart rate (HR) increases as 
a result of this to maintain normal blood pressure. 
Cardiac 
Output 
Volume of blood ejected from left side of the heart in 1 minute. As the blood loss 
increases cardiac output and blood pressure (SBP) will fall. Urine output and 
Glasgow coma score (GCS) is dependent on the perfusion of blood to kidney and 
brain respectively. 
PVS Vascular resistance to the flow of blood in peripheral arterial vessels. Degree of 
PVS can be estimated by capillary refill time (CRT). 
Oxygen 
Delivery 
Amount of oxygen delivery to the tissues. Body temperature (Temp) indicates the 
degree of overall oxygen delivery to the tissues. 
Metabolic 
Acidosis 
As oxygen delivery to the tissues decreases, less efficient (anaerobic) metabolism 
takes over to compensate for the lack of oxygen. The by-products of anaerobic 
metabolism increase the acidity of blood and tissues, which in turn causes the 
respiration rate (RR) to increase. The degree of metabolic acidosis can be estimated 
by pH, base excess (BE) and lactate values in blood. 
Death The risk of death in 48 hours 
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It is not possible to directly observe the state of the many variables explained above. 
For example, the oxygen perfusion to the tissues cannot be measured precisely. 
Instead, these ‘latent’ variables are inferred from related measurements and clinical 
observations. Reasoning of this type suggests the potential of a BN to detect shock. 
7.5.2 Shock Fragment of the ATC BN 
We developed a BN structure for reasoning about the physiology of bleeding patients 
and for predicting the risk of death from shock. We did not consider the limitations 
of data at this stage; our aim was to model all main variables and relations indicated 
by the domain experts. The structure of the initial BN is shown in Figure 7.13. The 
circular nodes in this BN are the main clinical variables, and rectangular nodes are 
the measurements and observations relevant to the main clinical variables. Table 7.2 
shows the definition of the main variables in the BN. We do not have data about 
some of these variables since they either cannot be directly observed or are not 
recorded in practice. We choose to simplify the BN structure using abstraction 
operations before applying the methodology described in Section 5 to learn the 
parameters of this BN fragment. 
 
Figure 7.13 Initial Structure of the Physiology BN 
7.5.3 Node Removal 
We removed the Metabolic Acidosis, Loss of Blood Volume, CRT, PVS, Urine 
Output, RR, Temp and GCS variables from the BN structure. These variables are 
selected with domain experts, considering both the objectives of the BN and 
availability of data. 
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Removing the blood loss and metabolic acidosis variables requires 1 and 4 edge 
reversal operations respectively. The measurement variables CRT, RR, Temp and 
Urine Output are already barren nodes therefore they can be removed without any 
edge reversal operations. The PVS variable become barren after CRT is removed so 
no edge reversal is needed for it either. The resulting BN structure after the node 
removal operations can be seen in Figure 7.14.  
 
Figure 7.14 BN Structure after Node Removals 
Removing metabolic acidosis with a compatible abstraction made the abstracted BN 
more complex: 3 edges were added between the children of this variable and one of 
its children (BE) has 3 parents now. These edges do not represent causal relations 
but removing them will introduce CIs that were not present in the initial BN. Before 
simplifying the graph, the effects of removing each of these edges, in terms of CI 
assertions, should be investigated by the domain experts (see Section 7.4.5). 
 
Figure 7.15 BN Structure after Node Merging 
7.5.4 Node Merging 
The state of the cardiac output, oxygen delivery and hypovolemia variables cannot 
be directly observed. The domain experts do not recommended removing these 
variables as they represent an important physiological mechanism about bleeding. 
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The parameters of these variables can be estimated by combining the observed data 
of their measurements and expert knowledge using the methodology described in 
Chapter 5.  However, the domain experts indicated that the BN structure could be 
further simplified before starting to learn or elicit the parameters. 
The domain experts stated that oxygen delivery, cardiac output and hypovolemia are 
elements of a more abstract physiological definition that can be called hypoperfusion 
or shock. Shock is clinically defined as a metabolic disturbance due to the failure of 
the circulatory system to maintain adequate perfusion to vital organs. Hypovolemia 
and cardiac output is associated with failure of the circulatory system, oxygen 
delivery and its relation to death represents the metabolic disturbance. Therefore 
these 3 variables can be merged into a single variable. We did not have to reverse 
any edges during merging since the merged node do not have directed path that 
includes a non-merged node between them. The resulting BN after merging is shown 
in Figure 7.15. 
Table 7.3 States of Shock before and after State-Space Abstraction 
Before  
state-space 
abstraction1 
 After  
state-space 
abstraction 
A,A,A 
 
Abnormal 
N,N,N 
: 
: 
N,A,A 
 
Normal 
1A: Abnormal, N: Normal 
7.5.5 State-Space Abstraction 
The node merging operations have simplified the structure of the BN resulting in a 
hypoperfusion variable that is easier to elicit clinically. However, the state-space of 
the hypoperfusion variable still requires simplification since it is formed by the 
Cartesian product of the states of each merged variable. For simplicity we defined 
binary states for the merged variables: {Normal, Abnormal}. The domain experts 
stated that Shock is present when all of the 3 factors are abnormal. In other words, 
we are interested in two states of Shock variable: the state when all of the factors are 
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abnormal, and when all of the factors are not abnormal. An illustration of this state-
space abstraction is shown in Table 7.3. 
7.5.6 Edge Removal 
Several edges were added between BE, Lactate and pH as a result of removing the 
‘Metabolic Acidosis’ variable. We listed the CI conditions that removing each of 
these edges can bring, and discussed these CIs with the domain experts. For 
example, when we remove pH → BE, pH becomes independent of BE given that 
Shock or the variables that are merged into Shock are observed. This CI was not 
present in the initial BN. The resulting BN structure after edge removals can be seen 
in Figure 7.16. 
 
Figure 7.16 Final Abstracted BN after Edge Removal 
7.6 Graphical Notation for Abstractions 
In this section, we present a graphical notation that shows the order and type of 
abstraction operations applied to a BN. The notation shows how the abstracted 
structure is derived from the initial BN by showing each abstraction step. This is 
essential for communicating the knowledge-base of a BN or for deriving a more 
detailed version of the BN when, for example, more data become available. We use 
both the initial and the abstracted BN structures to show the steps of abstraction. 
These structures are annotated by the symbols shown in Table 7.4.  In the remainder 
of this section, we illustrate the application of these symbols using the case study. 
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Table 7.4 Symbols for Abstraction Operations 
Operation Symbol Operation Symbol 
Node merging 
 
Edge added after  
node merging  
Node removal 
 
Edge reversed after  
node merging  
State-space abstraction 
 
Edge added after  
node removal  
Edge removal  
Removed nodes are shown with dashed boundaries and annotated by ‘xR’ where x is 
an integer that indicates the order of the abstraction operation and R indicates a 
removal operation. Edges that are added as a result of node removal operation are 
shown by an ‘xR’ annotation with the same ‘x’. In the case study, first abstraction 
operation is the removal of the ‘Metabolic Acidosis’ node, and this operation adds 
several edges to the model. Both the variable, and the added edges are annotated by 
‘1R’ in the initial and abstracted BNs respectively as shown in Figure 7.17. 
 
Figure 7.17 Notation for initial (a) and abstracted (b) BN fragment for removal of Metabolic 
Acidosis variable 
Nodes involved in a merging operation are annotated by ‘xM’ where x is the order of 
the abstraction operation and M stands for ‘merging’. In the shock example, we 
merged three nodes: ‘Oxygen Delivery’, ‘Cardiac Output’ and ‘Hypovolemia’. The 
node resulting from this merging operation is called ‘Hypoperfusion (Shock)’. We 
annotate each of these variables with ‘2M’ since it is the second abstraction 
operation and it is a merging operation. The initial and abstracted BNs after this 
operation can be seen in Figure 7.18. 
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Figure 7.18 Notation showing before (a) and after (b) merging multiple variables into Shock 
variable 
A node merging operation may introduce edges (see Section 7.4.3). In this case, both 
the added and the reversed edges are annotated by ‘xM’, and the reversed edges are 
shown by bold lines. 
Variables with state-space abstractions are shown by a double lined boundary, and 
removed edges are shown by dashed lines. The order of state-space abstraction and 
edge removal does not change the BN structure (other than the removed edge itself) 
so the order is not annotated. However, the collapsed or removed states after state-
space abstraction must be documented (for example, as in Table 7.3). In the case 
study, the state-space of ‘Shock’ is abstracted and the edges between ‘pH’, ‘RR’, 
‘BE’ and ‘Lactate is removed in order to simplify the BN, as shown in Figure 7.19. 
 
Figure 7.19 Notation showing edge removals and state-space abstraction (a) and the BN 
structure after edges are removed (b) 
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Figure 7.20 shows the initial and abstracted structure of the Shock BN with all the 
abstraction operations annotated. The graphical notation presented in this section 
clarifies the derivation of the final abstracted structure from the initial – detailed – 
structure. Multiple graphs each showing a particular step of abstraction should be 
recorded if the BN is simplified with multiple abstraction operations. 
 
Figure 7.20 Initial (a) and abstracted (b) bleeding physiology BN with abstraction notation 
7.7 Motivation from ABEL 
ABEL (Patil, 1981; Patil et al., 1981) was a pioneering clinical expert system that 
was developed for diagnosing acid-base disturbances of patients. Given laboratory 
data about a particular patient, ABEL generates the relevant causal diagrams from its 
knowledge-base, which is known as the patient specific model (PSM). It reasons by 
abstracting and elaborating these causal models to make diagnostic inferences, which 
is considered to be similar to how clinicians express their decisions. The causal 
models at the higher levels are directed acyclic graphs like BNs. Although widely 
referenced, PSMs have not become a commonly used approach for developing 
clinical decision support models. 
The causal diagrams of ABEL have several differences from the BN formalism. 
Firstly, each node in a PSM represents a single state of a variable, whereas the nodes 
in a BN are variables that can have multiple states. Secondly, the lower abstraction 
levels of PSM can have feedback loops which are always eliminated at higher levels; 
but BNs are acyclic graphs. Thirdly, PSM do not reason probabilistically and its 
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reasoning mechanism does not take the prior probabilities of diseases into account; 
BNs have superior probabilistic reasoning algorithms that are able to calculate 
complex learning and inference problems. Finally, BNs are lacking techniques for 
abstracting their knowledge-base for different levels of detail in a similar way to the 
abstraction mechanism in ABEL. Abstraction is clearly necessary for developing 
knowledge-based BNs for complex domains, and for explaining these models to 
external users. Our work on this paper was initially motivated by ABEL, notably its 
hierarchical structure and abstraction operations. 
7.8 Conclusion 
This chapter proposed abstraction as a knowledge engineering method for 
simplifying a BN structure. The method is illustrated by a medical case study about 
haemorrhagic shock. Our method provided: 
1. A sufficient set of operations that simplify a BN by removing and merging 
nodes, removing edges and reducing the number of states 
2. The compatibility properties of each abstraction in terms of CIs added to the 
BN structure 
3. A graphical notation that captures the sequence and type of abstraction 
operations, and thereby showing the link between the knowledge-base and 
the abstracted BN 
Some of the abstraction operations in our method are based on existing techniques 
that has been mainly used for learning and inference problems. This paper 
emphasises the potential of these techniques for following a systematic approach to 
knowledge engineering. The compatible abstraction operations do not add CIs but 
they can make the BN structure increasingly complex by adding edges. Incompatible 
abstraction can be used to simplify the structure but they approximate the BN 
structure by adding new CI conditions. Trade-offs between the approximations and 
complexity must be considered carefully. The next stage in this research is to 
implement these abstraction operations in BN software such as AgenaRisk (Agena 
Ltd, 2013). The BN software, augmented with the abstraction operations, would 
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guide the user through BN development by showing the impacts of compatible 
abstractions and presenting the approximations resulting from incompatible 
abstractions. Moreover, it would be beneficial to evaluate practical impacts of our 
method to BN development. 
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Evidence behind Clinical 
Bayesian Networks 
Clinicians may reject a prognostic model if they are not convinced that the model’s 
performance, for their patients, will be similar to its published performance in 
validation studies (Moons et al., 2009a; Wyatt and Altman, 1995). It may be difficult 
to evaluate the prospective performance of a model in clinical practice if the 
reasoning mechanism and clinical evidence behind the model is not completely 
understood (Wyatt and Altman, 1995). The graphical structure of a BN is well suited 
for representing causal and associational reasoning between a large number of 
variables. However, the current representation of BNs is not descriptive enough to 
show the details of clinical evidence behind a BN. In many clinical BNs, the names 
of variables are often short and ambiguous, the relations modelled by edges are not 
explained, and the corresponding evidence from the clinical literature and data is not 
presented. Consequently, domain knowledge and evidence behind these BNs are 
clear only to their developers. 
The clarity of a BN and relevant evidence also enables other domain experts to 
recommend local modifications in the BN when new evidence becomes available. 
For example, a part of the BN may become obsolete due to recent evidence and a 
modification may be required.  Prognostic models are often redesigned from scratch 
in such circumstances by disregarding all information present in the previous model 
(Altman et al., 2009; Moons et al., 2009a; Royston et al., 2009). BNs allow local 
modifications as their parameters can be defined locally, and their graphical structure 
can be built consistent with clinical evidence. However, evidence relevant to all parts 
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of a BN, including relations, variables, and a group of variables (BN fragments), 
must be defined in order to identify and refine the parts with obsolete evidence. 
In this chapter, we present an evidence framework for representing the evidence 
behind clinical BNs. Our framework is composed of two elements: an ontology for 
organising evidence, and a browser for presenting evidence. The main aim of the 
evidence framework is to organise and present evidence that supports or conflicts 
with a clinical BN. We use the ATC BN (see Section 5.3.3) as a case study to 
illustrate the evidence framework. Evidence behind ATC BN can be browsed online 
at the ATC BN website (ATCBN, 2013). 
8.1 Challenges of the Evidence Framework 
The challenges of describing the evidence behind a BN can be summarised in two 
points: 
1. Organising Evidence: The evidence about a BN must be detailed enough to 
prevent ambiguities about its relevance, source and type. First of all, the 
evidence can be relevant to different parts of the BN: some can be relevant to 
a particular variable or relation whereas others can be relevant to an entire 
group of variables. The evidence framework must be able to store evidence 
relevant to the fragments of the BN as well as to the individual variables and 
relations. Secondly, there may be different items of evidence. A part of the 
BN may have evidence from the data, and another part may be based on 
clinical publications. Thirdly, conflicting evidence must also be taken into 
account in order to have a comprehensive description of the evidence. The 
evidence framework must contain all of the relevant evidence even if it  
belongs to something not modelled in the BN. The type of the evidence must 
be recorded to show whether the evidence supports or conflicts with the BN 
model. Finally, the meaning of the variables must also be clear. Variable 
names in a BN structure are often short and may be ambiguous (see Section 
3.3); more detailed information must be given in the evidence framework.  
2. Presenting Evidence: Another challenge is to present evidence in a clear and 
simple way without losing any important information. Although the evidence 
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framework may require a complicated structure to store the evidence data, 
users do not necessarily need to see the technical details of the structure when 
browsing the evidence. Evidence should be presented in a user-friendly 
environment that is compatible with commonly available software such as 
web page browsers.  
The first challenge shows that BNs require a supporting evidence structure that is 
able to cope with the complications of organising and recording evidence with 
adequate amount of detail. The evidence structure must be flexible to deal with 
changing requirements in different applications. For example, some clinical models 
may require additional types of evidence to be defined, and the evidence structure 
must be flexible in addressing such requirements. Moreover, the evidence structure 
must be able to answer the queries about its completeness by showing the parts of 
the BN that lacks evidence.  
The second challenge can be overcome by an evidence browser that is automatically 
generated from the evidence structure. The evidence browser aims to present the 
evidence in a clear and understandable way without necessarily showing the details 
of the structure that organises evidence data. 
In order to overcome these challenges, we propose an evidence framework that is 
composed of two elements: a structure for organising the evidence data and a web 
page for browsing the evidence. We use ontology technology to build the structure 
and organise the data about evidence. The web page is automatically generated from 
the ontology. In the following sections, we describe the structure (Section 8.2) and 
browser (Section8.3) parts of the evidence framework. 
8.2 Evidence Structure 
We use the web ontology language (OWL) (W3C, 2013) framework for modelling 
and organising the evidence data, and the Protégé software (version 4.3.0) 
(Knublauch et al., 2004) to create and populate the OWL ontologies. In Section 
8.2.1, we give a brief introduction to ontologies. We present the structure of the 
evidence ontology in Section 8.2.2, illustrate how data is entered to this structure in 
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Section 8.2.3, and show queries for assessing the completeness of evidence in 
Section 8.2.4. 
8.2.1 Introduction to Ontologies 
Ontology is a formal definition of the relations among terms (Berners-Lee et al., 
2001), and OWL is a flexible language for building ontologies (W3C, 2013). Our 
primary reason for storing the evidence data in an ontology is their flexibility in 
building, modifying and querying a data structure. Our aim is to develop a general 
structure for recording and presenting evidence for BNs in medical domain but we 
do not assume that our evidence structure will satisfy the needs in all other BN 
applications. For example, some clinical applications may require additional types of 
evidence to be defined in the ontology structure, and ontologies offer a simple and 
robust framework for making such changes. Making similar modifications in 
relational databases is, however, difficult and time-consuming due to their highly 
structured schema and query system. 
An OWL ontology is composed of individuals, classes, object properties and data 
properties. Individuals represent objects in the domain, and classes represent the sets 
that individuals belong. Properties define the relations between individuals: object 
properties define the relation between two objects, and data properties define the 
relation between an object and a data value. In the remainder of this chapter, 
individuals are represented by purple diamonds, classes are represented by yellow 
circles, object properties are represented blue squares, and data properties are 
represented by green squares as shown in Figure 8.1. 
 
Figure 8.1 Representation of Ontology Elements 
160 
 
An example of a relation between two individuals is shown in Figure 8.2. In this 
example, John and Anna are individuals, and hasMother is an object property that 
defines the relation between these individuals. 
 
Figure 8.2 Individuals and Properties 
 
Figure 8.3 Classes and Individuals 
Members of a class can be defined by the user or it can be inferred from classes and 
property characteristics. For example, we can either manually define that Anna is a 
member of the Mother class (see Figure 8.3) or we can infer this from the 
characteristics of the hasMother property. Let the hasMother property have 3 
characteristics: 
1. The inverse of the hasMother property is the hasChild property 
2. The domain of the hasMother property is the Child class 
3. The range of the hasMother property is the Mother class 
Based on each of these characteristics, we are able to infer that (see Figure 8.4): 
1. Anna hasChild John – inferred from the inverse of hasMother 
2. Anna belongs to the Mother class – inferred from the domain of hasMother 
3. John belongs to the Child class – inferred from the range of hasMother 
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Figure 8.4 Inferred Classes and Properties 
Classes can be defined in multiple levels of hierarchy. For example, we can define 
that the Mother class is a subclass of the Woman class, and that the Woman class is a 
subclass of the Human class (see Figure 8.5). In this case, all individuals that are 
members of the Mother class are also members of the Woman and Human classes. 
An individual can belong to multiple classes with different hierarchies unless the 
classes are explicitly defined as disjoint. For example, Anna can belong to both 
Mother and Child classes but she cannot belong to both Human and Item classes as 
these are disjoint classes. 
 
Figure 8.5 Class Hierarchy 
Data properties describe the relation between an individual and a data value. Figure 
8.6 shows the relation between an individual and a string type of data value using a 
data property.   
162 
 
 
Figure 8.6 Data Property Example 
OWL contains many other features for defining properties and objects. A thorough 
description of OWL is, however, beyond the scope of this chapter, and the readers 
are referred to Allemang and Hendler (2011), and Segaran et al. (2009) for an 
introduction to ontology modelling and OWL. In the following section, we describe 
the classes, and properties of the evidence ontology. 
8.2.2 Evidence Ontology 
Our evidence structure is based on three main classes: BN element, evidence and 
source (see Figure 8.7). The BN element class contains the nodes, edges and BN 
fragments that form a BN. Each node in a BN represents a variable, and each edge 
represents a relation. We use the terms node and variable, and edge and relation 
interchangeably throughout this chapter. The evidence class defines the type and 
description of evidence. The source class describes the source of evidence; which 
can be a dataset, a domain expert or a scientific publication. Individuals of the 
evidence class may have multiple sources, for example, a relation in the BN structure 
may have evidence from several publications.  
 
Figure 8.7 Class Hierarchy of the Evidence Ontology 
In the remainder of this section, we describe the subclasses and properties related to 
the BN element, evidence and source classes. 
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8.2.2.1 BN element 
The BN element class has 3 subclasses: fragment, node and edge. This section 
describes the object and data properties related to each of these subclasses. 
Fragment 
A BN is composed of variables and edges, and it is necessary to clarify the meaning 
of these in order to describe knowledge behind the BN model. Several studies used 
BN substructures to assist BN development and to give a more concise summary of a 
BN model (see Section 2.6.1). A BN substructure represents a part of the BN that 
describes an important concept in its domain. Our ontology defines BN substructures 
in a general way as ‘BN fragments’. Any group of variables can be defined as a BN 
fragment in the evidence ontology. The complete structure of the BN is always 
defined as a BN fragment containing all of the other fragments and nodes in the BN. 
The information about a BN fragment is stored within the fragment class. Figure 8.8 
shows the object and data properties related to this class. A BN fragment may 
contain nodes and other – smaller – BN fragments. Members of a fragment can 
overlap with other fragments. Description of clinical knowledge modelled in the BN 
fragment, and evidence relevant to the entire BN fragment can be stored in the 
evidence ontology. 
 
Figure 8.8 Object and Data Properties related to Fragment Class 
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Subclasses of the fragment class can be defined if certain type of BN fragments, such 
as idioms (Neil et al., 2000) and object oriented BNs (Koller and Pfeffer, 1997), are 
used repetitively in the BN. In the ATC BN, we use measurement idiom structure 
multiple times to define parts of the BN structure (see Section 5.3.3). In order to 
distinguish the measurement idioms from other BN fragments in the evidence 
framework, we could add a class called ‘MeasurementIdiom’ as a subclass of the 
fragment class (see Figure 8.9).  
 
Figure 8.9 Subclasses of Fragment Class 
Node 
Individuals of the node class represent the variables in a BN. Knowledge modelled in 
a BN cannot be understood without having a clear understanding of the meaning of 
its variables. Variable names are often short, consisting of a few letters, therefore 
they may not clearly describe the concept that is represented by the variable (see 
Section 3.3). For example, a BN variable named ‘Heart Rate’ may be sufficient to 
show that this variable represents a measurement of the patient’s heart rate; but this 
name may not be descriptive enough if the time and location of this measurement is 
important for the use of the BN. In order to avoid such ambiguities, the evidence 
ontology stores a description of each BN variable (see Figure 8.10). 
The variables in a BN can be discrete or continuous. For discrete variables, we 
define the names of the states in the evidence ontology. Continuous variables have 
infinitely many states therefore we define the upper and lower bounds of the 
distribution. 
Since the edges of a BN are directed, we have an object property for both the edges 
that are directed to the variable (hasIncommingEdge) and the edges that are directed 
away from the variable (hasOutgoingEdge) (see Figure 8.10). The hasParent and 
hasChild properties show the parent – child relations between the BN variables. 
These 4 properties about edge directions and parent – child relations are inferred 
from the object properties related to the edge class described in the remainder of this 
section. The within property shows the BN fragments that contain the variable.  
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Figure 8.10 Object and Data Properties related to Node Class 
Different sources can be used to define the parameters of different BN variables as 
BN parameters can be learnt locally. For example, we can use data to define the 
parameters of some variables, and use expert knowledge to elicit the parameters of 
others. For each variable, we record the source used for defining its parameters (see 
Figure 8.11). 
Some variables may not be modelled in the BN even when evidence exists that they 
are relevant to the problem domain. For example, the knowledge engineers and 
domain experts may choose to exclude some variables to keep the BN simple. The 
evidence about the excluded variables and relations is recorded to have a 
comprehensive evidence base for the BN (see Figure 8.11).  
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Figure 8.11 Object Properties related to Node, Evidence and Source Classes 
Edge 
Edges represent the relations in a BN. BNs are directed acyclic graphs, therefore 
only one directed edge can exist between two variables. The variables that an edge 
connects are defined with two object properties in the evidence ontology: pointsTo 
shows the variable that the edge is directed to, and comesFrom shows the variable 
that the edge is directed away.   
 
Figure 8.12 Object Properties related to Edge Class 
Defining the direction of edges using pointsTo and comesFrom properties is 
sufficient for the ontology to infer the other object properties about the relation 
between two variables. For example, in order to define the directed relation A → B 
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between two variables A and B, we define an individual for the edge class, e.g. 
Edge1, and we define that Edge1 pointsTo B and comesFrom A (see Figure 8.13).  
The evidence ontology is able to infer the other object properties related to the 
relation between A and B (shown by dashed arrows in Figure 8.13) by using the 
following characteristics: 
1. The inverse of the comesFrom property is the hasOutgoingEdge property. By 
using the inverse property, the ontology can infer that A hasOutgoingEdge 
Edge1 when it is defined that Edge1 comesFrom A. Similarly, the inverse of 
the pointsTo property is the hasIncomingEdge property. 
2. The hasParent property can be inferred from the combination of the 
hasIncomingEdge and comesFrom properties. For example, if the variable B 
hasIncomingEdge Edge1 and Edge1 comesFrom the variable A, then the 
ontology can infer that the variable B hasParent A. Similarly, the ontology 
can infer the hasChild property from the combination of the 
hasOutgoingEdge and pointsTo properties.   
 
Figure 8.13 𝑨 → 𝑩 modelled in Evidence Ontology 
Each relation modelled in a BN should have supporting evidence in an evidence-
based BN (see Figure 8.12). When the BN structure is built with domain experts, 
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evidence for the relations often comes from expert knowledge or scientific 
publications. The justification for including the relation is recorded as the statement 
of evidence. In purely data-driven BNs, the evidence comes from the dataset only. It 
may be difficult to describe knowledge supporting the relations in data-driven 
models apart from saying that the variables were correlated in the data (see Section 
3.2 and 3.3). Conflicting evidence may also exist for a relation in the BN. For 
example, one publication may claim that two variables are independent, whereas 
another publication may find correlation between those variables. If these variables 
are connected by an edge in the BN structure, in accordance with the latter 
publication, the conflicting evidence from the former publication must also be 
recorded in order to have a comprehensive evidence base.  
The meaning of a modelled relation is shown by its supporting evidence. In order to 
include an edge in a BN model, the BN developer must have evidence that the 
relation exist between two variables. Therefore, all edges in a BN must have 
supporting evidence in an evidence-based model, which may come from domain 
experts, publications or data. An edge does not require a separate description like a 
variable since evidence associated with the edge describes its meaning. 
8.2.2.2 Evidence 
Figure 8.14 shows the properties related to the evidence class. The evidence class 
organises the data about the type and statement of evidence related to the BN 
elements. There are 3 types of evidence in our ontology: 
1. Supporting Evidence: This class contains the statement of evidence that 
supports the elements of a BN model. 
2. Conflicting Evidence: Evidence in this class conflicts with the BN model. 
For example, two variables that are found to be independent in a scientific 
study may not be modelled as independent in the BN model. In this case, the 
results of the scientific study must be recorded as conflicting evidence in the 
evidence ontology.  Conflicting expert opinions may also be recorded as 
conflicting evidence. 
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3. Excluded BN Element: Evidence about relevant variables or relations that 
are not included in the BN model is recorded within this class. The statement 
of evidence relevant to a excluded BN element and the justification for not 
including the element should be recorded. The excluded BN element class 
has 3 subclasses related to the type of the BN element excluded. The 
excluded child (parent) classes indicate that a variable in the BN may have an 
effect (cause) that is not modelled in the BN. The excluded relation class 
indicates that a direct relation may exist between two variables that are not 
directly linked in the BN.  
Each type of evidence is a subclass of the evidence class. The subclasses can be 
inferred from the type of object property that refers to the evidence. For example, 
any evidence recorded by the hasSupportingEvidence property is inferred as a 
member of the SupportingEvidence class. Similarly, any evidence that is recorded by 
the hasConflictingEvidence or hasExcludedBNElement properties are inferred as the 
members of the ConflictingEvidence or ExludedBNElement classes respectively. 
 
Figure 8.14 Object and Data Properties related to Evidence Class 
A BN element can have multiple items of evidence, and an item of evidence can 
have multiple sources. For example, two publications that are stating similar results 
about a relation in the BN can be recorded as a single evidence item with two 
sources (publications). Two publications that are discussing different aspects of a 
relation can be recorded as two separate items of evidence with one source each. 
More examples about recording evidence and source are shown in Section 8.2.3. The 
following section describes the ontology class about the source of evidence.  
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8.2.2.3 Source 
The source class contains information about the publication, expert opinion or data 
providing evidence. The subclasses, object and data properties of the source class are 
shown in Figure 8.15. The source class has three subclasses as shown below: 
1. Publication: The members of this class are scientific publications. 
Information for referring these publications, such as digital object identifier 
(DOI) and PubMed identification number (PMID), can be stored in this class. 
A PMID is a unique identifier assigned that makes it convenient to find the 
publications in the PubMed database. 
2. Expert: The domain experts’ credentials and contact information can be 
recorded in this class. 
3. Data: Evidence supporting or conflicting with model may come from data. 
The individuals of this class contain information about the details of the 
dataset including the sample size and the method of collecting the data. 
 
Figure 8.15 Object and Data Properties related to Source Class 
8.2.3 Entering Data to Evidence Ontology 
In this section, we illustrate how data is entered to the evidence ontology by using a 
simplified version of the ATC BN that has 3 variables and 2 edges (see Figure 8.16).   
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Figure 8.16 Simplified ATC BN 
8.2.3.1 Fragment 
The simplified ATC BN in Figure 8.16 contains a BN fragment called shock 
measurements. The state of hypoperfusion variable cannot be directly observed in 
clinical practice; it is estimated by several tests and observations including the lactate 
and pH levels in blood (see Chapter 5 for the description of the ATC BN). The shock 
measurements fragment models the relation between hypoperfusion and its 
measurements.  
Table 8.1 Defining Shock Fragment 
 
Type: 
 
Object Properties: 
 
 
 
 
 Data Properties: 
 
 
Table 8.1 shows the classes, object and data properties related to the shock 
measurements fragment. The structure of the shock measurements fragment is 
modelled using a pre-defined BN structure called a measurement idiom (see Sections 
5.3.3 and 8.2.2).  We use the object property ‘contains’ to show the variables and 
fragments within this fragment, and ‘within’ to show the larger fragments that 
contain this fragment. The entire BN is also defined as a BN fragment 
(SimplifiedATCBN) that contains all of the other variables and fragment in the 
BNElement within SimplifiedATCBN 
contains Hypoperfusion 
contains Lactate 
contains pH 
description “This 
part of the model 
estimates…” 
MeasurementIdiom 
Fragment 
ShockMeasurements 
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evidence ontology. A free-text description of the fragment is recorded using a data 
property.  
8.2.3.2 Variable 
Table 8.2 shows the data related to the Hypoperfusion variable in the evidence 
ontology. This variable is within the Shock fragment, and it has three children: ATC, 
Lactate and pH. The parameters of the variable are learnt from the RLH dataset. The 
description of the variable and the names of its states are recorded by the 
‘description’ and ‘stateName’ data properties. The edges between the Hypoperfusion 
variable and its children are modelled by the ‘hasOutgoingEdge’ object property that 
shows the edges that is directed away from the Hypoperfusion variable. For example, 
‘HypoToLactate’ is a member of the edge class that represents the edge 
Hypoperfusion → Lactate. The evidence supporting the relation between 
Hypoperfusion and Lactate variables is defined under the edge individual. More 
information about the edge class and its individuals are shown in Section 8.2.3.3. 
Table 8.2 Defining Hypoperfusion Variable 
 
Type: 
 
Object Properties: 
 
 
 
 
 Data Properties: 
 
 
Table 8.3 shows the information recorded about the lactate variable. Since lactate is 
a continuous variable, we define its upper and lower bounds instead of state names. 
There is evidence that some factors affecting lactate are not included in this model. 
BNElement within Shock 
hasChild ATC 
hasChild Lactate 
hasOutgoingEdge HypoToLactate 
hasOutgoingEdge HypoToATC 
description “The degree of 
inadequate oxygen…” 
stateName “None” 
stateName “Compensated” 
stateName “Uncompensated” 
Variable 
parameterisedFrom RLHDataset 
Hypoperfusion 
hasChild pH 
hasOutgoingEdge HypoToPH 
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This information is recorded in an item of evidence named ‘LactateExParEv1’ 
belonging to the evidence class (see Section 8.2.3.4). 
Table 8.3 Defining Lactate Variable 
 
Type: 
 
Object Properties: 
 
 
 
 
Data Properties: 
 
 
8.2.3.3 Edge 
HypoToLactate represents the edge Hypoperfusion → Lactate in the simplified ATC 
BN (see Table 8.4). The variables connected by this edge are modelled with 
‘comesFrom’ and ‘pointsTo’ properties. There are two items of evidence supporting 
the modelling of this edge. 
Table 8.4 Defining the Hypoperfusion → Lactate Edge 
 
Type: 
 
Object Properties: 
 
 
 
 
8.2.3.4 Evidence 
Two publications indicated that lactate is an important marker of the degree of 
hypoperfusion. We recorded this as an item of evidence supporting the edge 
Hypoperfusion → Lactate in the ATC BN (see Table 8.5). The details of the 
publications are described under the source class in Section 8.2.3.5. 
Lactate 
BNElement within Shock 
hasParent Hypoperfusion 
hasIncommingEdge HypoToLactate 
hasExcludedParent LactateExParEv1 
description “The amount of 
lactate in…” 
hasLowerBound 0 
hasUpperBound 100 
Variable 
parameterisedFrom RLHDataset 
BNElement comesFrom Hypoperfusion 
pointsTo Lactate 
hasSupportingEvidence LactateSuppEv2 
hasSupportingEvidence LactateSuppEv1 
Edge 
HypoToLactate 
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Table 8.5 Supporting Evidence 1 
 
Type: 
 
Object Properties: 
 
 
Data Properties: 
 
Hypoperfusion and lactate levels were highly correlated in our dataset. We recorded 
this correlation as a second item of evidence supporting the edge 
Hypoperfusion →  Lactate (see Table 8.6). 
Table 8.6 Supporting Evidence 2 
 
Type: 
 
Object Properties: 
 
Data Properties: 
 
 
One publication indicated that several factors, including excessive alcohol use, can 
affect lactate levels independent from the effects of hypoperfusion but these factors 
were not included in the ATC BN. We recorded this as evidence for a parent variable 
for Hypoperfusion that is not included in the BN (see Table 8.7). 
Table 8.7 Evidence about Excluded Parent 
 
Type: 
 
Object Properties: 
 
 
Data Properties: 
 
 
Evidence hasSource RixenEtAl2005 
hasSource VanDrommeEtAl2010 
statement “Lactate is 
produced during anaerobic…” 
SupportingEvidence 
LactateSuppEv1 
LactateSuppEv2 
LactateExParEv1 
Evidence hasSource RixenEtAl2005 
statement “…excessive 
alcohol use can increase 
the lactate levels …” 
ExcludedBNElement 
ExcludedParent 
Evidence hasSource RLHDataset 
statement “The likelihood 
of hypoperfusion increases 
with increasing lactate 
values in the RLH dataset…” 
SupportingEvidence 
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8.2.3.5 Source 
Table 8.8 shows the details of the publication related to the items of evidence in 
Table 8.5 and Table 8.7. The publication is recorded as a member of the source class 
with its referencing details and PMID. 
Table 8.8 Publication Source 
 
Type: 
 
Data Properties: 
 
 
Table 8.9 shows the details of the database related to the item of evidence in Table 
8.6. We recorded the description, sample size and method of collecting the dataset.  
Table 8.9 Data Source 
 
Type: 
 
Data Properties: 
 
 
 
8.2.4 Completeness Queries using SPARQL Query 
Language 
The parts of a clinical BN that lacks evidence may be interesting to clinicians who 
review the BN. Therefore, an efficient way of assessing the completeness of 
evidence can be a useful feature for the evidence framework. SPARQL is a query 
language that can retrieve the data stored in an OWL ontology. In this section, we 
show several SPARQL queries to find the BN elements that have or lack evidence. It 
RixenEtAl2005 
Source 
Publication 
hasPMID 16277731 
hasRefDetails “D. Rixen and 
J. H. Siegel, Critical Care, 
vol. 9, no. 5, p. 441, 2005  
…” 
RLHDataset 
Source 
Data 
datasetInfo “A dataset of 
600 patients who were 
treated at the…” 
dataCollection “Prospective 
Observational” 
sampleSize 600 
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is beyond the focus of this chapter to give a comprehensive description of SPARQL, 
a thorough introduction is given by Allemang & Hendler (2010). 
The simplest form of query in SPARQL is the SELECT query that extracts the data 
from the ontology and presents them in a table format. SELECT query is followed by 
the WHERE block that limits the query by question pattern. For example, we can get 
a list of the edges that has supporting evidence by: 
SELECT ?x 
 WHERE { ?x a :Edge. 
     ?x :hasSupportingEvidence ?evidence.} 
 
The first line of the WHERE construct above filters out the individuals that are not 
members of the Edge class. The second line filters out the individuals that do not 
have supporting evidence. When we apply this query to the evidence ontology of the 
simplified ATC BN (see Section 8.2.3), we get the following result: 
:HypoToLactate 
:HypoToLactate 
Note that we get duplicate results since the edge Hypoperfusion ⟶ Lactate (named 
HypoToLactate in the ontology) has two items of supporting evidence 
(LactateSuppEv1 and LactateSuppEv2). We can use the DISTINCT keyword to filter 
out the duplicate results:   
SELECT DISTINCT ?x 
 WHERE { ?x a :Edge. 
     ?x :hasSupportingEvidence ?evidence.} 
We get the following results after adding the DISTINCT keyword:  
:HypoToLactate 
The BN elements without evidence can be retrieved by using the MINUS keyword. 
The UNSAID keyword can be used as an alternative to MINUS keyword in SPARQL 
1.1. The MINUS keyword is used within the WHERE construct. 
SELECT DISTINCT ?x 
 WHERE { ?x a :Edge. 
  MINUS { ?x :hasSupportingEvidence ?evidence . } } 
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The SPARQL query above can be used to find the edges that do not have supporting 
evidence. The first line of the WHERE construct extracts all of the individuals that 
are edges. The second line filters out the individuals that have supporting evidence. 
For the simplified ATC BN example, it gives the following result: 
:HypoToPH 
:HypoToATC 
The ASK query is another kind of SPARQL query that can answer Yes/No questions 
in the ontology. The answer for an ASK query is either ‘True’ or ‘False’.  For 
example, we can ask whether the Hypoperfusion ⟶ ATC edge has supporting 
evidence in the simplified ATC BN by: 
ASK WHERE { atcbn:HypoToATC atcbn:hasSupportingEvidence 
?evidence} 
Since we haven’t defined any evidence for this edge in Section 8.2.3, we get the 
following answer: 
FALSE 
8.3 Browsing Evidence 
The evidence ontology is well suited for organising and querying evidence but it is 
not a convenient tool to browse evidence especially if the user is not proficient with 
the ontology language. Therefore, our ontology framework prepares a web page 
(HTML files) for browsing evidence after the data is entered to the evidence 
ontology. The web page is automatically generated from the ontology (a Protégé 
OWL file)2. 
The web page generator is not specific to a particular BN; it can generate the HTML 
files for browsing any BN model given that evidence is entered to Protégé OWL 
using the structure presented in Section 8.2.2. In the remainder of this section, we 
use the complete version of the ATC BN (see Section 5.3.3) as a case study to 
                                               
2 An early prototype of the web page generator was prepared as a part of an undergraduate graduate 
project at Queen Mary, University of London. The author continued the development of the browser 
and completed the current version. 
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demonstrate a web page generated from the evidence ontology. We call this web 
page the evidence browser for the ATC BN (see ATCBN, 2013).  
The ATC BN has a total of 7 fragments (see Figure 8.17): 
 The entire BN structure (‘ATCBN’) 
 The mortality, injury, coagulopathy and shock fragments that are described in 
Section 5.3.3 
 Two measurement idioms that models the relation between the latent 
variables and their measurements (‘ShockMeasurements’ and 
‘ATCMeasurements’). These measurement idioms fragments exist within the 
shock and coagulopathy fragments. 
 
Figure 8.17 Shock Fragment shown in the Evidence Browser 
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Figure 8.17 is the presentation of the Shock fragment in the evidence browser. The 
browser shows a description of the fragment and links to other variables and 
fragments that are members of this fragment. 
 
Figure 8.18 Hypoperfusion variable shown in the evidence browser 
If the user clicks to the Hypoperfusion variable in Figure 8.17, the evidence browser 
shows the details of this variable as in Figure 8.18. The browser shows the 
description of the variable, type of its probability distribution, list of its states, and 
relevant evidence. In this example, there are two items of evidence relevant to the 
hypoperfusion variable. The first item, named ‘Hypoperfusion States’, shows 
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evidence for selecting the states of this variable. The second item, named 
‘Hypoperfusion ↛ Respiratory Rate’, shows that the degree of Hypoperfusion can be 
also be measured with other markers that are not included in the ATC BN. These 
markers could be added as a child of the hypoperfusion variable. The reason for not 
adding these variables is also described.  
The variables that are directly related to the hypoperfusion variable, as its child or 
parent, are also listed in Figure 8.18. Each variable in this list is linked to a page 
showing the evidence about the relation. For example, when the user clicks to ATC 
which is in the relations section in Figure 8.18, the evidence related to the 
Hypoperfusion ⟶  ATC relation is shown (see Figure 8.19). 
 
Figure 8.19 Relation between Hypoperfusion and ATC shown in the Evidence Browser 
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There are 4 items of evidence relevant to the relation Hypoperfusion ⟶  ATC (see 
Figure 8.19). The user can click any of the references in Figure 8.19 to examine the 
source of the evidence statements.  For example, if the user clicks to 
BrohiEtAl2007a, the browser shows the details of this publication by connecting to 
the PubMed database (see Figure 8.20). The browser uses the PMID stored in our 
evidence ontology to find the publication in the PubMed database. If the source is a 
domain expert or a dataset, the browser shows the related information such as the 
institution and credentials of the expert or the description of the dataset. 
 
Figure 8.20 A Referred Publication shown in the Evidence Browser 
8.4 Related Work 
Several other frameworks have been proposed to describe knowledge behind a BN 
model. Antal et al. (2001) propose annotated BNs that describe the background 
knowledge for each node, edge and state in a BN by annotations. This representation 
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was primarily used for automated learning of BNs from the textual information in 
medical literature (Antal et al., 2004). 
Helsper and van Der Gaag (2007) use ontologies to clarify the elicited knowledge 
used for building a BN. They use a semi-formal ontology language that includes 
tables, figures and natural language descriptions. Their ontology documents expert 
knowledge from static, dynamic and definitional perspectives. Causal and temporal 
relations are described using Rieger and Grinberg's representation (1977). Helsper 
and van der Gaag (2002) also propose a methodology to derive a BN structure from 
this ontology however the method was not used to develop the model in their case-
study since the ontology is prepared retrospectively from an existing BN. Van der 
Gaag and Tabachneck-Schijf (2010) extend Helsper and van Der Gaag's ontology 
framework (2007) for describing BNs that are built for similar tasks. 
While both Helsper and van Der Gaag's ontologies (2007) and Antal et al.'s 
annotated BNs (2001) aims to clarify knowledge behind BNs but these frameworks 
do not aim to show the link between the model and evidence. Helsper and van Der 
Gaag (2007) focus on describing knowledge elicited from experts in more detail. For 
example, their ontology has numerous types of causal and temporal relations that can 
distinguish between continuous and one-shot causal events. However, Helsper and 
van der Gaag do not show the link between the model and evidence. Knowledge for 
their ontology is elicited from experts. Evidence from publications or conflicting 
expert opinions is not shown. Annotated BN (Antal et al. 2004; 2001) lacks the 
structure for recording information regarding type and source of evidence which is a 
crucial feature for the clarity of an evidence-base.  
Several studies have developed methodologies to use existing ontologies for 
automated construction of BNs. Devitt et al. (2006) propose a methodology for 
automated construction of a BN from ontologies in telecommunication networks 
domain. In this method, an ontology specific to the BN is derived from a more 
general ontology, and BN is automatically generated from the specific ontology. 
Similarly, Sadeghi et al. (2005) build an ontology more specific for the problem 
domain using the concepts from the unified medical language system (UMLS) 
(Bodenreider, 2004) and they learn a BN is based on this specific ontology. UMLS is 
a complicated medical terminology system but it lacks information about the causal 
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relations between clinical factors. Ishak et al. (2011) presents a set of rules that 
transform an ontology into a preliminary OOBN structure. Bucci et al. (2011) uses 
ontologies to build BNs on a predefined hierarchical structure in medical diagnosis 
domain. Fenz (2012) uses a semi-automated methodology to generate BNs from 
ontologies. In their methodology, the experts review the ontology and identify the 
nodes and states of the BN based on the classes and individuals in the ontology. 
Afterwards they identify the edges in the BN based on the object properties in the 
ontology. Fenz proposes a technique that uses weights defined in the ontology to 
parameterise NPTs in a similar approach to the parameterisation of ranked nodes 
(Fenton et al., 2007). An evidence-based BN requires justification for the relations 
modelled in the BN. Each edge in the BN should be supported with clinical studies, 
expert opinion or data. Many clinical ontologies are defined as clinical terminologies 
therefore they do not contain detailed information about causal and associational 
relations, and medical publications and datasets relevant to those relations. 
Therefore, the reviewed studies about automated BN construction from ontologies 
are not aligned with the aims of our evidence framework. 
Another active field of research focuses on extending ontologies with BNs to 
represent uncertain knowledge. Ding and Peng (2004) propose additional mark-ups 
to OWL to represent probabilistic information. They present a set of rules that 
transforms ontology into a BN. Similarly, Yang and Calmet (2005) present a BN 
extension to OWL that is also able to cope with multinomial variables. Costa et al. 
(2008) extend OWL to express uncertainty using multi entity BNs (Laskey and 
Costa, 2005) which is a combination of first-order logic and Bayesian reasoning. 
Zheng et al. (2008) propose mark-ups to transform an ontology representing clinical 
concepts into a BN. The aims of these studies are also different from the aims of our 
evidence framework. These studies extend ontology languages, such as OWL, so that 
the ontologies are able to cope with uncertainties about class membership, object 
properties and their other features. The evidence framework uses ontology as a 
complementary tool to clarify knowledge and evidence behind a decision support 
model, and it does not require the ontology to deal with uncertainty.  
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8.5 Conclusion 
This chapter proposed an evidence framework that complements clinical BNs by 
representing relevant knowledge and clinical evidence. The proposed framework 
consists of two parts: an ontology that stores evidence relevant to different elements 
of a BN, and a browser that presents the BN and evidence to clinicians. The ATC 
BN is used as a case-study to illustrate the evidence framework.  
Our evidence framework is able to organise and present the evidence in more detail 
than it is possible with the existing BN representation or previously proposed 
annotation techniques. The evidence framework can store various types of evidence 
including evidence supporting or conflicting with the BN, as well as evidence 
justifying the exclusion of variables and relations from the BN. Although the 
evidence is stored within a complicated ontology structure, users can browse the 
evidence in a web page that is automatically generated from the ontology, without 
dealing with any of the underlying technical details. 
The next step is to run a validation session with a group of clinicians to evaluate 
whether browsing evidence can improve their understanding of a BN model and its 
applicability in clinical practice. The evidence framework can also be improved to 
receive comments and suggestions from clinicians browsing the BN. Clinicians from 
different institutions can criticise evidence behind the BN and suggest modifications 
when new evidence becomes available.  
The evidence ontology could be proposed as a standardised format for recording BN 
models. This would require the ontology to store information about NPTs. Another 
option could be to extend the currently available XML formats for representing BNs 
(Cozman, 1998) to include information about evidence using the structure presented 
in this chapter. The evidence framework could also be extended to match its data 
with the definitions from medical terminology systems such as UMLS and 
SNOMED (Bodenreider, 2004; Spackman et al., 1997). This would make it possible 
to have a universally consistent terminology for the evidence recorded in the 
framework. However, synchronising the evidence framework with the terminology 
systems is challenging due to the complexity of these systems. 
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Finally, the evidence framework could be integrated with the abstraction 
methodology presented in Chapter 7. Such integration would enable the abstraction 
methodology to show how each simplification in the BN structure relates to 
underlying evidence supporting the model.  
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Summary and Future Directions 
This chapter summarises the contributions of the thesis in three topics: combining 
evidence, assisting BN development and understanding evidence. The chapter also 
discusses the future directions of research.   
9.1 Combining Evidence 
One of the challenges of applying EBM for individual patients is to combine the 
relevant evidence about different aspects of the treatment from multiple sources. In 
this thesis, we proposed methodologies to develop BN models that combine 
evidence from previous publications, data and expert opinion based on clinical 
knowledge about the domain. The proposed methodologies contribute to EBM as 
they can provide decision support by combining evidence from multiple sources 
based on clinical knowledge. We claim novelty for the methodologies and BN 
models presented in Chapters 5 – 8. 
Chapter 5 proposed a methodology for building decision support models that are 
consistent with clinical knowledge without being limited by the availability of data. 
The proposed methodology systematically used a combination of knowledge and 
data to develop and refine BN models. In this methodology, domain experts define 
the BN structure that explicitly models the important clinical variables even when 
they are not a part of the available data. The expert knowledge and data is used at 
two different stages: 1) to understand and model the behaviour of the latent 
variables, 2) to identify the potential improvements and refine the BN accordingly. 
We demonstrated the success of this methodology by using it for the development of 
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the ATC BN, which accurately predicts ATC, a fatal physiological disorder, in early 
stages of trauma care.  
The challenges that Chapter 5 address are not specific to the trauma case study. In 
order to build a BN model that is consistent with domain knowledge, variables that 
are important for expressing causal knowledge must be included in the model 
whether or not they are a part of the available data. Our methodology allows 
inclusion of these variables into decision support as long as domain knowledge is 
provided by experts. Moreover, we proposed a systematic way of identifying the 
potential model improvements. Our approach can be applied to other domains where 
all important factors cannot be directly observed but domain knowledge and some 
data is available. 
Chapter 6 proposed a methodology for building decision support models based on 
the evidence provided by meta-analyses. This methodology combines the evidence 
from a meta-analysis with expert knowledge and data to define the structure and 
parameters of a BN. This chapter also proposed a novel auxiliary Bayesian 
parameter learning model that combines data with the probabilities, from a meta-
analysis, that are conditioned on fewer variables than the parameter being learned. 
We demonstrate the success of this methodology by applying it to a BN for 
predicting the short-term outcomes of a traumatic lower extremity with vascular 
injury. The results of our methodology are better than the results of purely data-
based structure and parameter learning approaches, and an existing decision support 
model. 
Both Chapters 5 and 6 proposed methodologies to combine the evidence from 
different sources for providing decision support. Yet, these methodologies address 
different aspects of this problem. Chapter 5 combined expert opinion and data for 
discovering knowledge about important variables that cannot be directly observed. 
Chapter 6 addressed the case where the data for some combinations of factors, in this 
case injuries, were small and inadequate to build a decision support model. This 
chapter combined evidence from systematic reviews and meta-analysis with data for 
these rare combinations. The methodologies proposed in Chapters 5 and 6 can be 
used together when, for example, a decision problem has both latent variables and 
inadequate data for some combinations of factors. The case-study in Chapter 6 
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contained several latent variables that were modelled by using ranked nodes. These 
latent variables could also be modelled with the methodology proposed in Chapter 5 
instead of ranked nodes.  
9.2 Assisting BN Development 
Chapter 7 proposed a knowledge engineering methodology of simplifying a BN 
structure without losing the link to clinical knowledge supporting the BN structure. 
This chapter presented a sufficient set of operations that simplify a BN by merging 
or removing nodes, removing edges and collapsing states. Our methodology shows 
how each abstraction operation changes knowledge encoded in the BN. This chapter 
also proposed a graphical notation that shows the link between the initial and 
abstracted models by capturing the sequence and type of the abstraction operations 
applied. The proposed knowledge engineering problems addresses the problems of 
making ad-hoc simplifications in the BN structure without considering their effects 
to the BN’s knowledge-base.  
9.3 Understanding Evidence 
Chapter 8 proposed a framework to organise and present evidence behind clinical 
BNs. The evidence framework can represent evidence related to different variables, 
relations and fragments of a BN. It also provides a detailed description of the BN 
elements and evidence to clarify the BN for other clinicians. The evidence 
framework is composed of an ontology that organises evidence, and a browser that 
presents evidence without showing the technical details of the ontology. The 
evidence framework is able to represent evidence in a more detailed and structured 
way than it is possible with the structure of a BN or with making annotations on the 
structure. 
Both Chapters 7 and 8 aims to clarify knowledge encoded in a BN to its users. The 
methodology proposed in Chapter 7 addresses this issue at the stage of BN 
development. The methodology shows how simplifications of the BN structure affect 
knowledge behind the model. The evidence framework in Chapter 8 focuses on the 
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application stage. The framework aims to clarify knowledge and evidence behind a 
BN model that has already been developed and is being used. The evidence 
framework could complement the abstraction methodology at the development stage 
of a model. For example, while the abstraction methodology shows how encoded 
knowledge changes after a simplification, the evidence framework can enhance this 
by showing evidence relevant to these changes. 
9.4 Future Directions 
This thesis has showed that BNs can contribute to EBM by being used as a 1) 
evidence repository for organising evidence about clinical problems 2) risk 
calculator that quantifies uncertainties and calculates risks based on encoded 
evidence. The potential benefits for EBM can only be utilised if evidence-based BN 
models can be easily built by any BN developer who has access to clinical evidence. 
A BN developer must know the basic properties of BNs and relevant knowledge 
engineering methodologies in order to build a BN that correctly represents clinical 
knowledge and evidence. This thesis has contributed to the latter of these issues by 
proposing knowledge engineering methodologies for developing evidence-based 
BNs. BN developers also require tools that assist them in using correct modelling 
techniques and that provide them with state-of-the-art algorithms. Fenton and Neil’s 
recent BN textbook (2013), and some commercial BN tools including AgenaRisk, 
has addressed some of these issues by focussing on the practical use of BNs and 
handling calculations details by the algorithms implemented in software. However, 
some techniques for BN development cannot be widely used in practical applications 
as they are not implemented in user friendly BN tools, whereas most traditional 
statistical techniques are readily implemented in software that is convenient and 
familiar to the medical community. More BN resources, textbooks and software 
must be targeted to practical applications in order to make BNs a mainstream 
modelling approach in clinical care. Further development of the ideas presented in 
this thesis could contribute to a wider use of BNs in clinical care. 
The abstraction methodology proposed in Chapter 7 requires graphical operations 
with complicated calculations. The use of this methodology in practical applications 
could be improved if it could be implemented in an interactive development 
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environment (IDE) that handles the graphical operations. The IDE could assist a BN 
user in developing knowledge-based models and making abstractions without 
making undesirable changes in knowledge encoded in these models. Moreover, the 
IDE could show the equivalent ways of making an abstraction and recommend the 
option that adds the least amount of parameters to the BN. The result of each 
abstraction could be presented both graphically and textually. The evidence 
framework (see Chapter 8) could be integrated with the abstraction IDE to show 
evidence related to abstracted BN elements. A more systematic approach to 
knowledge-based modelling can be achieved by implementing the abstraction IDE to 
major BN software.   
In Chapters 5 and 6, we proposed methodologies to combine data with knowledge 
and published studies to define the parameters of a BN. Data could also be integrated 
with other sources of evidence to build the BN structure. For example, it could be 
used to identify the parts of the BN that require more attention from the domain 
experts. The domain experts could review the BN structure more systematically by 
focusing on the edges that has weak correlations, and the unconnected variables that 
have strong correlations in the data. Although hybrid structure learning methods that 
combine knowledge with data exists, these methods are aligned for using expert 
knowledge to assist a data-driven learning. However, it could be beneficial for an 
evidence-based BN to use expert knowledge as the primary source of information for 
the BN structure, and the data as a way of reviewing the structure. 
The evidence framework proposed in Chapter 8 could be expanded as a 
communication medium that aims to organise and disseminate state-of-the-art 
clinical evidence. The expanded framework could use a causal BN structure to give 
an overview of evidence about a particular medical topic. For example, a causal 
structure can show an overview of how various background factors, treatments and 
comorbidities are related with a disease. Since clinicians have limited amount of 
time to identify relevant evidence for individual patients, summarising evidence in a 
graphical BN structure could be beneficial for employing EBM in daily clinical 
practice (see Alper et al., 2004; Smith, 2013 for some examples of the challenges of 
identifying relevant evidence in daily practice). The meaning of each factor in the 
causal structure and the link with the publications would be provided by the evidence 
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framework. The expanded framework would also allow experts to suggest 
refinements on the causal structure when new evidence becomes available. 
Consensus methods such as Delphi could be used to update the causal structure when 
multiple expert opinions are available. Since the aim of the causal structure would be 
to give an overview of evidence, it does not have to be a complete – parameterised –
BN. However, organising evidence in causal structures would make it easier to 
derive evidence-based decision support models from them. If causal knowledge 
about a subject is well documented, a BN developer would only need to focus on 
defining the parameters. 
The BNs proposed in this paper provide predictions that are useful for the decision 
makers in trauma care. A useful next step would be to explain the predictions 
generated by the BN based on clinical evidence. For example, instead of plainly 
showing the probability of death, explaining why the model has calculated such 
probability of death can be more helpful to make a better risk assessment. Several 
techniques are available for explaining BN predictions by showing the influences 
and reasoning pathways of observed variables. By coupling the explanation 
techniques with the evidence framework, it could be possible to show how different 
items of evidence support a particular prediction of the model.  
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